<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20230220">5.0</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="01397772">주식회사 큐라클</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">110111-6058485</EXTRACTION>
</SUMMARY>


<BODY>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P></P>
<P USERMARK="F-16">                                    (제 7기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20220101">2022년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2023년  03월  22일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">주식회사 큐라클</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">유재현</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="35">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="35">서울특별시 서초구 효령로 23-1(방배동, 큐라클빌딩)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 070-4193-4067</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.curacle.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 이 사              (성  명) 황 용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 070-4193-4067</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TITLE ATOC="N">목     차</TITLE>
<P></P>
<PGBRK></PGBRK>


<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">큐라클_제7기 사업보고서(2022년 온기)_대표이사 등의 확인,서명.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사 및 신고담당이사 서명</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>
<P></P>
<P USERMARK=" B">가. 연결대상 종속회사 개황</P>
<P>1. 연결대상 종속회사 개황</P>

<TABLE-GROUP ACLASS="SUB_CMPN_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="601" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="1">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">구분</TH>
<TH WIDTH="400" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="4" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">연결대상회사수</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">주요종속회사수</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">기초</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">증가</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">감소</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">상장</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_BASE">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_INC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_DEC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_FIN">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_MSUB">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비상장</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_BASE">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_INC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_DEC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_FIN">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_MSUB">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BASE_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="INC_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="DEC_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="FIN_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MSUB_SUM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-001|ADX-001">※상세 현황은 '상세표-1. 연결대상 종속회사 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>1-1. 연결대상회사의 변동내용</P>

<TABLE-GROUP ACLASS="CONT_CHG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="66"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="335"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">자회사</TH>
<TH WIDTH="344" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사 유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">신규연결</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_RES">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_RES">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">연결제외</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_RES">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_RES">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK=" B">나. 회사의 법적ㆍ상업적 명칭</SPAN>당사의 명칭은 
<SPAN>"주식회사 큐라클"이며, 영문명은 "</SPAN>
<SPAN>C</SPAN>
<SPAN>uracle </SPAN>
<SPAN>C</SPAN>
<SPAN>o., </SPAN>
<SPAN>L</SPAN>
<SPAN>td." 입</SPAN>니다. 
<SPAN USERMARK=" B">다. 설립일자</SPAN>당사의 설립일은 2016
<SPAN>년 05월 </SPAN>
<SPAN>12</SPAN>
<SPAN>일 입니</SPAN>다. 
<SPAN USERMARK=" B">라. 본사의 주소, 전화번호, 홈페이지 주소</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="490"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="499" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">본사 주소</TD>
<TD WIDTH="499" HEIGHT="33">서울특별시 서초구 효령로 23-1(방배동, 큐라클빌딩)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전화번호</TD>
<TD WIDTH="499" HEIGHT="30">070-4193-4067</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">홈페이지</TD>
<TD WIDTH="499" HEIGHT="30">www.curacle.com</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">마. 중소기업 등 해당 여부
<SPAN USERMARK=" !B">보고서 작성기준일 현재「중소기업기본법」제2조에 의거하여 중소기업에 해당하며,「벤처기업육성에 관한 특별조치법」제25조의 규정에 의거하여 벤처기업에 해당합니다.</SPAN>
</P>

<TABLE-GROUP ACLASS="SM_VEN_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="31"></COL>
<COL WIDTH="251"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" COLSPAN="2">중소기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="SML_YN" AUNITVALUE="Y">해당</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="40" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="260" HEIGHT="30" AUPDATECONT="N">벤처기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="VEN_YN" AUNITVALUE="Y">해당</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" COLSPAN="2">중견기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="MID_YN" AUNITVALUE="N">미해당</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK=" B">바. 대한민국에 대리인이 있는 경우네는 이름(대표자), 주소 및 연락처</SPAN>보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">사. 주요 사업의 내용 및 향후 추진하려는 신규사업에 관한 간략한 설명</SPAN>
</P>
<P>당사는 고령화에 따른 난치성 혈관 및 대사성질환의 혁신적인 치료제 연구/개발업을 주력사업으로 영위하고 있습니다. 기타 자세한 사항은 「Ⅱ. 사업의 내용」을 참조하시기 바랍니다.당사의 정관에 기재된 목적 사업은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="502"></COL>
<COL WIDTH="81"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="511" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사업목적</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="511" HEIGHT="283">
<P>1. 의약품, 의약외품 개발, 제조, 판매업</P>
<P>2. 의료기기, 기자재 개발, 제조, 판매업</P>
<P>3. 건강식품, 건강기능 및 보조식품 개발, 제조, 판매업</P>
<P>4. 식품 및 화장품 개발, 제조, 판매업</P>
<P>5. 농축산약품, 화공약품 개발, 제조, 판매업</P>
<P>6. 화장품 및 화장품 원료, 신변잡화 개발, 제조, 판매업</P>
<P>7. 의료기기, 미용기기, 미용제품, 의료장비, 헬스용품 개발, 제조, 판매업 </P>
<P>8. 위 각호와 관련된 도소매, 유통, 임가공, 서비스업</P>
<P>9. 위 각호와 관련된 무역(수출입) 및 무역중개업</P>
<P>10. 부동산임대 및 전대업</P>
<P>11. 동물 의약품/의약외품 개발 제조, 판매업</P>
<P>12. 위 각호와 관련된 부대사업 일체</P>
</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">아. 신용평가에 관한 사항</SPAN>보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">자. 회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</SPAN>
</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="740" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="213"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등여부</TH>
<TH WIDTH="222" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHK">코스닥시장</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="SPC_DATE" AUNITVALUE="20220722">2022년 07월 22일</TU>
<TE WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHP">기술성장기업 특례상장</TE>
<TE WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_LAW">코스닥시장 상장규정 제7조 2항</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>
<P></P>

<LIBRARY>
<P USERMARK=" B">가. 회사의 본점소재지 및 그 변경</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="670">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="555"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">일자</TH>
<TH WIDTH="564" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">본점소재지</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.05.12</TD>
<TD WIDTH="564" HEIGHT="30">서울시 강남구 밤고개로1길 10, 912호 (수서동, 현대벤처빌)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.11.18</TD>
<TD WIDTH="564" HEIGHT="30">경기도 성남시 분당구 판교로 253, 비동 801호 (삼평동, 판교이노밸리)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018.10.10</TD>
<TD WIDTH="564" HEIGHT="30">경기도 성남시 분당구 판교로 255번길 9-22, 512호 (삼평동, 우림더블유시티)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019.09.27</TD>

<TD WIDTH="564" HEIGHT="53">
<P>경기도 성남시 수정구 창업로 54, 608, 609, 610, 611호 (시흥동, 엘에이치 판교</P>
<P>제2테크노밸리 기업성장센터) </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32">2022.04.15</TD>
<TD WIDTH="564" HEIGHT="32">서울특별시 서초구 효령로 23-1(방배동, 큐라클빌딩)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">나. 경영진 및 감사의 중요한 변동 </P>

<TABLE-GROUP ACLASS="MNG_IMP_CHG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="802" BORDER="1">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="219"></COL>
<COL WIDTH="188"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변동일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주총종류</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="425" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기만료또는 해임</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">신규</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재선임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="76" AUNIT="CHG_DT" AUNITVALUE="20190322">2019.03.22</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="76" ACODE="NAPP_NM">사내이사 김영명</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="76" ACODE="RAPP_NM">사내이사 권영근대표이사 박광락감사 김활년</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="76" ACODE="DISM_NM">사내이사 이인규</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20190724">2019.07.24</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="2">임시주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="NAPP_NM">사내이사 김명화</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20190724">2019.07.24</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="NAPP_NM">사내이사 김명화 대표이사 취임</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="CHG_DT" AUNITVALUE="20191224">2019.12.24</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUNIT="GM_TYPE" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="53" ACODE="NAPP_NM">기타비상무이사 김영명기타비상무이사 권영근</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="53" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20200330">2020.03.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="NAPP_NM">사외이사 추연성</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20210105">2021.01.05</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="2">임시주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="NAPP_NM">사외이사 최동훈</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="CHG_DT" AUNITVALUE="20210329">2021.03.29</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="53" ACODE="NAPP_NM">기타비상무이사 추연성감사 고민석</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="53" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACODE="DISM_NM">사외이사 추연성감사 김활년</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20210930">2021.09.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="NAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">대표이사 김명화</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20211126">2021.11.26</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="2">임시주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="NAPP_NM">사내이사 유재현</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">대표이사 박광락</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="CHG_DT" AUNITVALUE="20211126">2021.11.26</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUNIT="GM_TYPE" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="53" ACODE="NAPP_NM">사내이사 유재현 대표이사 취임사외이사 조상헌</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="53" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="CHG_DT" AUNITVALUE="20220330">2022.03.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="53" ACODE="NAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="53" ACODE="RAPP_NM">기타비상무이사 김영명기타비상무이사 권영근</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="CHG_DT" AUNITVALUE="20220722">2022.07.22</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUNIT="GM_TYPE" AUNITVALUE="2">임시주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="53" ACODE="NAPP_NM">감사 서규영</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="197" HEIGHT="53" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACODE="DISM_NM">감사 고민석</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<P USERMARK=" B">다. 최대주주의 변동
<SPAN USERMARK=" !B">보고서 작성기준일 현재 해당사항이 없습니다.</SPAN>라. 상호의 변경
<SPAN USERMARK=" !B">보고서 작성기준일 현재 해당사항이 없습니다.</SPAN>마. 회사가 화의, 회사정리절차 그 밖에 이에 준하는 절차를 밟은 적이 있거나 현재 진행 중인 경우 그 내용과 결과
<SPAN USERMARK=" !B">보고서 작성기준일 현재 해당사항이 없습니다.</SPAN>바. 회사가 합병 등을 한 경우 그 내용
<SPAN USERMARK=" !B">보고서 작성기준일 현재 해당사항이 없습니다.</SPAN>사. 회사의 업종 또는 주된 사업의 변화
<SPAN USERMARK=" !B">보고서 작성기준일 현재 해당사항이 없습니다.</SPAN>아. 그 밖에 경영활동과 관련된 중요한 사항의 발생내용
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="649">

<COLGROUP>
<COL WIDTH="79"></COL>
<COL WIDTH="552"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>일자</P>
</TH>
<TH WIDTH="561" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주요 연혁</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.01 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>신약연구소 이전 (대전시 한국화학연구원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.04 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CU06 (혈관내피기능장애) 기술도입계약 체결 (연세대학교)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.05 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CU01 (당뇨병성 신증) 임상 2a상 IND 식약처 승인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>2019.06</P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>Covance(UK)와 연구협약 체결 (CU06 global GLP 시험 관련)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>액면분할(5,000원 →500원)후 빌행주식총수 4,848,980주</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.08</P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>IPO 대표주관사 계약 체결 (삼성증권)                           </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>2019.10 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>본사이전 (경기도 판교제2테크노밸리 기업성장센터)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>Patheon (cGMP, USA)와 협약 체결</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.10</P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>3차 유상증자(3자배정) : 561,291주 / 증자 후 자본금 2,705백만원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.12 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CU03 (습성 황반변성) 임상 2a상 IND 식약처 승인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020.01 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>중앙연구소 설립 (판교제2테크노밸리 기업성장센터)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020.03 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>유한화학(cGNP)과 계약 체결 (미국 임상용 DS생산 관련)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>2020.04 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>중소벤처기업부 연구기반활용사업(연구집중형) 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CUO06 보건복지부 제약사업 전주기 글로벌 진출 강화 지원사업 과제 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020.06 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>LS Pharma 와의 연구협약 체결(제제연구)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>2020.08 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CU01 (당뇨병성 신증) 임상 2a상 시험대상자 모집 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CU03(습성 황반변성) 임상 2a상 내약성 평가완료. 추가환자 60명모집</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>2020.10 </P>
</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">전자증권제도 도입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">CU06 (혈관내피기능장애) 미국 임상용 DP 생산완료 (cGMP)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>4차 유상증자 : 149,213주 / 증자 후 자본금 2,780백만원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>2020.11 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>연세대학교 연구협약 체결 및 산학협력 바이오랩 개설</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>이노비즈 인증 (중소벤처기업부 인증번호 : 200605-01197)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>스톡옵션 행사 : 98,500주 / 증자 후 자본금 2,829백만원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>2020.12 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>연세대 세브란스병원과 신약 연구개발 및 학술활동 연구협약 체결</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>2차 무상증자 : 5,657,984주 / 증자 후 자본금 5,658백만원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>2021.01 </P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CU06-RE, 미국 임상1상 IND 신청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>고려대 약학대학 및 약과학연구소와의 혁신 신약개발 연구협약 체결</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>2021.03</P>
</TD>

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CU06-RE, 미국 임상1상 IND 승인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">
<P>CU01, 국내 임상2a상 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">기술특례상장을 위한 기술성 평가 통과 (등급:AA. A)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.07</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">코스닥시장 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">CU01 (당뇨병성 신증) 국내 임상 3상 IND 신청</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">CU06 (당뇨 황반부종 및 습성 황반변성 치료제) 기술이전 계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.11</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">유재현 단독 대표이사 취임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">바이오연구소 설립</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.04</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">본사이전 (서울 서초구 효령로 23-1 큐라클빌딩)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.06</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">CU06 임상1상 결과 보고서 확보</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.07</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">CU01(당뇨병성 신증), 임상2b상IND 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.09</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">CU06 (당뇨병성 황반부종), 임상 2a상 미국 IND 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.11</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">연구개발유형 벤처기업 인증 획득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.12</TD>
<TD WIDTH="561" VALIGN="MIDDLE" HEIGHT="30">산업통상자원부 첨단기술제품 확인인증 획득</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P>당사는 기업공시서식 작성기준에 따른 소규모기업에 해당하여 '자본금 변동사항' 을 기재하지 아니합니다.</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P></P>
<P USERMARK=" B">가. 주식의 총수 현황  </P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N" USERMARK=" 0XC00020">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N" USERMARK=" 0XC00020">우선주</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">50,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK1">50,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">13,845,968</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK2">13,845,968</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RST">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RDC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RFD_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ETC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">13,845,968</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK3">13,845,968</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_TRS_STK">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">13,845,968</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_FLT_STK">13,845,968</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주1) 발행할 주식의 총수는 50,000,000주로 보통주식과 종류주식의 수는 정관 제5조의 범위 내로 발행하며, 의결권이 제한 또는 배제된 종류주식은 신발행주식수를 포함하여 발행할 주식 총수의 4분의 1범위를 초과하지 못합니다.
<SPAN USERMARK=" B">나. 자기주식</SPAN>보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">다. 다양한 종류의 주식</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
</P>

<P></P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 정관에 관한 사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 정관의 최근 개정일</SPAN>당사 정관의 최근 개정일은 2022년 3월 30일 입니다.
</P>

<LIBRARY>
<P USERMARK=" B">나. 정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="720" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="219"></COL>
<COL WIDTH="204"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="186" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="53" AUNIT="ART_DATE" AUNITVALUE="20190627" VALIGN="MIDDLE">2019.06.27</TU>
<TE ALIGN="CENTER" WIDTH="186" HEIGHT="53" ACODE="ART_NAME" VALIGN="MIDDLE">제4기 임시주주총회(1차)</TE>
<TE WIDTH="228" HEIGHT="53" ACODE="ART_CHN" VALIGN="MIDDLE">- 회사가 발행할 주식의 총수- 일주의 금액</TE>
<TE ALIGN="CENTER" WIDTH="213" HEIGHT="53" ACODE="ART_RSN" VALIGN="MIDDLE">액면분할에 따른 정관 변경</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="536" AUNIT="ART_DATE" AUNITVALUE="20190926" VALIGN="MIDDLE">2019.09.26</TU>
<TE ALIGN="CENTER" WIDTH="186" HEIGHT="536" ACODE="ART_NAME" VALIGN="MIDDLE">제4기 임시주주총회(2차)</TE>
<TE WIDTH="228" HEIGHT="536" ACODE="ART_CHN" VALIGN="MIDDLE">- 주식등의 전자등록- 주식의 종류- 신주인수권- 주식의 명의개서 및 재발행- 전환사채의 발행- 신주인수권부사채의 발행- 이익참가부사채의 발행- 교환사채의 발행- 소집통지- 소집지 - 의장의 질서유지권- 주주의 의결권- 상호주에 대한 의결권 제한- 의결권의 불통일 행사- 이사의 수- 이사의 선임- 이사회의 구성과 소집- 감사의 수 - 감사의 선임- 감사의 직무- 외부감사인의 선임- 이익배당- 분기배당</TE>
<TE ALIGN="CENTER" WIDTH="213" HEIGHT="536" ACODE="ART_RSN" VALIGN="MIDDLE">전자증권제도 도입 및 코스닥상장을 위한 정관 변경</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="398" AUNIT="ART_DATE" AUNITVALUE="20210329" VALIGN="MIDDLE">2021.03.29</TU>
<TE ALIGN="CENTER" WIDTH="186" HEIGHT="398" ACODE="ART_NAME" VALIGN="MIDDLE">제5기 정기주주총회</TE>
<TE WIDTH="228" HEIGHT="398" ACODE="ART_CHN">- 주식의 종류- 주식의 전환에 관한 종류주식- 신주인수권- 주식매수선택권- 신주의 배당기산일- 명의개서대리인- 주주명부- 주주명부의 폐쇄 및 기준일- 전환사채의 발행 - 신주인수권부사채의 발행- 사채 및 신주인수권증권에 표시하여야 할 권리의 전자등록- 소집시기- 이사의 수- 감사의 선임- 이익배당- 분기배당</TE>
<TE ALIGN="CENTER" WIDTH="213" HEIGHT="398" ACODE="ART_RSN" VALIGN="MIDDLE">상법 개정에 따른 변경</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="76" AUNIT="ART_DATE" AUNITVALUE="20220330" VALIGN="MIDDLE">2022.03.30</TU>
<TE ALIGN="CENTER" WIDTH="186" HEIGHT="76" ACODE="ART_NAME" VALIGN="MIDDLE">제6기 정기주주총회</TE>
<TE WIDTH="228" HEIGHT="76" ACODE="ART_CHN">- 본점의 소재지- 기준일- 시행일</TE>
<TE ALIGN="CENTER" WIDTH="213" HEIGHT="76" ACODE="ART_RSN" VALIGN="MIDDLE">본점 이전에 따른 변경</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>

<LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-1-L1">1. 사업의 개요</TITLE>
<P></P>
<P>당사는 플랫폼 기술을 기반으로 모세혈관 기능장애에 기인하는 난치성 혈관질환치료제를 연구/개발하는 바이오 벤처기업으로 고령화에 따른 난치성 혈관 및 대사성질환의 혁신적인 치료제 개발을 목표로 미충족 의료 수요(Unmet Medical Needs)가 높고 시장의 지속적인 성장세를 보이는 연령 관련 혈관질환, 만성 대사성질환 및 암질환 등을 핵심 연구개발 분야로 정하고 핵심 파이프라인을 구축하여 연구/개발을 진행하고 있습니다.</P>

<IMAGE>
<IMG WIDTH="595" HEIGHT="348" ALIGN="CENTER" HSPACE="0">큐라클 솔바디스 플랫폼 기술.jpg</IMG>
<IMG-CAPTION ATOC="N">큐라클 솔바디스 플랫폼 기술</IMG-CAPTION>
</IMAGE>

<P>당사는 세계 최초로 혈관내피기능장애 차단제(Endothelial Dysfunction Blocker, ED Blocker) 개발에 특화된 신개념 플랫폼 기술인 SOLVADYS®를 활용하여 혈관누수 및 염증 차단을 특징으로 하는 ED Blocker 물질, CU06-1004를 개발하였습니다. CU06-1004는 2021년 10월에 기술수출을 통해 아시아를 제외한 전세계 지역에 대한 판권을 떼아오픈이노베이션(Thea Open Innovation)에 이전하였습니다. 떼아오픈이노베이션에 이전한 판권은 당뇨황반부종 및 습성 황반변성에 국한되며, 그 외의 적응증에 대한 권리는 당
<SPAN>사가 소유하고 있습니다. CU06은 2022년 6월 건강인을 대상으로 임상1상을 완료하고, 9월 미국 FDA로 부터 당뇨병성 황반부종에 대한 임상2a상  IND를 승인 받았으며, </SPAN>
<SPAN>미국에서 임상시험을 진행하고 있습니다.</SPAN>
<SPAN> 또한 대표적</SPAN>인 ED 질환 중 하나인 당뇨병성 신증치료제 CU01은 2022년 7월 국내 2b상을 승인받아 환자 모집을 준비하고 있으며, 경구용 습성 황반변성치료제 CU03 은 2021년 1월 국내 임상 2a상이 완료되었습니다. 
</P>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="321" ALIGN="CENTER" HSPACE="0">큐라클_파이프라인(2022.12.31).jpg</IMG>
<IMG-CAPTION ATOC="N">큐라클 파이프라인</IMG-CAPTION>
</IMAGE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-2-L1">2. 주요 제품 및 서비스</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 주요 제품 등의 현황</SPAN>당사는 혈관내피기능장애 차단제 개발의 혁신 플랫폼 기술인 SOLVADYS® 플랫폼 기술을 이용한  First-in-Class 신약후보물질을 개발하고 파트너사와의 공동연구 또는 기술이전을 사업화 모델로 하고 있어 제품 판매에 대한 매출은 존재하지 아니합니다. 
<SPAN>다만, 라이선스 계약에 따른 초기 기술료(Upfront), 개별 단계별 마일스톤(Milestone), </SPAN>
<SPAN>판매액에 대한 로열티와 임상연구비용 및 제반비용 등을 수익으로 인식하고 있습니다.</SPAN>
<SPAN> 당사는 2021년 10월 떼아오픈이노베이션에 기술 이전한 CU06에 대하여 계약금(Upfront)을 수령하였습니다.</SPAN>
</P>
<P></P>

<TABLE WIDTH="808" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="799"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="808" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="809" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="62"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="647"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P> 품목</P>
</TH>
<TH WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">매출액(비율)</TH>

<TH WIDTH="656" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>제품설명</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>CU06</P>
</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">2,544(100%)</TD>

<TD WIDTH="656" VALIGN="MIDDLE" HEIGHT="214">
<P>□ 망막 질환의 하나인 당뇨병성 황반부종 치료제로서 전임상에서 보여준 신생혈관 생성 억제 효과는 유리체강내주사제(아일리아)의 전임상 연구 결과와 비교해 볼 때 동등 이상의 효능을 보임.□ 글로벌 최초 ED 차단제로서 기존 주사제에 반응하지 않는 환자를 포함하여 경증에서 중증환자에까지, 단독 또는 병용요법에서의 효과가 기대되며, 경구용 치료제로서 복용 편의성을 획기적으로 개선.□ 2021년 10월 프랑스 떼아오픈이노베이션에 당뇨병성 황반부종, 습성 황반변성에 대한 전세계판권(아시아 제외) 이전하였음. □ 2022년 6월 미국 임상 1상을 완료하고, 미국 FDA에 당뇨병성 황반부종 치료제에 대하여 2022년 9월 임상2a상 IND 승인 받음.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>CU01</P>
</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">-</TD>

<TD WIDTH="656" VALIGN="MIDDLE" HEIGHT="122">
<P>□Nrf2 활성 및 TGF-β/Smad3 억제를 통해 당뇨병성 신증을 치료할 수 있는 새로운 작용 기전의 First-in-Class 혁신신약임□미국 Biogen 사의 블록버스터 의약품(다발성경화증 치료제 Tecfidera, 2019 Peak Sales 4,433 Million US$)의 주성분 디메틸푸마레이트(DMF)를 Drug Repositioning(신약재창출) 방법을 이용하여 당뇨병성 신증 치료제로 개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>CU03</P>
</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>

<TD WIDTH="656" VALIGN="MIDDLE" HEIGHT="76">
<P>□경구용 습성 황반변성 치료제이며 글로벌 최초의 천연물 신약으로서 높은 인체 안전성이 특징□기존 안구내주사제와의 병용으로 주사투여의 횟수 감소와 동시에 황반변성치료 효과의 시너지를 기대할 수 있음</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">나. 주요 제품 등의 가격변동추이 및 가격변동원인</SPAN>당사의 사업구조는 신약후보물질을 개발하여 기술이전을 사업화 모델로 하고 있습니다. 신약의 기술이전은 거래구조와 조건에 따라 크게 변동하므로 주요 제품 등의 가격변동 추이를 기재하기 어렵습니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-3-L1">3. 원재료 및 생산설비</TITLE>
<P USERMARK=" B"></P>

<P>
<SPAN USERMARK=" B">가. 원재료 매입에 관한 사항</SPAN>
</P>
<P>당사의 주요 영업활동은 신약연구개발로서 제품 제조를 위한 별도의 원재료에 대한 매입은 없습니다.</P>

<P>
<SPAN USERMARK=" B">나. 생산설비에 관한 사항</SPAN>당사의 주요 영업활동은 신약연구개발로서 제품 제조를 위한 별도의 생산 및 생산 설비에 관하여는 해당사항이 없습니다. 비임상 및 임상약 생산은 위탁생산전문업체(CMO, Contract and Manufacturing Organization)가 업무를 수행하고 있습니다. 
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-4-L1">4. 매출 및 수주상황</TITLE>

<P></P>

<P>
<SPAN USERMARK=" B">가. 매출실적</SPAN>
</P>

<P>당사는 신약 개발을 통한 기술이전을 사업화모델로 하고 있습니다. 당사의 주요 파이프라인 CU06은 2021년 10월 떼아오픈이노베이션(Thea Open Innovation) 에 기술 수출을 통해 당뇨병성 황반부종 및 습성 황반변성에 대한 아시아를 제외한 전세계 지역에 대한 판권이 이전되어 이에 따른 계약금(Upfront) 6백만불을 수취하였고 원가 투입법기준 진행률에 따라 기간에 걸쳐 수익을 인식하였
<SPAN>으며, </SPAN>
<SPAN>임상연구비용 및 제반비용 등을 수익으로 인식하고 있습니다.</SPAN>
</P>

<TABLE WIDTH="606" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="597"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="606" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="606" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매출유형</P>
</TH>

<TH COLSPAN="2" WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제7기</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제6기</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제5기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>용역(라이선스매출)</P>
</TD>

<TD WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P> CU06</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수출</P>
</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,583</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">6,255</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="195" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합     계</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,583</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,255</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P> -</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">나. 판매경로 및 판매방법</SPAN>(1) 판매조직당사는 신약후보물질을 개발하여 기술이전을 목표로 하고 있으며 이를 위한 조직으로 사업개발본부를 운영하고 있습니다. 미국 및 북미시장은 BIO USA 및 각 북미학회 지회 Conference 참가 및 Business meeting을 통하여 다수의 글로벌 제약사 및 사업기회가 있는 회사들과 라이선스 아웃에 대한 접촉을 하고 있으며, 아시아 및 유럽은 Bio China, Bio Japan, Bio Europe 등의 Conference 참가 및 SM SINO사와 계약을 맺고 활발히 진행하고 있습니다. 또한, 국내 Major 제약회사들과 지속적으로 접촉하는 등 다방면으로 사업기회를 찾고 있습니다.(2) 판매전략
</P>
<P>당사는 신약개발을 전문으로하는 바이오벤처 기업이며, 비즈니스 모델은 SOLVADYS® 플랫폼을 통해 개발한 차세대 혈관관련질환 치료제와 더불어 난치성 질환에 대한 혁신적인 신약 파이프라인으로 글로벌 제약사와의 전략적 기술제휴를 통한 기술료매출 및 수익 창출입니다.</P>
<P>글로벌 제약사와의 라이선스 아웃 추진은 해외 컨퍼런스, 파트너사와의 네트워크를 통해 상호 정보교환으로 착수되며 기본적인 프로세스는 '파트너링 미팅 → NCD 자료공개 → CDA 체결 → 지속적인 정보공유 → MTA 계약 → Term sheet 작성 → Due diligence → 라이선스 계약' 단계로 구성되어 있습니다. 당사는 이미 라이선스 대상 기술 및 파이프라인에 대하여 다수의 글로벌 제약사와 CDA 계약을 체결하고 '지속적인 정보공유' 단계로 파트너사의 Unmet needs에 대해 지속적으로 연구결과를 업데이트하며 소통하고 있습니다.</P>

<P>
<SPAN USERMARK=" B">다. 수주상황</SPAN>당사의 주요 영업활동은 신약연구개발로서 수주 산업이 아니므로 해당사항이 없습니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-5-L1">5. 위험관리 및 파생거래</TITLE>

<P>
<SPAN USERMARK=" B">가. 시장위험과 위험관리</SPAN>당사는 금리위험, 가격위험, 환위험 등 다양한 시장위험에 노출되어 있습니다.  이러한 위험요소들을 관리하기 위하여 각각의 위험요인에 대해 면밀하게 모니터링하고 대응하는 위험관리 정책을 운용하고 있으며, 이에 대한 자세한 사항은「III. 재무에 관한 사항 → 5. 재무제표 주석」을 참조하시기 바랍니다.
<SPAN USERMARK=" B">나. 파생상품 및 풋백옵션 등 거래 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-6-L1">6. 주요계약 및 연구개발활동</TITLE>

<P>
<SPAN USERMARK=" B">가. 경영상의 주요 계약</SPAN>
</P>
<P>(1) 라이선스 아웃(License out) 계약</P>
<P>보고서 작성기준일 현재 당사가 체결 중인 주요 라이선스 아웃 계약의 현황은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="932" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="50"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>품목</P>
</TH>

<TH WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>계약 상대방</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>대상 지역</P>
</TH>

<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>계약 체결일</P>
</TH>

<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>계약 종료일</P>
</TH>

<TH WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>계약금액</P>
</TH>

<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>수취금액</P>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>진행 단계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>CU06-RE</P>
</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">Thea Open Innovation(떼아오픈이노베이션)</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">아시아제외전세계</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2021.10.27</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">각 나라별 상업화시점부터 10년</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">US$163,500,000</TD>

<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>US$6,000,000</P>
</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">미국 임상2a상진행중</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>■  품목: CU06 </P>

<TABLE BORDER="1" WIDTH="747" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="102"></COL>
<COL WIDTH="627"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">
<P>계약상대방</P>
</TD>
<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="30">Thea Open Innovation (떼아오픈이노베이션, 프랑스)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">
<P>계약내용</P>
</TD>
<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="30">떼아오픈이노베이션이 CU06-RE에 대한 독점권 권리를 갖고 임상시험, 허가, 상업화를 진행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="30">
<P>아시아를 제외한 전세계 지역</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">
<P>계약기간</P>
</TD>
<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="30">계약체결일 : 2021.10.27 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">
<P>총계약금액</P>
</TD>

<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="30">
<P>US$163,500,000, 로열티는 매출액의 8% 별도 수취</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">
<P>수취금액</P>
</TD>

<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="30">
<P>반환 의무가 없는 계약금(Upfront) : US$6,000,000 (2021.11.10)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="76">
<P>계약조건</P>
</TD>

<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="76">
<P>계약금(Upfront): US$6,000,000마일스톤(Milestone) : US$157,500,000경상기술료(Royalty) : 매출액의 8%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">
<P>회계처리방법</P>
</TD>
<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="30">계약금은 2021년~2022년 동안 분할하여 수익 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="30">
<P>대상기술</P>
</TD>
<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="30">당뇨 황반부종 및 습성 황반변성 치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="99">
<P>개발진행경과</P>
</TD>

<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="99">2022.06 미국 임상 1상 완료 (당뇨병성 황반부종/습성 황반변성)2022.08 미국 임상 2a상 IND 신청 (당뇨병성 황반부종)2022
<SPAN>.09 미국 임상 2a상 IND 승인 (당뇨병성 황반부종)</SPAN>
<SPAN>2022.12 미국 임상 2a상 대상자 등록 진행 (당뇨병성 황반부종)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="111" VALIGN="MIDDLE" HEIGHT="99">
<P>기타사항</P>
</TD>
<TD WIDTH="636" VALIGN="MIDDLE" HEIGHT="99">상기 마일스톤은 임상 성공시, 적응증 및 지역에 따른 허가시, 매출에 따른 목표 달성시 수령하며, 계약금과 각 단계별로 수령하는 마일스톤과 로열티는 반환 의무가 없음.당사는 FDA 1상까지의 비용을 부담하며, 2상 진입시부터는 떼아오픈이노베이션에서 비용을 부담함</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 라이선스 인(License in) 계약</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1077">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="165" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약 상대방(국적)</P>
</TH>
<TH WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대상지역</TH>
<TH WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약체결일</TH>
<TH WIDTH="204" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약종료일</TH>
<TH WIDTH="113" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약의 목적 및 내용</TH>
<TH WIDTH="68" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총 계약금액</TH>
<TH WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지급금액</TH>
<TH WIDTH="124" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">진행단계</TH>
<TH WIDTH="124" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">CU06</TD>

<TD WIDTH="165" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>연세대학교산학협력단(한국)</P>
</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전세계</TD>

<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2019.04.12</P>
</TD>

<TD WIDTH="204" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" 0XFF1200 B">
<SPAN USERMARK=" 0X000000 !B">2030.10.29</SPAN>
</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">특허기술 양도</TD>
<TD WIDTH="68" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="124" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">임상 2a상(미국)진행중</TD>
<TD WIDTH="124" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">경상기술료 별도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">CU01</TD>

<TD WIDTH="165" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>경북대학교산학협력단,경북대학교병원(한국)</P>
</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">전세계</TD>
<TD WIDTH="93" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2017.02.01</TD>

<TD WIDTH="204" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" 0XFF1200 B">
<SPAN USERMARK=" 0X000000 !B">2033.02.13</SPAN>
</TD>
<TD WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">특허기술 양도</TD>
<TD WIDTH="68" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="54" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="124" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">임상 2b상(한국)진행중</TD>

<TD WIDTH="124" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-DU10 0X0000FF">
<SPAN USERMARK="F-GL11 0X000000">경상기술료 별도</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">CU03</TD>
<TD WIDTH="165" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">한국한의학연구원(한국)</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">전세계</TD>
<TD WIDTH="93" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2017.03.21</TD>
<TD WIDTH="204" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">특허권 만료일(2035.05.21) 또는 제품출시후 10년 중 더 늦은 기간</TD>

<TD USERMARK="F-DU10" WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11">특허기술실시계약(전용실시권)</SPAN>
</TD>

<TD USERMARK="F-DU10" WIDTH="68" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11">주1)</SPAN>
</TD>
<TD WIDTH="54" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="124" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">임상 2a상(한국)완료</TD>

<TD USERMARK="F-DU10 0X0000FF" WIDTH="124" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11 0X000000">경상기술료 별도</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">CU05</TD>
<TD WIDTH="165" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">연세대학교산학협력단(한국)</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">전세계</TD>

<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-DU10 0X0000FF">
<SPAN USERMARK="F-GL11 0X000000">2017.02.03</SPAN>
</TD>
<TD WIDTH="204" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2035.06.29</TD>

<TD USERMARK="F-DU10 0X0000FF" WIDTH="113" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11 0X000000">특허기술 양도</SPAN>
</TD>

<TD USERMARK="F-DU10 0X0000FF" WIDTH="68" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11 0X000000">주1)</SPAN>
</TD>
<TD WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="124" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">후보물질 최적화진행중</TD>

<TD USERMARK="F-DU10 0X0000FF" WIDTH="124" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11 0X000000">경상기술료 별도</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="707" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="6">합계</TD>
<TD WIDTH="68" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="54" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-DU11 0X1814FF">
<SPAN USERMARK="F-GL 0X000000">주1) 계약 세부 내용의 경우 영업기밀에 해당하므로 기재하지 않았습니다.자료: ㈜큐라클</SPAN>
<SPAN USERMARK="F-BT12 0X000000">■ 품목 : CU06</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="479"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약상대방</TD>
<TD WIDTH="488" HEIGHT="30">연세대학교 산학협력단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약내용</TD>

<TD WIDTH="488" HEIGHT="53" USERMARK="F-DU10 0X1814FF">
<SPAN USERMARK="F-GL11 0X000000">특허 양수도 계약에 따라 큐라클이 신약후보물질 CU06-1004 물질특허권리를 양도 받고 임상시험, 허가, 생산, 상업화를 진행</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상지역</TD>
<TD WIDTH="488" HEIGHT="30">전세계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약기간</TD>
<TD WIDTH="488" HEIGHT="30">계약체결일 (2019.04.12) ~ 2030.10.29</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">총 계약금액</TD>
<TD WIDTH="488" HEIGHT="30">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">지급금액</TD>
<TD WIDTH="488" HEIGHT="30">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약조건</TD>
<TD WIDTH="488" HEIGHT="30">매출 발생에 대한 로열티 수취</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">회계처리방법</TD>
<TD WIDTH="488" HEIGHT="30">기술료는 향후 발생 시 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상기술</TD>
<TD WIDTH="488" HEIGHT="30">신규 혈관누출 차단제,당뇨병성 황반부종 치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">개발 진행경과</TD>

<TD WIDTH="488" HEIGHT="30" USERMARK="F-DU10">
<SPAN USERMARK="F-GL11">임상2a상 진행 중 (미국)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">기타사항</TD>
<TD WIDTH="488" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-DU11 0X1814FF">
<SPAN USERMARK="F-GL 0X000000">자료: ㈜큐라클</SPAN>
<SPAN USERMARK="F-BT12 0X000000">■ 품목 : CU01</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="479"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약상대방</TD>
<TD WIDTH="488" HEIGHT="30">경북대학교 산학협력단, 경북대학교병원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약내용</TD>

<TD WIDTH="488" HEIGHT="53" USERMARK="F-DU10 0X1814FF" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11 0X000000">특허 양수도 계약에 따라 CU01 용도 특허권리를 양도 받고 임상시험, 허가, 생산, 상업화를 진행</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상지역</TD>
<TD WIDTH="488" HEIGHT="30">전세계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약기간</TD>

<TD WIDTH="488" HEIGHT="30" USERMARK="F-DU10">
<SPAN USERMARK="F-GL11">계약체결일 (2017.02.01) ~ 2033.02.13</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">총 계약금액</TD>
<TD WIDTH="488" HEIGHT="30">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">지급금액</TD>
<TD WIDTH="488" HEIGHT="30">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약조건</TD>
<TD WIDTH="488" HEIGHT="30">매출 발생에 대한 로열티 수취</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">회계처리방법</TD>
<TD WIDTH="488" HEIGHT="30">기술료는 향후 발생 시 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상기술</TD>
<TD WIDTH="488" HEIGHT="30">만성 신장 질환 포함 당뇨병성 신증 치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">개발 진행경과</TD>
<TD WIDTH="488" HEIGHT="30">임상 2b상 진행 중(한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">기타사항</TD>
<TD WIDTH="488" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">자료: ㈜큐라클</SPAN>■ 품목 : CU03
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="476"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약상대방</TD>
<TD WIDTH="485" HEIGHT="30">한국한의학연구원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약내용</TD>

<TD WIDTH="485" HEIGHT="53" USERMARK="F-DU10 0X1814FF">
<SPAN USERMARK="F-GL11 0X000000">특허 전용실시권 계약에 따라 독점권 물질 특허 권리를 양도 받고 임상시험, 허가, 생산, 상업화를 진행</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상지역</TD>
<TD WIDTH="485" HEIGHT="30">전세계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약기간</TD>

<TD WIDTH="485" HEIGHT="53" USERMARK="F-DU10">
<SPAN USERMARK="F-GL11">계약체결일 (2017.03.21) ~ 특허권 만료일(2035.05.21) 또는 제품출시후 10년 중 더 늦은 기간</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">총 계약금액</TD>
<TD WIDTH="485" HEIGHT="30">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">지급금액</TD>
<TD WIDTH="485" HEIGHT="30">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약조건</TD>
<TD WIDTH="485" HEIGHT="30">매출 발생에 대한 로열티 수취</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">회계처리방법</TD>
<TD WIDTH="485" HEIGHT="30">기술료는 향후 발생 시 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상기술</TD>
<TD WIDTH="485" HEIGHT="30">습성 황반변성 치료제 및 당뇨망막병증 치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">개발 진행경과</TD>

<TD WIDTH="485" HEIGHT="30" USERMARK="F-DU10">
<SPAN USERMARK="F-GL11">임상 2a상 완료(한국)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">기타사항</TD>
<TD WIDTH="485" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-DU11 0X1814FF">
<SPAN USERMARK="F-GL 0X000000">자료: ㈜큐라클</SPAN>
<SPAN USERMARK="F-BT12 0X000000">■ 품목 : CU05</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="479"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약상대방</TD>
<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE">연세대학교 산학협력단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="53" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약내용</TD>

<TD WIDTH="488" HEIGHT="53" VALIGN="MIDDLE" USERMARK="F-DU10 0X1814FF">
<SPAN USERMARK="F-GL11 0X000000">특허 양수도 계약에 따라 용도 특허권리를 양도 받고 비임상 후보물질 도출연구 진행</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상지역</TD>
<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE">전세계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약기간</TD>

<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-DU10">
<SPAN USERMARK="F-GL11">계약체결일 (2017.02.03) ~ </SPAN>
<SPAN USERMARK="F-11">2035.06.29</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">총 계약금액</TD>
<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">지급금액</TD>
<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약조건</TD>
<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE">매출 발생에 대한 로열티 수취</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">회계처리방법</TD>
<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE">기술료는 향후 발생 시 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상기술</TD>

<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE" USERMARK="F-DU10">
<SPAN USERMARK="F-GL11">항암제(췌장암, 대장암, 삼중음성유방암 등)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">개발 진행경과</TD>
<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE">후보물질 최적화 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">기타사항</TD>
<TD WIDTH="488" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-DU11 0X1814FF">
<SPAN USERMARK="F-GL 0X000000">자료: ㈜큐라클</SPAN>
</P>
<P>(3) 공동 연구개발 계약</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="915">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="54" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="170" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약 상대방(국적)</P>
</TH>
<TH WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약체결일</TH>
<TH WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약종료일</TH>
<TH WIDTH="113" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약의 목적및 내용</TH>
<TH WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약금액</TH>
<TH WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지급방법</TH>
<TH WIDTH="113" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">진행경과</TH>
<TH WIDTH="123" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">CU02</TD>
<TD WIDTH="170" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">광주과학기술원(한국),경북대학교(한국),한국과학기술원(한국)</TD>
<TD WIDTH="93" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2017.08.25</TD>
<TD WIDTH="93" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2038.08.24</TD>
<TD WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">공동 연구개발</TD>

<TD USERMARK="F-DU10" WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11">주1)</SPAN>
</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">후보물질 도출</TD>

<TD USERMARK="F-DU10 0X0000FF" WIDTH="123" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK="F-GL11 0X000000">경상기술료 별도</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">자료: ㈜큐라클</SPAN>■ 품목 : CU02
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="479"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약상대방</TD>
<TD WIDTH="488" HEIGHT="30">광주과학기술원, 경북대학교, 한국과학기술연구원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약내용</TD>

<TD WIDTH="488" HEIGHT="30" USERMARK="F-DU10 0X1814FF">
<SPAN USERMARK="F-GL11 0X000000">공동 연구개발 계약에 따라 CU02의 후보물질 도출연구 공동 진행</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상지역</TD>
<TD WIDTH="488" HEIGHT="30">전세계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약기간</TD>

<TD WIDTH="488" HEIGHT="30" USERMARK="F-DU10">
<SPAN USERMARK="F-GL11">계약체결일 (2017.08.25)~ </SPAN>
<SPAN USERMARK="F-11">2038.08.24</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">총 계약금액</TD>
<TD WIDTH="488" HEIGHT="30">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">지급금액</TD>
<TD WIDTH="488" HEIGHT="30">양사 합의에 의해 계약 규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">계약조건</TD>
<TD WIDTH="488" HEIGHT="30">매출 발생에 대한 로열티 수취</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">회계처리방법</TD>
<TD WIDTH="488" HEIGHT="30">기술료는 향후 발생 시 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">대상기술</TD>
<TD WIDTH="488" HEIGHT="30">비알콜성 지방간염 치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">개발 진행경과</TD>

<TD WIDTH="488" HEIGHT="30" USERMARK="F-DU10">
<SPAN USERMARK="F-GL11">후보물질 최적화 중</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7" VALIGN="MIDDLE" ALIGN="CENTER">기타사항</TD>
<TD WIDTH="488" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-DU11 0X1814FF">
<SPAN USERMARK="F-GL 0X000000">자료: ㈜큐라클</SPAN>
</P>

<P>
<SPAN USERMARK=" B">나. 연구개발 활동</SPAN>
</P>
<P>(1) 연구개발 활동의 개요당사는 플랫폼 기술을 기반으로 모세혈관 기능장애에 기인하는 난치성 혈관질환치료제를 연구 개발하는 바이오 벤처기업으로 고령화에 따른 난치성 혈관 및 대사성질환의 혁신적인 치료제 개발을 목표로 하고 있습니다.</P>

<P>(2) 연구개발 담당 조직가) 연구개발 조직 구성보고서 작성기준일 현재 당사는 박사급 11명, 
<SPAN>석사급 </SPAN>
<SPAN>8명</SPAN>
<SPAN> 등 총 </SPAN>
<SPAN>23명</SPAN>
<SPAN>의 </SPAN>연구인력을 보유하고 있으며 각 조직별 주요 역할은 아래와 같습니다.
</P>
<P></P>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="492"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">조직</TH>
<TH WIDTH="501" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">역할</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">신약연구본부</TD>
<TD WIDTH="501" HEIGHT="53">- 전임상 후보물질 개발, 합성 공정 개발- 공정 지표 물질 및 방사성 표지 물질 (Stable isotope) 합성 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임상개발본부</TD>
<TD WIDTH="501" HEIGHT="53">- 임상시험 전략 수립 및 임상개발 수행- 임상 인허가 관리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구개발본부</TD>
<TD WIDTH="501" HEIGHT="53">- 임상 DS/DP개발 및 생산, GLP 시험 관리, 지식재산권 관리- 대사체 분석 연구, 후보물질 분석 연구 및 MV 시험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">바이오연구본부</TD>
<TD WIDTH="501" HEIGHT="37">- 기전 및 in vitro/ in vivo 효능 시험</TD>
</TR>
</TBODY>
</TABLE>
<P>나) 연구개발 인력 구성</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">박사</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">석사</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">학사</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신약연구본부</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상개발본부</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구개발본부</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">바이오연구본부</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">23</TD>
</TR>
</TBODY>
</TABLE>
<P>다) 주요 연구개발 인력</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1215">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="432"></COL>
<COL WIDTH="496"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>직위</P>
</TH>

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>

<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>담당업무</P>
</TH>

<TH WIDTH="441" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요경력</P>
</TH>
<TH WIDTH="505" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요 연구실적</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">이사회의장</TD>

<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="145" ALIGN="CENTER">
<P>권영근</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="145" ALIGN="CENTER">
<P>기전 및</P>
<P>효력연구 자문</P>
</TD>

<TD WIDTH="441" VALIGN="MIDDLE" HEIGHT="145">
<P>미국 State University of New York at Buffalo, 이학박사(생화학)- 연세대 생화학과 교수('04~현재)- 연세대 생명시스템대학 학장 ('20~'22.01)- 연세대 BK21플러스 생체기능시스템사업단 단장 ('13~현재)</P>
</TD>

<TD WIDTH="505" VALIGN="MIDDLE" HEIGHT="145">
<P>-신규 혈관 누출 차단제 개발 (기술이전)AMIGO2와 3-포스포이노시티드-의존 키나아제1의결합억제용 데코이 펨타이드 개발 (기술이전)-허혈성 심혈관질환을 대상으로 한 DKK2 단백질치료제 개발 (기술이전)-국제학술지 SCI 논문 225편, 특허 출원/등록 25건</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="237">
<P>사외이사</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="237" ALIGN="CENTER">
<P>최동훈</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="237" ALIGN="CENTER">
<P>임상개발</P>
<P>및 중개 연구</P>
<P>자문</P>
</TD>

<TD WIDTH="441" VALIGN="MIDDLE" HEIGHT="237">
<P>연세대학교 의과대학, 의학박사(M.D)</P>
<P>- 연세대 의과대학 교수 ('99~현재)</P>
<P>- 세브란스병원 심혈관제품유효성평가센터 부센터장 ('10~'16)- 연세세브란스-심장혈관병원장 ('16~'19)- 용인 세브란스병원 병원장 ('19~현재)</P>
</TD>

<TD WIDTH="505" VALIGN="MIDDLE" HEIGHT="237">
<P>- 대한 심장학회 학술이사/기초과학연구회 회장- 한국생체재료학회 분과전문이사- 한국심장학회 학술이사- 대한심혈관중재학회 혈관중재시술연구회 회장- 식품의약품안전청 중앙약사심의위원회 전문위원- 한국지질동맥화학회 기획위원장- 대한심장학회 연구이사- 보건복지부 신의료기술평가위원회 위원- 식품의약품안전평가원 의약품 심사자문단- 국제학술지 SCI 논문 478편, 특허 출원/등록 31건</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>기타비상무이사</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="168" ALIGN="CENTER">
<P>추연성</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="168" ALIGN="CENTER">
<P>해외사업개발 자문</P>
</TD>

<TD WIDTH="441" VALIGN="MIDDLE" HEIGHT="168">
<P>미국 Univ. Illinois at Chicago 약학박사</P>
<P>- LG화학 바이오텍연구소 책임연구원 ('96~'00)- LG생명과학 부사장 및 고문 ('00~'17)</P>
<P>- ㈜스탠다임, ㈜바이오에스파트너즈, ㈜진메디신 등연구개발고문 (현재)</P>
</TD>

<TD WIDTH="505" VALIGN="MIDDLE" HEIGHT="168">
<P>- LG생명과학 합성신약(신규 퀴놀론계항균제) 한국 최초 美 FDA 승인 획득</P>
<P>- LG생명과학 바이오의약품(인간성장호르몬) 한국 최초 유럽 EMEA / 美 FDA 승인 획득</P>
<P>- LG생명과학 신약/신제품 (신규 당뇨병치료제, 골관절염치료제, 진통소염제) 출시</P>
<P>- 美 훽스트메리엔루셀 신규 항구토제 美 FDA 승인 획득</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>기타비상무이사</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="145" ALIGN="CENTER">
<P>김영명</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="145" ALIGN="CENTER">
<P>연구개발자문</P>
</TD>

<TD WIDTH="441" VALIGN="MIDDLE" HEIGHT="145">
<P>미국 Utah 주립대학교, 이학박사(생화학)- 피츠버드 의과대학 연구교수 및 조교수('92~'97)- 강원대 의학과 교수 ('97~현재)</P>
<P>- 강원대 우수연구센터장 ('01~현재)</P>
</TD>

<TD WIDTH="505" VALIGN="MIDDLE" HEIGHT="145">
<P>- 황반 및 당뇨성 망막질환 치료제 개발- 임신중독증 진단용 miRNA 발굴- 암혈관신생치료제 개발- 암혈관 정상화 치료전략 개발- 혈관기능 복원용 치료전략 개발- 국제학술지 SCI 논문 200편 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="260">
<P>상무이사/본부장</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="260" ALIGN="CENTER">
<P>이원일</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="260" ALIGN="CENTER">
<P>전임상</P>
<P>후보물질 및합성 공정개발</P>
</TD>
<TD WIDTH="441" VALIGN="MIDDLE" HEIGHT="260">서울대학교, 약학박사-C&C 신약연구소 책임연구원('01~'15)-젬백스앤카엘 연구개발본부 이사('15~'16)-제일약품 신약연구부 책임연구원('16~'17)-대원제약 신약연구부 이사('17~'22)</TD>
<TD WIDTH="505" VALIGN="MIDDLE" HEIGHT="260">-제2형 당뇨병, 고지혈증 치료제 및 항암제 개발-소염진통제, 제2형 당뇨병 치료제의 신규염/공결정을 이용한 개량신약 개발-GnRH 길항제의 process development 및 임상시험을 위한 API 합성-역류성식도염 치료제, 진통제, 항암제 개발-펩타이드 백신 및 약물 개발-유방암 치료제 개발-통풍 치료제 개발-아토피 피부염 치료제 개발-COPD치료제 개발(PDE4 inhibitor)-당뇨병 치료제 개발(SGLT2 inhibitor)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>상무이사/본부장</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="168" ALIGN="CENTER">김수정</TD>

<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="168" ALIGN="CENTER">
<P>임상 개발,임상 인/허가</P>
</TD>
<TD WIDTH="441" VALIGN="MIDDLE" HEIGHT="168">한양대학교 의학 박사-아모레퍼시픽기술 연구원 책임연구원 ('97.10 ~'09.05) -코미팜 의약사업부 이사('09.05~'19.01)-크리스탈지노믹스 임상개발본부 이사('19.03~'19.09)-파마리서치 연구소장 ('19.11~'22.05)</TD>

<TD WIDTH="505" VALIGN="MIDDLE" HEIGHT="168">
<P>- 항생제 내성 균주 제어를 위한 신규 항생제 임상 개발-항암제, 암성 통증 치료제 비임상, 임상 개발-유전체학, 생물정보학 기술을 이용한 노화 유전자 및 여성 호르몬 신호전달 체계 연구-유전체학, 생물정보학 기술을 이용한 seborrheic keratosis의 발생원인 규명, 논문/특허화-천연 소재의 항노화, 항비만, 항염 효과 연구, 제품화, 논문/특허화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="305">이사/본부장</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="305" ALIGN="CENTER">표정인</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="305" ALIGN="CENTER">DS/DP 생산 및 품질관리,조제물 및 생체시료 분석 연구</TD>
<TD WIDTH="441" VALIGN="MIDDLE" HEIGHT="305">연세대학교, 이학박사(의약화학)-한국과학기술연구원(KIST) 연구원('03-06~'14.12)-삼육대학교 특임교수/비전임('11.09~'14.07)-iNtRON Biotechnology 신약연구 팀장('15.01~'17.07)</TD>

<TD WIDTH="505" VALIGN="MIDDLE" HEIGHT="305">
<P>-CMC 총괄: 국내 2a상(2건), 2b상(1건), 미국 1상(1건), 2a상(1건)</P>
<P>-파키슨병 치료제 개발: Pyrazolopyrimidine</P>
<P>-Calcium channel blocker 개발: Oxo & thioxoquinaxoline carboxamides</P>
<P>-천연물 유래의 생리활성물질 개발: Xanthorrhizol, Vitamin D3 전합성</P>
<P>-약물전달 기술개발: nanoparticle(polymeric, liposome), BNCT modulater(Nucleoside, Inositol, Folic acid complex)</P>
<P>-Generic drug 개발: 항히스타민제, 과민성 방광증상 치료제, 당뇨병 치료제(DPP-4)</P>
<P>-발효균주를 이용한 빈혈 치료제 개발: eHeme-산업용 발효균주를 이용한 항생제 개발: S. Kanamyceticus 등</P>
<P>-산업용 소재개발(효소촉매 고정화 및 반응): 생체 고분자, Carbohydrate</P>
<P>-특허출원 국내외 77건</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">이사/본부장</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="214" ALIGN="CENTER">신주현</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="214" ALIGN="CENTER">후보물질약효평가</TD>

<TD WIDTH="441" VALIGN="MIDDLE" HEIGHT="214">
<P>KAIST, 생명과학 박사-JW 중외제약 C&C 신약연구소 선임연구원 ('13.10~'16.01)</P>
<P>-레고켐바이오 항암제팀 총괄팀장 ('16.02~'17.11)</P>
<P>-메디톡스 신약개발팀장 ('17.12~'19.01)</P>
<P>-환인제약 외부협력연구실 부장 ('19.01~'19.05)-일동제약 사업개발 이사 ('20.11~'21.01)</P>
</TD>
<TD WIDTH="505" VALIGN="MIDDLE" HEIGHT="214">-항암제 개발: STAT3 inhibitor(삼중음성 유방암), ALK inhibitor(폐암)을 포함하여 표적항암제, 면역항암제, 대사항암제 연구 -섬유화증, 천식, 아토피 치료제 개발: ATX inhibitor (폐섬유화증, 천식), H4R inhibitor (아토피)-신경계 질환: Kinase inhibitor, novel target antibody (알츠하이머병), kinase inhibitor (파킨슨병), neuro-receptor inhibitor (ADHD)-위암 진단키트 개발, 폐섬유화증, 자가포식(autophagy) 관련 논문, 특허, 발명자 권리 보유-저분자화합물, PROTAC, ADC, 항체, 펩타이드 관련 연구 수행</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-DU11 0X57CF8A">
<SPAN USERMARK="F-BT12 0X000000">(3) 연구개발 비용</SPAN>
</P>
<P>당사는 연구 및 임상개발 등에 소요되는 모든 비용을 당기 비용으로 회계처리하고 있습니다.</P>

<TABLE WIDTH="616" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="607"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="616" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[연구개발비 현황]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="616" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위: 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="182"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="299" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년(제7기)</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2021년(제6기)</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년(제5기)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="299" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">
<P>연구개발비용 총계</P>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,375</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,040</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,239</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>회계처리내역</P>
</TD>

<TD WIDTH="191" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회계처리금액</P>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,648</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,148</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,487</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="191" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>정부보조금</P>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(273)</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(108)</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(248)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="191" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>연구개발비용 합계</P>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XF2F2F2">11,375</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XF2F2F2">10,040</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>6,239</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="299" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구개발비/매출액 비율(주4)</P>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">317.6%.</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">160.5%</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-DU11 0X57CF8A"></P>
<P></P>
<P>(4) 연구개발 실적 </P>
<P>가) 연구개발 진행 현황 및 향후계획</P>

<TABLE WIDTH="757" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="748"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="757" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[연구개발 진행 총괄표]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="760" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="43"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품목</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">적응증</TH>
<TH WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">현재 진행단계 (국가)</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="10" WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="323">혁신신약</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="263" ROWSPAN="8">화학합성</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">CU06</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">당뇨병성 황반부종</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임상 2a상 진행중 (미국)</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022.09 (임상 2a상 IND 승인)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU06</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">습성 황반변성</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 1상 완료 (미국)</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210" ROWSPAN="7">CU06 적응증 확장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU101</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">심근경색</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 1상 완료 (미국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU102</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">급성 폐손상</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 1상 완료 (미국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU103</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">뇌졸중</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 1상 완료 (미국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU104</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">궤양성 대장염</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 1상 완료 (미국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU105</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유전성 혈관부종</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 1상 완료 (미국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU106</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">면역항암제 병용</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 1상 완료 (미국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">화학합성</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU01</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">당뇨병성 신증</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 2b상 진행중 (한국)</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.07 (임상 2b상 IND 승인)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">천연물</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU03</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">습성 황반변성</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 2a상 완료 (한국)</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.12 (임상 2a상 IND 승인)</TD>
</TR>
</TBODY>
</TABLE>
<P>■ 품목 : CU06</P>

<TABLE BORDER="1" WIDTH="659" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="549"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">구분</TD>
<TD WIDTH="558" HEIGHT="30">화학합성 신약(경구용)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="558" HEIGHT="30">당뇨병성 황반부종</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="76">작용기전</TD>
<TD WIDTH="558" HEIGHT="76">- 혈관내피세포의 actin 구조 변형을 통해 내피세포 연접을 안정화- 혈관내피세포 NF-kB 염증신호체계 차단- 혈관내피세포의 생존율 향진 및 보호 효과</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="122">제품의 특성</TD>

<TD WIDTH="558" VALIGN="MIDDLE" HEIGHT="122">
<P>[경구용 당뇨황반부종 치료]- 당뇨황반부종은 망막 혈관 장벽의 파괴 및 염증을 동반하며 비정상적 혈관신생으로 진행하여 혈관내피기능장애를 차단하는 것이 중요한 치료 타깃임. </P>
<P>- 전임상단계에서 보여준 신생혈관생성억제 효과는 유리체강내 주사제 (아일리아)의 전임상 연구 결과와 비교해 볼 때 동등 이상의 효능을 보임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="168">진행경과</TD>

<TD WIDTH="558" HEIGHT="168">- 2021.01 미국 FDA 임상 1상 IND 신청- 2021.02 미국 FDA 임상 1상 IND 승인- 2021.03 임상시험 개시 후, 7월에 첫 투여 실시함- 2022.03 마지막시험대상자의 마지막 방문 완료- 2022.08 미국 FDA 임상 2a상 IND 신청- 2022.09 미국 FDA 임상 2a상 IND 승인
<SPAN>- 2022.12 미국 임상 2a상 대상자 등록 진행</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="76">향후계획</TD>

<TD WIDTH="558" HEIGHT="76">- 1상을 마친 후 다양한 난치성 질환 (급성 폐손상, 급성 심근경색, 뇌졸중, 궤양성대장염, 유전성 혈관부종, 면역항암제 병용요법)을 목표로 하여 적응증 확장을 준비하고 있음
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="122">경쟁제품</TD>
<TD WIDTH="558" HEIGHT="122">- 현재 시장에 출시되어 있는 경구용 당뇨황반부종 치료제 없음.- 레이저 치료(국/격자/범안저광응고술) 또는 스테로이드 유리 체강내 주사 및 Anti-VEGF 주사제가 치료에 사용되고 있으며, 대표적인 제품은 Anti-VEGF 주사제인 Lucentis(ranibizumab), Avastin(bevacizumab), Eylea (aflibercept) 등이 90%의 시장 점유율을 차지하고 있으며, 연평균 6%의 증가가 예상됨</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="76">관련논문 등</TD>
<TD WIDTH="558" HEIGHT="76">Sac-1004, a novel vascular leakage blocker, enhances endothelial barrier through the cAMP/Rac/cortactin pathway. Biochem Biophys Res Commun. 435(3): 420-427 (2013)를 통한 기전규명 등 다수 적응증 확장 논문/학회 발표 진행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="53">글로벌시장규모</TD>
<TD WIDTH="558" VALIGN="MIDDLE" HEIGHT="53">2017년도 27억 달러에서 2025년 32억 달러(CAGR: 3.30%)로 성장예측</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="558" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>■ 품목 : CU01</P>

<TABLE BORDER="1" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="551"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">구분</TD>
<TD WIDTH="560" HEIGHT="30">화학합성 신약(경구용)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="560" HEIGHT="30">당뇨병성 신증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="122">작용기전</TD>
<TD WIDTH="560" HEIGHT="122">Nrf2 활성(Nuclear factor erythroid-2-related factor 2,  항산화 유전자의 유도발현에 영향을 주는 대표적인 전사인자)과 TGF-β(전환성장인자 베타, Transforming growth factor-beta)/Smad3(전환성장인자의 수용체에 작용하는 단백질) 억제 기전의 First-in-Class 약제로 항산화 및 섬유화 억제 작용을 갖고 있어 신섬유증 및 신섬유증을 수반하는 만성신장질환 환자의 예방 및 치료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="237">제품의 특성</TD>
<TD WIDTH="560" HEIGHT="237">[당뇨병성 신증의 근본적인 치료]- 당뇨병성 신증은 혈역학적 요인과 당뇨 및 고혈압 등과 관련된 대사성 요인에 의하여 발생하며, 여기에는 각종 세포내 신호전달 경로와 TGF-β 등의 여러 사이토카인이 작용함. - CU01은 디메틸푸마레이트(DMF)의 Nrf2 활성 및 TGF-β/Smad3 억제를 통한 신장 섬유화를 치료할 수 있는 새로운 작용 기전의 First-in-Class 혁신 신약임. - 미국 Biogen 사의 블록버스터 의약품(다발성 경화증 치료제 Tecfidera, 2019 Peak Sales;제네릭 출시 이전 4,433 Million US$ / 2021 Sales 486.5 Million US$)의 주성분 디메틸푸마레이트를 Drug Repositioning 방법을 이용하여 당뇨병성 신증 치료제로 개발하였음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="283">진행경과</TD>

<TD WIDTH="560" HEIGHT="283">
<P>- 2019.05 식품의약품안전처 임상2a상 IND 승인- 2019.09 첫 환자 투여- 2020.08 안전성자료모니터링위원회(DSMB)에서 안전성 중간분석 회의 결과, CU01의 안전성 이슈가 없으므로 임상시험 지속 권고 받음.- 2021.03 국내에서 진행한 임상 2a 상 임상시험결과보고서(CSR) 발행됨- 알부민뇨가 나타나는 제2형 당뇨병성 신증 (Diabetic Nephropathy) 환자 39명을 대상으로 CU01-1001 또는 위약을 12주간 투여한 결과 CU01-1001 투여군에서 ACR 개선에 효과 확인.</P>
<P>- 신기능 개선에 주요 지표가 되는 사구체 여과율 (estimated Glomerular Filtration Rate)의 통계적으로 유의한 증가를 관찰함[임상 2a시험 → 유효성/안전성 확인]-2022.07 식품의약품안전처 임상 2b상 IND 승인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="560" HEIGHT="30">-2022년 국내 임상 2b상 진행 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="99">경쟁제품</TD>
<TD WIDTH="560" HEIGHT="99">- 현재 당뇨병성 신증 치료제는 고혈압 및 당뇨병 치료제가 주로 사용되고 있으며, 섬유화 진행을 억제하는 경쟁 약물은 없음.- 고혈압 치료제: Cozaar(Losartan Potassium), Micardis(Telmisartan)- 당뇨병 치료제: Ozempic(semaglutide), Trulicity(dulaglutide)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="76">관련논문 등</TD>
<TD WIDTH="560" HEIGHT="76">Dimethylfumarate Attenuates Renal Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-β/Smad3 Signaling, PLoS One 2012, 7(10):e45870를 통한 기전규명 등 다수 논문/학회 발표 진행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="53">글로벌시장규모</TD>
<TD WIDTH="560" VALIGN="MIDDLE" HEIGHT="53">2022년 1,011 Million US$ (CAGR : 1.23%) (출처:Global Data) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="560" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>■ 품목 : CU03</P>

<TABLE BORDER="1" WIDTH="665" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="555"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">구분</TD>
<TD WIDTH="564" HEIGHT="30">천연물 신약(경구용)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="564" HEIGHT="30">습성 황반변성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="564" HEIGHT="30">항산화, 항염증, 항신생혈관 및 항투과성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="122">제품의 특성</TD>
<TD WIDTH="564" HEIGHT="122">- 경구용 천연물 신약으로 안전하고 효과적인 천연 약재인 계지와 목단피가 주성분- 경구투여로 기존 유리체강내 주사 치료제가 갖는 부작용을 줄이고, 황반변성 치료에 큰 효과를 나타낼 수 있는 것이 동물실험에서 확인됨. - 기존 anti-VEGF 주사제와 병용 사용하여 치료 효율을 높일 수 있는 장점이 있고, - 약리 활성 연구를 통해 항염증/항신생혈관/항과투과성/항산화효과 등이 검증함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="145">진행경과</TD>
<TD WIDTH="564" HEIGHT="145">[임상 2a시험 진행]- 2019.12 식품의약품안전처 IND 승인- 2020.09 내약성 평가완료- 마지막 대상자의 마지막 방문 완료- 2022.01 국내에서 진행한 임상 2a상 임상시험결과보고서(CSR) 발행됨-비임상시험(26주 반복투여 독성시험), 생식독성 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="564" HEIGHT="30">-후기 임상 진입 전략수립 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="145">경쟁제품</TD>
<TD WIDTH="564" HEIGHT="145">- 현재 시장에 출시되어 있는 경구용 황반변성 치료제 없음.- 레이저 치료 (국/격자/범안저광응고술) 또는 스테로이드 유리체강내 주사 및Anti-VEGF 주사제가 치료에 사용되고 있음 - 대표적인 제품은 anti-VEGF 주사제인 Lucentis(ranibizumab), Avastin(bevacizumab), Eylea (aflibercept) 등이 90%의 시장 점유율을 차지하고 있으며, 연평균 6%의 증가가 예상됨</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="76">관련논문 등</TD>
<TD WIDTH="564" HEIGHT="76">Extract of Moutan radicis cortex and Cinnamomi ramulus ameliorates laser-induced choroidal neovascularization in Brown-Norway rats, Phytomedicine, 심사中를 통해 CNV 동물모델 효능을 논문/학회 발표함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="53">글로벌시장규모</TD>
<TD WIDTH="564" VALIGN="MIDDLE" HEIGHT="53">2017년 63억 달러에서 2025년 88억 달러(CAGR: 3.8%)로 성장예측</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="564" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>나) 계획 중인 후속 프로젝트 당사는 보고서 작성기준일 현재 임상연구 중인 프로젝트와 함께 계획중인 후속 프로젝트는 아래와 같습니다. 다만 임상 1상 전 단계의 개발 초기 단계로 당사의 사업 전략에 따라 연구 개발 계획의 변동이 발생할 수 있습니다.</P>

<TABLE WIDTH="750" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="741"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="750" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[계획 중인 후속 프로젝트 총괄표]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="750" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="342"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="78"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품목</TH>
<TH WIDTH="351" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">적응증</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">현재진행단계</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">화학합성</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">신약</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">CU02</TD>
<TD WIDTH="351" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">Non-alcoholic steatohepatitis(비알콜성 지방간염)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">후보물질 도출</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">공동연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">화학합성</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">신약</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">CU04</TD>
<TD WIDTH="351" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">Oncology(차세대 항암제)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">선도물질 탐색</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="37">자체연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39">화학합성</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39">신약</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39">CU05</TD>
<TD WIDTH="351" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39">Oncology(차세대 항암제)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39">후보물질 도출</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="39">공동연구</TD>
</TR>
</TBODY>
</TABLE>
<P>다) 보유 기술에 대한 연구실적 (논문 및 학회 발표)</P>
<P>- CU06 핵심기술에 대한 논문 9편 및 학회 발표 25건(주저자: 연세대 권영근 교수)- CU01 핵심기술에 대한 논문 4편 및 학회 발표 2건(주저자: 경북대 의대 이인규 교수)- CU03 핵심기술에 대한 논문 1편 및 학회 발표 1건 (주저자: 한국한의학연구원 김진숙 박사) - CU05 핵심기술에 대한 논문 1편 및 학회 발표 5건 (주저자: 연세대 권영근 교수)</P>

<TABLE WIDTH="1019" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1010"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1019" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[논문발표 목록]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1017" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="489"></COL>
<COL WIDTH="261"></COL>
<COL WIDTH="171"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="498" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>논문제목</P>
</TH>

<TH WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>게재정보</P>
</TH>

<TH WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="9" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="523">
<P>CU06</P>
</TD>

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>CU06-1004-inducedvascular normalization improves immunotherapy by modulating tumor microenviroment via cytotoxic T cell.</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Front. Immunol.</P>
<P>(Accepted, in editing)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>종양 미세환경개선 효과 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>PLoS One. 15(12):e0243497(2020)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>비알코올성 지방간모델에서 효과 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Front Pharmacol. 15;11:571266(2020)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>대장염 모델에서 효과 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="76">
<P>CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>J Mol Med (Berl).</P>
<P>98(6): 875-886 (2020)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>뇌졸중 모델에서 효과 및 기전 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>Sac-1004, a vascular leakage blocker, reduces cerebral ischemia-reperfusion injury by suppressing blood-brain barrier disruption and inflammation</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>J Neuroinflammation. </P>
<P>14: 122 (2017)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>뇌졸중 모델에서 효과 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="76">
<P>Sac-1004, a Pseudo-Sugar Derivative of Cholesterol, Restores Erectile Function through Reconstruction of Nonleaky and Functional Cavernous Angiogenesis in the Streptozotocin Induced Diabetic Mouse</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>J Urol. 195(6): 1936-46 (2016)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>당뇨 마우스에서 발기 기능 회복 효과 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Oncotarget. 5(9): 2761-77 (2014)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>종양 혈관 정상화 효과 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>Combined effect of vascular-leakage-blocker Sac-1004 and antiangiogenic drug sunitinib on tumor angiogenesis</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Biochem Biophys Res Commun. 450(4): 1320-6 (2014)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>항암제와의 병용투여 효과 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>Sac-1004, a novel vascular leakage blocker, enhances endothelial barrier through the cAMP/Rac/cortactin pathway.</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Biochem Biophys Res Commun. 435(3): 420-427 (2013)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기전 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="212">
<P>CU01</P>
</TD>
<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">Dimethylfumarate Attenuates Renal Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-β/Smad3 Signaling</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>PLoS One 2012,</P>
<P>7(10):e45870 </P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Renal fibrosis</P>
<P>감소효능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>Dimethylfumarate suppresses adipogenic differentiation in 3T3-L1 preadipocytes through inhibition of STAT3 activity </P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>PLoS One 2013, 18;8(4):e61411</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Adipocytes </P>
<P>분화 억제효능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>Activation of Nrf2 by dimethyl fumarate improves vascular calcification </P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Vascul Pharmacol. </P>
<P>2014, 63(1):29-36. </P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Vascular calcification</P>
<P>억제효능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms </P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Redox Biol 2014 </P>
<P>24;2:855-64</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Vascular restenosis</P>
<P>감소효능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>CU03</P>
</TD>

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>Extract of Moutan radicis cortex and Cinnamomi ramulus ameliorates laser-induced choroidal neovascularization in Brown-Norway rats</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Phytomedicine,심사中</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>CNV 동물모델 효능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>CU05</P>
</TD>

<TD WIDTH="498" VALIGN="MIDDLE" HEIGHT="53">
<P>AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation</P>
</TD>

<TD WIDTH="270" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>J Cell Biol. 211(3): 619-37 (2015)</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기전 규명</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>(5) 연구개발 완료 실적당사는 보고서 작성기준일 현재 연구개발 완료 실적이 없습니다.(6) 연구활동 및 판매 중단 현황당사는 보고서 작성기준일 현재 연구활동 및 판매 중단 현황이 없습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-7-L1">7. 기타 참고사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 지적재산권 보유 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-1|ADX-1">※상세 현황은 '상세표-4. 지적재산권 보유 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당사는 파이프라인의 시장 진입장벽을 확보하기 위하여 특허권 보유전략 및 관리체계를 확립하였고, 핵심특허의 지역적 실효성 평가를 통해 플랫폼 및 파이프라인에 대한 다양한 특허 출원 및 등록으로 광범위한 지적재산권을 확보하고 있습니다. 현재 당사의 지적재산권 현황은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="641" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="135"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>특허</P>
<P>(전용실시권)</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>등록</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>25 (3)</P>
</TD>

<TD ROWSPAN="2" WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>상표권</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>등록</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>9</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>출원</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>49 (4)</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>출원</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>6</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="640" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>CU06</P>
</TH>

<TH COLSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>CU01</P>
</TH>

<TH COLSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>CU03(전용실시권)</P>
</TH>

<TH COLSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>CU02</P>
</TH>

<TH COLSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>CU05</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>등록</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>출원</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>등록</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>출원</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>등록</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>출원</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>등록</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>출원</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>등록</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>출원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>12</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>26</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>7</P>
</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">18</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(3)</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2(4)</P>
</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">나. 영업에 영향을 미치는 법률 또는 제규정</SPAN>의약품의 제품 개발에서 의약품이 판매되기 위해서는 신약후보물질의 발굴에서부터 동물을 대상으로 하는 비임상시험, 인체를 대상으로 하는 임상 1상부터 3상 시험, 신약 판매 허가라는 각 단계를 모두 거쳐야 합니다. 모든 단계에서 한국을 포함한 각 국가는 엄격히 허가 및 규제기관을 통해 통제되고 있으며, 본 사업과 밀접하게 연관된 국내외 규제는 『약사법』, 『의약품 등의 안전에 관한 규칙』, 『생명윤리 및 안전에 관한 법률』, 『국민건강보험법』, 『독점규제 및 공정거래에 관한 법률』, 『The Food, Drug and Cosmetic Act, the Code of Federal Regulations』 등의 법령과 미국(FDA), 유럽 (EMEA) 및 일본 (PMDA) 등의 선진국의 규제가 매우 엄격합니다. 이에 당사는 연구개발 초기단계부터 관련국에 규격에 맞게 모든 자료를 준비하고 있고 해외 컨설턴트와 지속적으로 협업하여 진행하고 있습니다.
<SPAN USERMARK=" B">다. 산업의 특성</SPAN>(1) 산업의 특성제약산업(Pharmaceutical Industry)은 「약사법」제2조제4호와 「제약산업 육성 및 지원에 관한 특별법」제2조에는 의약품을 연구개발ㆍ제조ㆍ가공ㆍ보관 및 유통하는 것과 관련된 산업으로 정의되어 있습니다. 전 세계적으로 고령화로 인한 뇌/심혈관 질환, 난치성 및 만성 질환 환자 규모는 증가하여 제약산업은 꾸준히 성장하고 있습니다. 제약산업은 인간의 생명과 보건에 관련된 제품을 개발하고 생산하는 첨단산업으로서 우수한 의약품 개발과 접근성 제고를 통해 질병으로 인한 사회적 비용 감소 등 국민 건강증진 및 건강권 확보와 직결된 산업입니다.(2) 의약품의 분류
</P>
<P>의약품은 제조방식에 따라 화학합성으로 제조되는 합성의약품, 천연물로부터 약효를 가진주성분을 함유하는 천연물의약품, 생물학적 제제로서 재조합 단백질, 백신, 혈액제제를 포함하는 생물학적 반응을 이용하여 제조하는 바이오의약품으로 분류되며, 「약사법」제2조제10항에 따라 일반의약품(Over the Counter Drug, OTC)과 전문의약품(Ethical the Counter Drug, ETC)으로 구분됩니다.</P>

<TABLE WIDTH="627" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="618"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[의약품의 분류]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="628" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="68"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="412"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">의약품 구분</TH>
<TH WIDTH="421" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="159">제조방식</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">합성의약품</TD>
<TD WIDTH="421" VALIGN="MIDDLE" HEIGHT="53">실험실에서 유기화학에 기반하여 합성에 의해 인위적으로 만들어진 저분자 화합물 의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">천연물의약품</TD>
<TD WIDTH="421" VALIGN="MIDDLE" HEIGHT="53">약용식물 등 이미 존재하는 천연물로부터 약효를 가진 성분만을 분리 정제하여 만든 의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">바이오의약품</TD>
<TD WIDTH="421" VALIGN="MIDDLE" HEIGHT="53">생물체(미생물, 동식물 세포 등)를 활용하여 바이오기술을 응용하여 만들어진 의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="175">의사 처방유무</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">전문 의약품</TD>
<TD WIDTH="421" VALIGN="MIDDLE" HEIGHT="76">일반의약품이 아닌 의약품을 말하는 것으로, 약리작용 또는 적응증으로 볼 때, 의사의 전문적인 진단과 지시·감독에 따라 사용되어야 하는 의약품 (Ethical the Counter Drug, ETC)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">일반 의약품</TD>
<TD WIDTH="421" VALIGN="MIDDLE" HEIGHT="99">의약품의 제형과 약리작용상 인체에 미치는 부작용이 비교적 적거나, 오용·남용의 우려가 적고 의사나 치과의사의 처방 없이 사용하더라도 안전성 및 유효성을 기대할 수 있는 의약품(Over the Counter Drug, OTC)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당사는 난치성 혈관질환의 First-in-Class 혁신신약으로 합성의약품(CU06-RE, CU01)과 천연물의약품(CU03)의 연구 개발을 진행하고 있으며, 해당 파이프라인들은 약리작용 또는 적응증으로 볼 때, 의사의 전문적인 진단과 지시/감독에 따라 사용하는 전문의약품(ETC)으로 분류됩니다.</P>
<P>(3) 산업의 특성당사가 추진 중인 사업은 제약 및 바이오산업에 속해 있으며, 동 산업의 특성은 다음과 같습니다.- 각 국가별 식품의약국의 규정 준수 필요신약은 기존 약물의 유효성 혹은 안전성 측면에서 현저한 개선이 포함되어야 하며, 신물질 탐색 작업, 비임상 시험, 임상시험, 허가 신청 (NDA) 등을 거쳐 제조 승인 및 시판허가를 받은 의약품을 말합니다. 한 개의 신약이 나오기 위해서는 여러 단계를 수행해야 합니다. 첫 번째로 신약 후보물질을 도출하기 위한 탐색 과정에서 신약의 효능이나 작용기전을 기반으로 신약개발 대상 품질을 선정합니다. 유효물질, 선도물질을 거쳐 신약 후보물질이 선정되면 후보물질의 안전성과 효과를 확인하기 위해 동물 모델을 대상으로 비임상시험을 진행합니다. 비임상시험을 통해 후보물질의 효과와 안전성이 검증되면 식약처에 임상시험 허가신청 (IND)을 하고, 사람을 대상으로 약물의 효과 및 부작용을 확인하는 임상시험 (Clinical Trial)을 수행합니다. 임상시험을 완료한 후에는 식약처에 임상시험 결과를 제출하게 되는데, 이를 신약 허가신청(NDA) 이라고 합니다. 신약 허가 신청이 정상적으로 이루어지면, 제4상 임상시험으로 분류되는 시판 후 안전성 조사(PMS)를 통해 임상시험에서 발견하기 어려웠던 부작용에 대해서 추적 조사를 수행합니다. 이처럼 새로운 의약품이 개발되어 소비자에게 전달되기까지는 높은 비용과 노력이 필요하며, 시판으로 이어질 확률은 10,000분의 1 정도로 낮은 편입니다. 이렇게 성공 가능성이 낮지만, 성공했을 경우 특허법, 각 국가별 약사법 등으로 독점적 시장 보호가 가능하고 막대한 경제적 가치를 창출할 수 있기 때문에 글로벌 시장에 도전하는 신약개발은 여전히 매력적인 사업입니다.- 다양한 정책에 따른 높은 진입장벽 존재신약개발 산업은 높은 기술력과 천문학적인 개발비용, 국가별 허가 당국의 시판 승인 등 진입장벽이 상당히 높은 편입니다. 또한 특허법, 의약품 특허존속기간 연장제도, 희귀의약품 지정제도, 의약품 자료 독점권 제도 등 신약 개발사에 혜택을 주는 다양한 보호 제도가 있어 제네릭사의 시장 진입을 제한하고 있습니다.</P>
<P>- 국내 의약품 시장의 글로벌 성장성</P>
<P>글로벌 제약산업 시장 조사기관인 IQVIA가 발표한 리포트에 따르면 2021년 글로벌 제약산업 시장 규모는 1조 4,003억 달러를 형성하고 있으며 이후 연평균 4.1%로 성장하여 2025년에는 1조 6,420억 달러에 달할 것으로 예상됩니다. 대한민국의 제약산업 시장 규모는 2021년 179억 달러에서 글로벌 성장보다 빠른 연평균 5.8%의 성장을 통해 2025년에는 224억 달러를 형성할 것으로 예상됩니다.  2021년 기준으로 대한민국의 제약산업 시장 규모는 글로벌 전체 시장 규모의 1.27%를 차지하고 있으며 국내 제약기업과 바이오벤처가 다국적기업과의 기술 제휴 또는 라이선스 아웃 등을 통해 글로벌 파트너사와 임상 개발을 진행하여 경험과 노하우를 습득하면서 고도화되고 있어 향후 글로벌 성장성 대비 높은 성장성을 보이며 시장이 확대될 것으로 보입니다.- 고부가가치 산업제약산업은 다른 어떤 산업보다도 기술과 자본이 집약된 ‘고부가가치 지식산업’으로, 개발된 의약품의 제조원가 자체는 매우 낮지만, 장기적인 R&D 투자를 통한 신약개발 여부가 성패를 좌우하는 특성을 가집니다. 글로벌 신약개발 시 평균 1조 원에서 2조 원에 이르는 개발비용과 10~15년의 개발기간이 소요되며, 더욱이 신약개발 성공확률은 5,000분의 1에 불과한 것으로 알려져 있습니다. 후보물질 발굴 단계에서 5,000~10,000개의 화합물이 R&D 파이프라인으로 들어간 이후 전임상단계에서 약 250여 개의 연구를 거쳐 임상단계에서 2~5개가량만 남게 되며, 이중 1개만이 최종 판매허가를 받고 상용화됩니다.신약 하나를 개발하기 위해서는 장기간에 걸친 R&D 과정에서 막대한 자본과 인력의 지속적인 투입이 수반되지만 성공을 확신할 수 없습니다. 그러나, 이른바 ‘죽음의 계곡’을 넘어 신약 개발에 성공하게 되면, 확실한 시장 우위를 점하며 그동안의 R&D에 투자한 것 이상의 많은 이익을 회수할 수 있습니다. 다국적 제약사 화이자에서 출시한 '비아그라(성분 실데나필)'는 임상 실패 이후 신약 재창출 과정을 통해 큰 성공을 거둔 사례입니다. 실데나필은 협심증 치료를 목표로 개발된 약물이었지만, 임상 실패 이후 발기부전 치료제로 재탄생했습니다. '20세기 최고의 발명품'으로 불리는 비아그라는 1998년 5월 출시 이후 단 3개월 만에 4억 달러(약 4,700억 원) 규모, 지난 20년 간 연간 평균 18억 달러(약 2조 1,300억 원) 규모의 매출을 기록하여 대표적인 블록버스터급 의약품으로 알려져 있습니다. 같은 회사에서 출시한 고지혈증 치료제 '리피토’는 2010년 무려 127억 달러의 매출을 기록하였는데, 이는 '자동차 100만 대 수출' 수익보다도 높은 수준입니다.- 주력 기술제품의 산업의 연혁</P>
<P>당뇨병은 췌장에서 분비되는 인슐린이 부족하거나 우리 몸에서 제대로 작용하지 못하여 혈액 속의 혈당이 에너지로 이용되지 않고 혈액 속에 축적되어 고혈당 증상과 이로 인한 합병증을 나타내는 질환입니다. 2017년에는 전세계적으로 당뇨 환자가 4억 5천 1백만 명(18세~99세) 발병했고 2045년경에는 6억 9천 3백만 명으로 증가할 것으로 예상되고 있으며, 당뇨 의약품 시장 또한 폭발적으로 증가하여 2026년경에는 950 ~ 1020억 달러(107 ~ 115조원)에 이를 것으로 추정되고 있습니다. 이와 같이 당뇨병 환자의 증가와 함께 고령인구 증가로 당뇨합병증 시장 또한 높은 성장성이 예상되어 글로벌제약사들이 치료제 개발을 위해 많은 투자를 진행하고 있습니다.</P>
<P> </P>
<P>합병증은 크게 혈관 합병증과 신경 합병증으로 나눌 수 있으며, 혈관 합병증은 다시 대혈관 손상과 미세혈관 손상으로 나눌 수 있습니다. 대혈관이 손상되면 협심증, 동맥경화, 심근경색, 뇌졸중이 발병하고 미세혈관이 손상되면 망막병증, 신장병, 신경병, 족부궤양 등의 다양한 합병증이 나타날 수 있습니다. 그리고 신경 합병증은 말초신경장애와 자율신경장애로 나누어 집니다.</P>
<P> </P>
<P>혈관 합병증의 원인은 아직까지 확실히 밝혀져 있지 않으나 대혈관 손상의 경우 고혈합, 고지혈증이 동반되면서 복합적인 원인에 의해 발생하는 것으로 알려져 있습니다. 또한 제2형 당뇨병 환자에서는 비만과 관상동맥질환 등이 위험인자로 작용함으로써 고혈당의 치료와 더불어 이들 질환의 치료가 동시에 이루어져야 합병증의 진행을 막을 수 있습니다. </P>
<P> </P>
<P>미세혈관 합병증 중 하나인 당뇨병성 신증은 당뇨환자의 주요 사망요인으로 아주 서서히 진행되기 때문에 초기에는 검사로도 식별이 어려우며 환자에 따라 다르나 대개 15년 정도 지난 후에 단백뇨 증상이 나타나게 됩니다. 처음에는 단백뇨로 인해 부종이 발생하고 더욱 진행이 되면 노폐물이 신장에서 배설되지 않음으로써 만성 신부전증으로 결국 요독증에 빠지게 됩니다. 당뇨병성 신증 치료제 중 신장 섬유화를 치료하는 전문치료제는 없으며, 질환의 원인이 될 수 있는 혈당과 혈압을 관리하는 치료제가 처방되고 있습니다. 60세 이상 당뇨병 환자 중 75%가 당뇨병성 신증 환자임을 고려할 때 전문치료제의 개발이 절실하다고 하겠습니다.</P>
<P>또한 미세혈관 합병증 하나인 당뇨황반부종도 당뇨병 환자에서 20년 유병 기간 후 약 30~50%정도 발생하는데, 25세 이후의 시력상실 질병 중 가장 많은 원인이 되고 있습니다. 그러나 모든 환자가 시력이 상실되는 것이 아니라 적극적으로 혈당을 조절하고 자주 검사하여 조기에 발견하면 예방할 수 있으며 그 진행속도 또한 늦출 수 있습니다. 최근에는 치료를 위해 혈관내피성장인자(VEGF) 저해제인 아일리아 혹은 루센티스를 유리체강 내에 주사(intravitreal injection)하여 치료제가 사용되고 있습니다. 다만, 2019년도 Scientific reports 에 의하면 이 약물에 불응성을 나타내는 환자가 41% 정도이고 약가는 각각 1,940달러/vial, 1,575달러/vial 로 상당히 고가여서 환자 및 국가 보험 재정에 부담을 주고 있어 높은 효능, 경제성, 투여방식 편의성 등의 측면을 개선할 수 있는 신약 개발이 필요한 상황입니다.</P>
<P>황반변성은 시력에 중요한 역할을 담당하는 망막중심부 신경조직인 황반이 노화, 염증 등으로 기능이 떨어지는 질환을 말하며 국내 65세 이상의 노인인구에서 실명을 일으키는 주요 원인으로 알려져 있습니다. 2017년 황반변성 환자는 70억 세계 인구의 약 8.3%인 5천800만명 이상으로 추정되고 있으며 2020년에는 환자수가 약 2억 명, 2040년경에는 약 3억명에 육박할 것으로 예측되고 있습니다. 당뇨황반부종도 동일하게 혈관 내피성장인자(VEGF) 저해제인 아일리아나 루센티스가 치료제로 사용되고 있으며 노령인구의 중가의 함께 황반변성 치료제 시장도 크게 성장할 것으로 예상됩니다.</P>
<P>(4) 산업의 전망- 글로벌 제약시장 전망글로벌 전문의약품(ETC) 시장은 지속적으로 성장해왔습니다. 전세계 전문의약품 매출액은 2020년 9,040억 달러(약 1,073조 원)에서 연평균 7.4%씩 성장해 2026년에는 1조 3,903억 달러(약 1,650조 원) 규모가 될 전망입니다. 이는 지난 2012∼2019년 처방의약품 매출액 연평균 성장률이 2.7%에 그친 것과 비교할 때 매우 빠른 성장세를 볼 수 있습니다.</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[전세계 전문의약품의 매출액(2012-2026)]</TD>
</TR>
</TBODY>
</TABLE>

<IMAGE>
<IMG WIDTH="600" HEIGHT="347" ALIGN="CENTER" HSPACE="0">전세계 전문의약품의 매출액(2012-2026).jpg</IMG>
<IMG-CAPTION ATOC="N">전세계 전문의약품의 매출액(2012-2026)</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11">자료: EvaluatePharma, World Preview 2020, outlook to 2026        생명공학정책 연구센터, 글로벌 제약산업 2020년 프리뷰 및 2026년 전망</SPAN>
</P>
<P>인구증가 및 고령화, 만성질환 증가, 규제장벽 완화, 맞춤형 치료제, 희귀병 치료제 등의 성장 요인(Market Drivers)에 따라 미국 FDA에서 최근 10년간(2010~2019년) 승인된 화학합성신약은 289건으로 이는 과거 10년(2000~2009년)에 비해 60% 증가되었습니다. 미국 FDA의 산업 친화적(industry-friendly) 입장은 유지 될 것으로 전망되며, 미국 FDA가 채택한 입장은 전세계 제약시장에 대한 투자심리를 결정하는 데 중요한 역할을 합니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[미국 FDA 신약 승인 현황(2010~2019)]</TD>
</TR>
</TBODY>
</TABLE>

<IMAGE>
<IMG WIDTH="598" HEIGHT="195" ALIGN="CENTER" HSPACE="0">미국 fda 신약 승인 현황 (2010~2019).jpg</IMG>
<IMG-CAPTION ATOC="N">미국 FDA 신약 승인 현황 (2010~2019)</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11">자료: FDA CDER, New Drug Therapy Approval 2019, 2020.01</SPAN>또한, 전세계적으로 신약 개발 기간 단축을 통한 효율성 제고를 위해 플랫폼 기술 도입이 늘어나고 있습니다. 전통적인 신약 탐색 과정에서 통상 약물 후보물질을 찾을 때까지 소요되는 시간과 비용을 플랫폼 기술을 활용함으로써 절감하려는 시도가 이루어지고 있습니다. 당사 또한 신개념 SOLVADYS® 플랫폼 기술을 이용하여 유효물질을 효율적으로 발굴하기 위한 초기 단계 연구개발을 적극적으로 진행하고 있으며 이 플랫폼을 통하여 신약개발기간을 효율적으로 단축시키고 실패를 줄일 수 있을 것으로 기대 하고 있습니다.
</P>
<P>(5) 경기변동의 특성- 라이프사이클</P>
<P>일반적으로 의약품은 관련된 특허의 존속기간(선출원 후 20년)이 만료될 때까지 독점적인 판매가 가능하며, 또한 국가별로 자료 및 시장독점권(Data & Market Exclusivity) 제도에 의하여 미국인 경우 신약 승인 후 5년간의 자료독점권을 그리고 유럽의 경우 자료독점권 8년에 시장독점권 2년을 추가로 부여하고, 희귀의약품으로 지정된 경우 미국은 7년 , 유럽은 11년간의 시장 독점권을 주는 것을 허용하는 등 다양한 제도를 통하여 독점적 판매권을 보장받을 수 있습니다.</P>
<P>당사는 신개념 SOLVADYS® 플랫폼 기술을 이용하여 난치성 혈관질환의 First-in-Class 혁신신약을 개발하고 있으며 각 파이프라인별로 물질, 용도(적응증/용법 용량). 조성물(제제, 병용투여), 결정형 및 제법 등 연구단계별 다양한 특허를 출원, 등록하는 evergreening 전략을 사용하여 특허의 존속기간을 연장하고 있습니다. 또한 특허존속기간 연장제도 (최장 5년 추가)로 대부분 제품이 2045년까지 특허보호를 받을 수 있어 제품 판매 후 13 ~ 17년간 시장 진입장벽이 존재할 것으로 예상합니다. </P>
<P>- 경기변동 및 계절성일반적으로 의약품은 크게 전문의약품(ETC)과 일반의약품(OTC)으로 분류됩니다. 전문의약품은 의사의 진단과 처방을 통해 약 복용이 엄격히 관리되어야 하는 의약품을 의미하며, 일반의약품은 안전성과 유효성이 충분히 인정되어 약사나 소비자가 임의로 선택할 수 있는 의약품을 의미합니다. 당사가 개발중인 파이프라인은 모두 전문의약품 분야에 속하며, 의학적 미충족 수요가 큰 영역이라 경기 변동에 거의 영향을 받지 않습니다.삶의 질 향상과 수명연장에 대한 요구가 높아지고 있고 GDP 수준 향상과 전세계적으로 고령화 사회가 확산됨에 따라 만성질환과 치매 같은 문제가 사회적 이슈로 대두되고 있어 이러한 추세로 인해 의약품 산업은 지속적이고 안정적인 증가가 예상됩니다. 한편, 의약품 산업의 특성상 국가별 의료 정책이나 약가 정책에 따라 변동성이 있을 수 있으나 당사가 개발중인 First-in-Class 혁신 신약의 경우 약가 결정에 이점이 있어 상대적으로 높고 안정적인 수익을 창출할 것으로 기대됩니다.앞서 설명한 바와 같이 당사가 개발중인 파이프라인은 모두 전문의약품 분야에 속하며, 당뇨합병증은 만성 질환이고 같은 유전적 또는 생활 환경 요인에 따라 발생되는 질환으로 날씨와 기후에 의한 계절적 요인에는 거의 영향을 받지 않습니다. 이와는 달리 일반의약품의 경우 소비자 선택으로 경기변동이나 기후에 의한 계절적 영향이 다소 있는 편입니다. 또한 인플루엔자나 전염성 질환 관련 의약품의 경우 계절, 환경적 요인에 따라 영향을 받을 수 있습니다.</P>

<P>- 대체재 현황당사에서 개발하고 있는 신약은 전문의약품(ETC)이며 의사의 진단과 처방에 의해서만 약을 구입할 수 있도록 제도적으로 엄격히 관리보호되고 있으며, 모든 단계에서 한국을 포함한 각 국가는 엄격히 허가 및 규제기관을 통해 통제되고 있으며 각 국가에서 설정한 기준에 의해 허가절차를 거쳐 승인을 받아야만 출시할 수 있습니다. 동일한 목표시장에 대해 경쟁제품이 있을 수 있으나 경쟁제품 상호 간에 제품의 약효와 안전성이 완전히 일치하는 신약은 존재할 수 없습니다.연구단계별 다양한 특허를 출원, 등록하는 evergreening 전략을 사용하여 특허의 존속기간을 연장하고 있습니다. 다만, 특허기간이 만료된 이후에는 다수의 복제약(제네릭/바이오시밀러)이 출시되어 오리지널 의약품이 경쟁력을 잃고 대체될 수 있겠으나, 특허 만료 이후에도 오리지널 제품에 대한 수요가 일정 부분 지속적으로 존재하는 현상이 있습니다
<SPAN USERMARK=" B">라. 회사 경쟁상의 특징</SPAN>- 당뇨 황반부종 치료제
</P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">글로벌 시장 조사 전문기관인 Global Market Insights 2016에 따르면 당뇨황반부종 및 습성 황반변성 치료제는 anti-VEGF 주사제인 Eylea, Lucentis, Avastin 등이 90%의 시장 점유율을 차지하고 있으며, 연평균 6%의 증가가 예상됩니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="753">

<COLGROUP>
<COL WIDTH="744"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="753" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[시판되고 있는 anti-VEGF, Steroid 유리체강내 주사제]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="751" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="107"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="243"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제품명(성분명)</P>
</TH>

<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제약사</P>
</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년 매출</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가격</TH>
<TH WIDTH="252" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Lucentis</P>
<P>(ranibizumab)</P>
</TD>

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Novartis/Genetech</P>
</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전세계 매출4조 6천억원</TD>
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">824,513~941,098원</TD>
<TD ROWSPAN="3" WIDTH="252" VALIGN="MIDDLE" HEIGHT="159" ALIGN="CENTER">시장에 주사제외에 경구제가 존재하지 않고, Endothelial dysfunction을  차단 하는 약물 역시 존재하지 않기에, First-in-class & Oral agent로 시장 진입 가능</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Avastin</P>
<P>(bevacizumab)</P>
</TD>

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Roche</P>
</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전세계 매출7조 5천억원</TD>
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">330,387~346,320원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Eylea</P>
<P>(aflibercept)</P>
</TD>

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Regeneron/Bayer</P>
</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전세계 매출8조 3천억원</TD>
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">751,493~851,788원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">자료: ㈜큐라클</SPAN>
</P>

<P USERMARK="F-DU11 0X513543">
<SPAN USERMARK="F-BT12 0X000000">하지만, anti-VEGF 안구내 주사제는 모두 병증이 많이 진행된 후에 처방되어 진단 초기 경증의 환자에게는 투약의 제한이 있습니다. 당뇨환자 중 당뇨황반부종 진단 후 첫해에 치료(anti-VEGF 항체, Laser치료, corticosteroid 및 병용 치료 등)를 받고 있는 환자는 40% 미만으로 60% 환자가 약물투여를 제대로 받지 못하는 것으로 알려져 있습니다. 이에 진단받은 후 많은 환자는 병의 진행을 악화시키고 있다고 볼 수 있어 환자에게 복용편의성이 높은 적절한 경구치료제가 개발된다면 환자의 삶의 질을 향상시킬 뿐만 아니라 엄청난 시장을 확보할 것으로 기대하고 있습니다.</SPAN>
</P>
<P> </P>

<P USERMARK="F-DU11 0X513543">
<SPAN USERMARK="F-BT12 0X000000">CU06-RE는 anti-VEGF 주사제와 비교하여 당뇨황반부종 및 습성 황반변성과 같은 다양한원인 인자에 기인되는 혈관 손상 및 누수를 치료할 수 있는 최적의 치료제입니다. 또한 경구 투여에 의한 복용편의성으로 만성질환인 당뇨황반부종 및 습성 황반변성 치료제로 개발된다면 글로벌 시장에서 충분히 경쟁력이 있습니다.</SPAN>
</P>
<P> </P>
<P>현재 세계적 제약기업 및 신약벤처들이 아래 다양한 타깃의 당뇨황반부종 치료제 개발에 집중하고 있습니다. </P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="158"></COL>
<COL WIDTH="424"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="53">▶ 유리체강내 주사제:</TD>
<TD WIDTH="433" HEIGHT="53">VEGF 외에 Tissue-protective receptor, Corticosteroid, c-Raf kinase, Plasma kallikrein, PIGF, pan RGD integrin 타깃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30">▶ 점안제:</TD>
<TD WIDTH="433" HEIGHT="30">Bradykinin receptor B1, Plasma kallikrein 타깃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30">▶ 경구제: </TD>
<TD WIDTH="433" HEIGHT="30">Steroid ethisterone, C-Kit, Plasma kallikrein 타깃 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P USERMARK="F-DU11 0X513543">
<SPAN USERMARK="F-BT12 0X000000">대표적인 혈관내피세포 타겟 치료제는 anti-VEGF 중화 항체로 주로 항암 및 망막 혈관질환 치료제로 사용되고 있습니다. 망막 혈관질환 치료제의 경우, 전세계 시장규모가 년간 150억 달러를 상회함에도 불구하고 안구내 주사의 불편함과 2019년도 Scientific reports 에 의하면 41% 의  불응 환자로 인하여 치료의 한계가 있어 대체 치료제가 절실하게 필요한 상황입니다 (자료: Scientific reports, 9(1), 10952) </SPAN>
</P>
<P>- 당뇨병성 신증 치료제</P>
<P>현재 당뇨병성 신증 치료제는 고혈압 및 당뇨병 치료제가 주로 사용되고 있습니다. </P>

<P USERMARK="F-DU11">
<SPAN USERMARK="F-BT12">안지오텐신 전환효소억제제(angiotensin converting enzyme inhibitor), 안지오텐신 II 수용체 차단제(angiotensin II receptor blocker) 등 고혈압 치료제가 있습니다.</SPAN>
</P>

<P USERMARK="F-DU11 0X513543">
<SPAN USERMARK="F-BT12 0X000000">J&J사의 Canagliflozin(Invokana), AstraZeneca/Mitsubishi Tanabe의 Dapagliflozin이 SGLT-2 억제제(Sodium Glucose Co-Transporter 2, 신장에서 포도당이 재흡수되는 것을 억제하여 소변으로 포도. 당이 배출되도록 하는 기전)인 당뇨병 치료제로 당뇨병성 신증 치료제로서 허가 받고 사용되고 있습니다.</SPAN>
</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="629">

<COLGROUP>
<COL WIDTH="620"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="629" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[시판되고 있는 고혈압 및 당뇨병치료제]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="631" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제품명(성분명)</P>
</TH>

<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제약사</P>
</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년 매출</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가격</TH>
<TH WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Cozaar(Losartan Potassium)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">BoehringerIngelheim</TD>
<TD WIDTH="110" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">1조원</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">416~585원</TD>
<TD ROWSPAN="2" WIDTH="178" VALIGN="MIDDLE" HEIGHT="106" ALIGN="CENTER">당뇨병성 신증 환자에게 보조치료제로 쓰임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Micardis (Telmisartan)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">MSD</TD>
<TD WIDTH="110" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">6,500억원</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">481원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Ozempic(semaglutide)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Novo nordisk</TD>
<TD WIDTH="110" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">3조 8천억원</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">TBD</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="106" ALIGN="CENTER" ROWSPAN="2">직접적인 경쟁관계 약물은 아님</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Trulicity (dulaglutide)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Lilly</TD>
<TD WIDTH="110" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">5조 6천억원</TD>
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">19,811~ 32,129원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">자료: ㈜큐라클</SPAN>
</P>

<P USERMARK="F-DU11 0X513543">
<SPAN USERMARK="F-BT12 0X000000">만성 신섬유증 치료제로 섬유화 진행을 억제하는 시장에 나온 경쟁 약물은 없습니다. CU01은 Nrf2 활성과 TGF-β/Smad3 억제 기전의 First-in-Class 약제로 항산화 및 섬유화 억제 작용을 갖고 있어 신섬유증 및 신섬유증을 수반하는 만성신장질환 환자의 예방 및 치료에 사용될 수 있고 발 빠른 국내 출시를 목표로 후기임상을 준비하고 있습니다.</SPAN>
</P>
<P> </P>

<P USERMARK="F-DU11">
<SPAN USERMARK="F-BT12">당사의 CU01은 물질특허가 없는 블록버스터 의약품이며 약물의 안전성이 확보된 Tecfidera의 주성분인 DMF를 신약재창출 방법으로 재평가하여 Nrf2 활성제 및 TGF-β/Smad3 억제 기전으로 당뇨병성 신증 모델에서 우수한 효능을 보였고, 당사가 국내에서 진행한 임상 2a상 시험에서 유효성, 안전성 및 내약성을 확보하였습니다.</SPAN>
</P>
<P> </P>
<P>- 습성 황반변성 치료제</P>
<P>글로벌 시장 조사 전문기관인 Global Market Insights 2016에 따르면 습성 황반변성치료제 시장도 anti-VEGF 제제가 90%를 차지하고 있으며, 연평균 6%의 증가가 예상됩니다.</P>
<P> </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="753">

<COLGROUP>
<COL WIDTH="744"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="753" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[시판되고 있는 anti-VEGF, Steroid 유리체강내 주사제]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="751" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="107"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="243"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제품명(성분명)</P>
</TH>

<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제약사</P>
</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년 매출</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가격</TH>
<TH WIDTH="252" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Lucentis</P>
<P>(ranibizumab)</P>
</TD>

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Novartis/Genetech</P>
</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전세계 매출4조 6천억원</TD>
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">824,513~941,098원</TD>
<TD ROWSPAN="3" WIDTH="252" VALIGN="MIDDLE" HEIGHT="159" ALIGN="CENTER">시장에 주사제외에 경구제가 존재하지 않고, Endothelial dysfunction을  차단 하는 약물 역시 존재하지 않기에, First-in-class & Oral agent로 시장 진입 가능</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Avastin</P>
<P>(bevacizumab)</P>
</TD>

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Roche</P>
</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전세계 매출7조 5천억원</TD>
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">330,387~346,320원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Eylea</P>
<P>(aflibercept)</P>
</TD>

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Regeneron/Bayer</P>
</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전세계 매출8조 3천억원</TD>
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">751,493~851,788원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">자료: ㈜큐라클</SPAN>
</P>

<P USERMARK="F-DU11 0X513543">
<SPAN USERMARK="F-BT12 0X000000">경구제로는 growth factor 저해제, kinase 저해제, 활성산소를 제거하는 항산화제, DNA lygase 등의 저분자 물질로 주로 단일 타깃을 저해하는 물질이 개발되고 있고 현재 시장에 나온 제품은 없습니다.</SPAN>
</P>
<P USERMARK="F-DU11"></P>
<P>천연물 신약인 CU03는 만성 난치성 질환의 다양한 병인에 의하여 발병되는 습성 황반변성의 경구용 치료제로 환자에게 복용 편의성 및 안전성을 제공하여 장기적 투여가 가능하고 기존의 주사제와 차별성이 있습니다. 당사는 천연물의 multi-component and multi-target (다중 성분과 다중 타깃)의 작용 원리로 다양한 인자가 원인이 되는 만성질환의 치료제 CU03를 개발하고 특허의 특허연장 전략으로 천연물 중 성분함량, 임상시험에 의한 용량, 추가 적응증 확보 등을 기반으로 특허를 출원하여 특허권리 확보 및 권리기간 연장을 할 계획입니다. 새로운 개념의 경구용 혈관내피기능장애 치료제는 전 세계적으로 당사가 유일하고 신약개발의 특성상 글로벌 제약사가 단기간 내에 진입하기는 어려울 것으로 봅니다.</P>

<P USERMARK=" B">마. 용어해설
<SPAN USERMARK=" !B">당사가 영위하는 사업의 내용을 이해하기 위하여 개념 정리가 필요한 용어에 대한 해설은 다음과 같습니다.</SPAN>
</P>

<TABLE WIDTH="1091" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1082"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1091" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[주요 용어 정리]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1098" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="366"></COL>
<COL WIDTH="714"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>용어</P>
</TH>

<TH WIDTH="723" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>해설</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>당뇨합병증</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>당뇨병이 발생하여 췌장에서 분비되는 인슐린이 부족하거나 우리 몸에서 제대로 작용하지 못하여 혈액 속의 혈당이 에너지로 이용되지 않고 혈액 속에 축적되어 고혈당증상과 이로 인한 합병증을 나타내는 질환입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>당뇨병성 신증(DN; Diabetic Nephropathy)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>미세혈관에 발생하는 당뇨 합병증으로 신장이 손상되어 단백뇨와 부종, 고혈압이 동반되고 노폐물이 신장에서 배설되지 않음으로써 만성신부전으로 진행되는 질환입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>당뇨병성 황반부종(DME; Diabetic Macular Edema)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>당뇨병으로 인하여 안구의 모세혈관의 파괴로 인하여 시각 세포가 손상되어 시력상실을 일으키는 질환입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">당뇨망막병증(DR; Diabetic Retionopathy)</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>당뇨병에 의한 발생하며 고혈당으로 인하여 일어나는 말초 순환장애로 인하여 망막에 발생하는 합병증입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">망막색소상피 박리(PED; Pigment epithelial Detachment)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">망막의 10개층 중에 가장 아래층을 구성하는 1개 층으로 유일하게 색소를 지니고 있어 망막색소상피로 불리며, 망막색소상피가 그 아래의 맥락막으로부터 떨어지는 현상을 망막색소상피 박리라고 합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">맥락망신생혈관(CNV; Choroidal Neovascularization)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">망상색소상피 박리로 생긴 공간에서 신생혈관이 자라나 맥락막신생혈관이 되며 우리 눈의 망막중에서 특히 중요한 황분부에 삼출물, 출혈 등을 일으켜서 중심시력에 영향을 주는 현상을 황반변성이라고 합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">습성 황반변성(wet AMD; wet Age-related macular degeneration)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">삼출성-연령관련 황반 변성, 시력에 매우 중요한 역할을 하는 황반에 나이가 들면서 드루젠(drusen), 망막 색소상피 위축(retinal pigment epithelial atrophy), 맥락막 신생혈관(choroidal neovascularization) 등 변화가 생겨 시력상실을 초래하는 질환입니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>생체 이용률</P>
<P>(Bioavailability)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>투여된 약물이 변화되지 않은 형태로 전신 순환혈에 도달하는 정도이며 주로 경구투여 시의 흡수정도를 의미하며, 약물의 화학적 형태, 제형, 투여경로, 위장관내 안정도, 초회통과효과 등에 영향을 받습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>신약후보물질</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>질병과 관련된 단백질(약물 타겟)의 기능을 조절하는 물질을 찾은 후 동물, 독성, 약물 체내동태 등을 평가하여 임상 개발 가치가 있는 물질로 선정하는 일련의 과정을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>신약허가신청</P>
<P>(NDA; new drug application)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>합성의약품에 대한 신약승인 신청서를 의미합니다. 바이오의약품의 경우는 BLA(Biologic License Application)라고 합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>임상시험(Clinical)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="99">
<P>임상시험용 의약품의 안전성과 유효성을 증명할 목적으로 해당 약물의 약동 · 약력 · 약리 · 임상적 효과를 확인하고 이상반응을 조사하기 위하여 사람을 대상으로 실시하는 시험 또는 연구를 총칭하는 것이며, 임상1상, 임상2상 (임상2a 와 임상2b를 구분하여 진행할 수도 있음), 임상3상 크게 3단계로 구분하여 운영되고 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>임상1상(Phase 1)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="99">
<P>건강한 사람을 대상으로 약물을 안전하게 부여할 수 있는 용량과 인체 내 약물흡수 정도 등을 평가합니다. 앞서 수행된 전임상 단계에서 독성시험 등 전임상시험 결과가 유효한 경우, 시험약을 최초로 사람에 적용하는 단계입니다. 건강한 지원자 또는 약물군에 따른 적응환자를 대상으로 부작용 및 약물의 체내동태 등 안전성 확인에 중점을 두고 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>임상2상(Phase 2)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="99">
<P>소규모 환자들을 대상으로 약물의 약효와 부작용을 평가하고, 유효성을 검증하는 단계입니다. 단기투약에 따른 흔한 부작용, 약물동태 및 예상적응증에 대한 효능 효과에 대한 탐색을 위해 실시하는 것으로 대상질환 중 조건에 부합되는 환자를 대상으로 합니다. 임상3상 시험에 진입하기 위해 적응증과 최적용법 용량을 결정하는 단계입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>임상 2a상</P>
<P>(Pilot study)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>약효확인, 작용시간 및 유효용량 검토하는 단계로 효과의 증거를 찾는 것이 목적입니다. 반드시 허가기관이 인정하는 변수를 사용하지 않아도 되며, 설계측면에서 여러 디자인 사용이 가능하고, 피험자 수도 통계적 검정력에 의해 결정하지만 디자인에 따라 현실적 이유를 반영하여 결정됩니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>임상 2b상</P>
<P>(Pivotal study)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>약효 입증, 용량-반응양상 검토, 최적의 용량 및 용법 결정하는 단계로 임상3상과 함께 허가의 핵심이 되는 단계입니다. 허가기관에서 인정하는 검증된 변수만을 사용해야 하고, 임상시험 디자인은 주로 평행군 시험으로 설계되며, 환자 수는 통계적 검정을 통해 결정됩니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상 3상</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>신약의 유효성이 어느 정도 확립된 후에 대규모(최소 수백 명에서 수천 명) 환자들의 자료를 식약처에 제출하여 승인을 받아야 판매가 가능합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>임상4상(PMS)</P>
<P>(시판 후 안전성, 유효성 조사)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>신약이 시판 사용된 후 장기간의 효능과 안전성에 관한 사항을 평가하기 위한 시험으로, 시판 전 제한적인 임상시험에서 파악할 수 없었던 부작용이나 예상하지 못하였던 새로운 적응증을 발견하기 위한 약물역학적인 연구가 실시되는데 이것을 시판 후 조사(Post Market Surveillance)라고 합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>유효성(Efficacy)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품 등이 그 적응증에 대해서 효능 및 효과를 갖는 것 또는 그 정도를 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>안전성(Safety)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품의 독성을 판단하는 것으로 그 사용용량과 투여방식에 있어 인체에 유해하지 않다는 것 또는 그 정도를 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>의약품 자료 독점권</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="122">
<P>데이터 독점권은 신약을 처음 개발한 혁신적인 회사를 보호하는 제도로 제네릭 또는 바이오시밀러를 개발하는 회사가 일정기간 동안 원개발사의 안전성, 유효성 자료 즉, 임상자료를 인용하지 못하도록 하는 제도입니다. 이럴 경우 후속개발자가 원개발사의 데이터 인용없이 의약품 허가를 받기 위해서는 임상을 수행해야 하기 때문에 경제적, 시간적 부담이 따르게 됩니다. 따라서 이 제도는 의약품 원개발사에게 유리한 제도입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>작용기전</P>
<P>(MOA; Mode of Action)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품이 효능을 나타내는 원리 및 치료 효능과 화학적 작용의 과정을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>전임상시험(Pre-Clinical)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="99">
<P>새로 개발한 신약후보물질을 사람에게 사용하기 전에 동물에게 사용하여 부작용이나 독성, 효과 등을 알아보는 시험입니다. 약물이 체내에 어떻게 흡수되어 분포되고 배설되는가를 연구하는 체내동태 연구와 약효약리 연구가 수행됩니다. 그 후 동물실험을 통해 시험약이 지니는 부작용 및 독성을 검색하는 안전성 평가를 진행하는 단계입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제형(Formula)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>약품을 인체에 투여하는 사용 목적이나 용도에 맞게 적절한 형태로 만든 물질을 의미합니다. (예: 정제, 캡슐제, 액제, 크림제, 주사제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>적응증</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>어떠한 약제나 수술 등에 의하여 치료효과가 기대되는 질병이나 증상을 의미합니다. 의약품의 적응증은 회사가 어떤 약을 허가 받기 위해 여러 효능시험과 성적서와 관련 논문, 안전성 자료 등을 종합하여 식품의약품 안전처에 제출하면 승인된 부분에 한해서 적응증으로 사용할 수 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">최종당화산물(AGEs;advanced glycation end products)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="122">당화(Glycation)는 우리 몸, 피부 등에 있는 단백질(콜라겐, 엘라스틴), 핵산(DNA), 지질 등에  당(포도당glucose, 과당fructose)이 효소작용 없이( 비효소반응) 공유 결합하여 단백질(콜라겐, 엘라스틴), 핵산(nucleotides), 지질의 물성이 변하는 현상을 말하며 이때 생성되는 당화산물(AGE, advanced glycation end product) 은 축적되어 노화 및 질병(당뇨합병증, 동맥경화)의  유발 과정에 깊이 관여한다는 것이 알려있습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>체내동태</P>
<P>(Pharmacokinetics, PK)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>생체 내 투여된 약물은 흡수되어 작용부위에 도달해 약효를 발현하고 생체 내에 분포합니다. 그리고 간 등에서 분해(대사)되고 뇨중으로 배설되어 생체로부터 소실됩니다. 이러한 약물의 생체 내 이행과 변화의 과정을 약물의 체내동태라고 합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>합성의약품 신약</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>화학적 합성에 의하여 생산되는 의약품으로 바이오의약품과 비교 시 QC 관리가 용이하고 생산단가가 저렴한 것이 특징입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">혈액-뇌 장벽(BBB; Blood-Brain Barrier) </TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="99">뇌-혈관장벽은 뇌와 혈액을 보다 격리시키는 혈관 장벽으로 높은 선택적 투과성을 갖고 있어 뇌를 포함한 중추신경계의 조절기능을 세균 등과 같은 혈액으로 운반될 수 있는 병원체와 혈액 내의 잠재적인 위험 물질로부터 격리시키는 역할을 합니다. 또한, 생체항상성을 조절하고 뇌기능에 필수적인 물질들을 선택적으로 뇌속으로 전달하는 기능을 합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>혈관 투여(IV)</P>
<P>(Intravenous Injection)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>치료제를 정맥주사를 통해 주입하는 방법을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">ALI(acute lung injury)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">급성폐손상을 의미합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Amigo2-PDK1</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="30">Amigo2의 세포질 도메인과 PDK-1의 PH 도메인과의 결합을 의미합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Ang-2(Angiopoietin-2)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">신생혈관의 혈관성장인자를 의미합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">ARDS(Acute respiratory distress syndrome)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">급성호흡곤란증후군을 의미합니다. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>CDA(Confidential Disclosure Agreement)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>기밀 공개 계약을 의미하며 독점정보를 보호하고 당사자들이 일정기간 동안 정보를 기말로 유지하도록 구속하는 법적 계약입니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>CRO: 임상시험수탁기관(Contract research organization)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>제약회사가 신약개발에 드는 비용을 절감하기 위해 임상시험 연구를 아웃소싱하는 기관으로 임상시험수탁기관은 신약개발 단계에서 제약사의 의뢰를 받아 임상시험 진행의 설계, 컨설팅, 모니터링, 데이터 관리, 허가 대행 등의 업무를 대행해 주는 기관을 말합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>CMO: 위탁제조기관</P>
<P>(Contract Manufacturing Organization )</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>위탁 받은 제품을 생산해 주는 기업으로 바이오, 제약부문에서 주로 사용되는 용어입니다. 의약품 대량생산시설을 갖추고 있지 않거나 생산역량이 부족할 때 경영효율화를 위하여 바이오·제약 기업은 CMO를 활용함으로써 공장 건설에 필요한 초기투자 비용을 아끼고 생산원가를 낮출 수 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">CNV(Choroidal Neovascularization)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">안구내 맥락막 신생혈관을 의미합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">cGMP(Current Good Manufacturing Practice)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">강화된 의약품 제조 및 품질관리기준으로 미국 FDA가 인정하는 의약품 품질관리 기준입니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Drug Repositioning</P>
<P>(신약재창출)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>기존에 나와 있는 약물이 다른 질환에 쓰일 수 있게 하는 것으로, ‘약물 재창출’이라고 합니다. 이는 이미 출시된 약의 새로운 기전을 찾아 새로운 증상에 대해 쓰일 수 있도록 개발을 진행하는 전략입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">DMF(Dimethyl Fumarate)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">푸마린산에 메틸에스터기가 붙은 물질을 의미합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>FDA(Food and Drug Administration)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="99">
<P>미국의 식품의약국이며 미국 내에서 생산되는 식품·의약품·화장품 뿐만 아니라 수입품과 일부 수출품의 효능과 안전성을 주로 관리하고 있습니다. 또한 FDA는 전세계적으로 가장 엄격하고 신중한 시판승인 결정을 내리는 것으로 유명하기 때문에 세계적으로 공신력을 인정받고 있습니다. 참고로 한국 식약처는 MFDS, 중국 식약처는 CFDA 라고 합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>EMA(The European Medicines Agency)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>유럽연합(EU)을 통해 설립된 유럽식약청이며, 유럽연합(EU) 소속 국가들의 의약품관련 규제를 맞추고 관리·감독하는 기관입니다. 의약품 시판승인과 관련하여 미국의 FDA와 비슷한 수준의 엄격한 기준을 가지고 있으며 그 공신력 또한 인정받고 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>First-in-Class 신약</P>
<P>(혁신 신약)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="99">
<P>기존에 치료제가 없는 질병을 고치는 신약이거나 특정 질환에 사용되는 약품이 있지만 기존의 약물과 비교 시 효능, 독성 면이 개선된 약물을 의미합니다. 질병을 일으키는 단백질을 밝혀내고 이를 치유하는 최적의 물질을 찾아 동물실험을 하는 전임상, 안전성과 약효를 검증하는 임상 1·2·3상 단계를 거쳐 각국의 식약처에서 의약품으로 승인받은 신약을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>GLP: 우수 실험실 관리기준(Good Laboratory Practice)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>의약품, 화장품 등의 안전성 평가를 위해 실시하는 각종 독성 시험의 신뢰성을 보증하기 위한 기준으로 '비임상시험 관리 기준’ 또는 '우수 실험실 운영기준' 이라고도 합니다. 식약처로부터 적격성을 승인 받아야 GLP기관의 자격이 부여됩니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>GCP: 임상시험 실시 기준(Good Clinical Practices)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>인체를 대상으로 하는 시험의 안전성 및 유효성 검증 절차를 규정하는 기준으로 시험결과에 대한 신뢰성 뿐만 아니라 시험 대상자의 인권보호 등 임상시험이 윤리적인 배려 하에 과학적으로 시행되도록 국가가 정한 기준을 말합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>GMP: 우수의약품 제조관리기준(Good Manufacturing Practice)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="99">
<P>의약품의 안정성과 유효성을 확보하기 위해 준수해야 하는 우수 의약품의 제조 관리 기준, 우리나라의 KGMP, 미국의 cGMP(Current Good Manufacturing Practice)와 유럽 EU GMP(또는 who GMP) 등 국가별 GMP규정을 두고 운영하고 있으며, 식약처의 실사 및 정기적 관리보고를 통해 적격성을 승인받아야 자격이 부여 됩니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>IVT 주사</P>
<P>(Intravitreal Injection)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>안구 내 약물 전달을 위해 유리체 내에 약물을 직접 주사하는 방법을 의미합니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">I/R injury(ischemia-reperfusion injury)</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>허혈/재관류 손상. 막힌 혈관을 재관류할 때 허혈조직으로의 혈류 회복과 산소화로 더 많은 조직 손상을 초래하는 현상입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">IBD(Inflammatory bowel disease)</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>만성염증성 장염을 의미합니다. 발병의 원인은 불명확하며 궤양성대장염과 크론병이 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>IND 신청: 임상시험계획 승인 신청</P>
<P>(IND; Investigational New Drug application)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">
<P>인체를 대상으로 한 안전성·유효성 자료 수집을 목적으로 해당 의약품을 사용하여 임상시험을 실시하고자 하는 자가 식약처에 승인을 신청하는 과정으로 신약개발의 경우 반드시 허가당국의 승인이 있어야 진행할 수 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>MTA(Material Transfer Agreement)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>물질이전계약을 의미하며 수신자가 자신의 연구목적으로 사용하려는 경우 두 조직간이 유형연구자료 혹은 물질을 이전하기 위해 체결하는 계약입니다.  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>MFDS</P>
<P>(한국 식품의약품안전처,Ministry of Food and Drug Safety)</P>
</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">식품과 의약품에 관해 임상실험이나 안전검증 등을 하여 국민들의 건강에 유익하거나 유해한 식품, 의약품을 분류, 고시, 단속하는 등의 업무를 수행합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NASH(Non-alcoholic steatohepatitis)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">비알콜성지방간염을 의미합니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">Nrf2(Nuclear factor erythroid 2-related factor 2)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">다양한 항산화 유전자들을 증가시킴으로써 세포 방어 기전에 중요한 역할을 담당하는 물질입니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>NCD 자료공개(Non-confidential data)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>기밀이 아닌 데이터의 자료공개를 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>NDA(Non-Disclosure Agreement)</P>
</TD>

<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">
<P>비공개 계약을 의미합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">SGLT2(Sodium glucose co-transporter 2)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">나트륨 / 포도당 공동 수송체 2를 의미하며, 신세뇨관에서 포도당이 재흡수되어 혈류 내로 들어가는데 이용됩니다..</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">TGF-β(전환성장인자 베타, Transforming growth factor-beta)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="76">상피세포와 조혈세포의 성장, 이동, 분화 및 사멸 등을 조절하여 세포의 성장과 고사를 통한 생물의 항상성 유지에 기본이 되는 세포 성장인자이며, 당뇨 병성 신증에서 TGF-β에 의해 활성화되어 혈관간세포가 콜라겐을 형성하는데 중요한 역할을 하는 것으로 알려져 있습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">TNF-α(tumor necrosis factor alpha)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">염증반응에 포함되고 급성기 반응의 구성원인 사이토카인입니다. TNF-α는 주로 활성화된 대식세포에 의해 분비되는데, 보조 T 세포, 자연살해세포, 그리고 손상된 뉴런 등의 다양한 세포에서도 분비됩니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">TPH1(Tryptophan Hydroxylase 1)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">혈관수축작용을 하는 물질인 세로토닌을 합성하는데 관여하는 효소입니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">VEGF(vascular endothelial)</TD>
<TD WIDTH="723" VALIGN="MIDDLE" HEIGHT="53">혈관내피세포에 특이적으로 작용하여 세포 증식이나 혈관신생을 촉진하는 당단백입니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</LIBRARY>

</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>
<P></P>
<P>당사는 기업공시서식 작성기준에 따른 소규모기업에 해당하여 '요약재무정보' 를 기재하지 아니합니다. 다음의 재무제표 본문을 참고하시기 바랍니다. </P>
</SECTION-2><LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>
<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}BS_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="684" BORDER="0">

<COLGROUP>
<COL WIDTH="675"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="684" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">재무상태표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="684" HEIGHT="30" AUPDATECONT="N">
<P>제 7 기          2022.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="684" HEIGHT="30" AUPDATECONT="N">
<P>제 6 기          2021.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="684" HEIGHT="30" AUPDATECONT="N">
<P>제 5 기          2020.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="684" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="685" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="277"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="286">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 7 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 6 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 5 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>33,406,557,981</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>46,522,184,069</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,735,286,189</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,510,611,529</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,441,591,400</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,541,240,138</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　단기금융상품</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>20,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>25,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,748,476,051</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　매출채권 및 기타유동채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,038,030,774</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>35,267,300</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　　매출채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>888,710,035</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　　계약자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>149,320,739</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>35,267,300</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타투자자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,073,466,867</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,046,226,730</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>220,978,801</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>388,161,597</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>172,696,531</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>563,470,010</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>610,937,042</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>272,873,469</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>22,250,914,726</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>19,007,160,825</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,951,986,760</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　장기금융상품</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>30,504,438</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>28,896,200</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　유형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>21,171,770,923</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>18,290,643,010</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,525,478,358</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　무형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>321,619,982</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>251,406,066</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>172,230,644</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　순확정급여자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>53,720,290</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타포괄손익공정가치측정금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>300,160,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타비유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>50,374,936</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>37,476,371</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>108,877,871</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>406,988,885</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>343,410,650</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>116,503,687</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　자산총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>55,657,472,707</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>65,529,344,894</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>12,687,272,949</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,370,678,057</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,384,440,244</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,261,813,211</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　전환상환우선주부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,917,166,318</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　매입채무 및 기타유동채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>44,043,015</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>933,419,354</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>94,231,550</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　　유동리스부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>44,043,015</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>82,704,554</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>94,231,550</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　　유동계약부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>850,714,800</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>67,833,320</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>115,469,487</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>70,599,285</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타유동금융부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,258,801,722</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,293,551,403</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>179,816,058</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　유동복구충당부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>42,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,116,067,674</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,128,151,654</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>699,017,844</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　순확정급여부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>9,348,328</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>53,861,057</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　비유동충당부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>18,590,486</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　장기매입채무 및 기타비유동채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,106,719,346</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,128,151,654</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>580,520,847</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　　장기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,000,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　　전환상환우선주부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　　비유동리스부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>106,719,346</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>128,151,654</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>580,520,847</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　기타비유동금융부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>46,045,454</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>9,486,745,731</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,512,591,898</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,960,831,055</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>자본</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,922,984,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,843,734,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,475,268,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　보통주자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,922,984,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,843,734,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,475,268,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　자본잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>101,263,129,602</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>99,848,101,817</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>45,989,091,910</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　주식발행초과금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>101,263,129,602</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>99,848,101,817</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>45,989,091,910</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　기타자본구성요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,597,450,326</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,649,973,752</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,717,847,261</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　주식선택권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,597,450,326</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,649,973,752</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,717,847,261</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　이익잉여금(결손금)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(64,612,836,952)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(53,325,056,573)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(46,455,765,277)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　　미처분이익잉여금(미처리결손금)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(64,612,836,952)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(53,325,056,573)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(46,455,765,277)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>　자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>46,170,726,976</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>55,016,752,996</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,726,441,894</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="286">
<P>자본과부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>55,657,472,707</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>65,529,344,894</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>12,687,272,949</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}IS_S1" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="799" BORDER="0">

<COLGROUP>
<COL WIDTH="790"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="799" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">포괄손익계산서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="799" HEIGHT="30" AUPDATECONT="N">
<P>제 7 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="799" HEIGHT="30" AUPDATECONT="N">
<P>제 6 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="799" HEIGHT="30" AUPDATECONT="N">
<P>제 5 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="799" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="800" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="400"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="409">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 7 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>제 6 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 5 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>영업수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,582,858,972</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>6,254,952,500</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　로열티수익(매출액)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,582,858,972</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>6,254,952,500</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>영업비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>15,565,070,430</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>13,124,547,681</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,852,987,206</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>영업이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,982,211,458)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(6,869,595,181)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(7,852,987,206)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>기타수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>34,297,105</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>84,196,028</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>21,743,718</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>기타비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>84,604,318</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>164,628,880</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>60,985,487</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,097,566,202</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>363,016,332</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>138,716,616</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>금융비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>470,640,060</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>90,777,162</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>20,856,282,048</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>법인세비용차감전순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,405,592,529)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(6,677,788,863)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(28,609,794,407)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>법인세비용</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,405,592,529)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(6,677,788,863)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(28,609,794,407)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>기타포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>117,812,150</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(191,502,433)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,520,879)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　당기손익으로 재분류되지 않는항목(세후기타포괄손익)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　　확정급여제도의 재측정손익(세후기타포괄손익)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>117,812,150</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(191,502,433)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,520,879)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　당기손익으로 재분류될 수 있는 항목(세후기타포괄손익)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(191,502,433)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,520,879)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,287,780,379)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(6,869,291,296)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(28,627,315,286)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>주당이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　기본주당이익(손실) (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(829)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(542)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,969)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　희석주당이익(손실) (단위 : 원)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}EF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="812" BORDER="0">

<COLGROUP>
<COL WIDTH="803"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="812" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">자본변동표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="812" HEIGHT="30" AUPDATECONT="N">
<P>제 7 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="812" HEIGHT="30" AUPDATECONT="N">
<P>제 6 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="812" HEIGHT="30" AUPDATECONT="N">
<P>제 5 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="812" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="815" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="160"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="169" ROWSPAN="2">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="646" COLSPAN="5">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="113">
<P>자본금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>자본잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="138">
<P>기타자본구성요소</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>이익잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>자본  합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>2020.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>1,772,640,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>362,680</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>1,290,694,539</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,828,449,991)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(14,764,752,772)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(28,609,794,407)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(28,609,794,407)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,520,879)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,520,879)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>74,606,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,921,766,580</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,996,373,080</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>주식선택권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>49,250,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>583,546,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>427,152,722</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,059,949,156</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>전환상환우선주 전환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>1,642,275,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>43,463,968,356</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>45,106,243,356</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>무상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>1,936,496,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(1,980,552,140)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(44,055,640)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>지분의 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>자본 증가(감소) 합계</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>2020.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>5,475,268,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>45,989,091,910</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>1,717,847,261</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(46,455,765,277)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,726,441,894</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>2021.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>5,475,268,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>45,989,091,910</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>1,717,847,261</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(46,455,765,277)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,726,441,894</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,677,788,863)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,677,788,863)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(191,502,433)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(191,502,433)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>1,020,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>47,161,771,500</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>48,181,771,500</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>주식선택권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>165,750,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,988,120,757</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>(67,873,509)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,085,997,248</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>전환상환우선주 전환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>182,716,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,709,117,650</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,891,833,650</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>무상증자</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>지분의 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>자본 증가(감소) 합계</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>2021.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>6,843,734,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>99,848,101,817</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>1,649,973,752</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(53,325,056,573)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>55,016,752,996</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>2022.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>6,843,734,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>99,848,101,817</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>1,649,973,752</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(53,325,056,573)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>55,016,752,996</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,405,592,529)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,405,592,529)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>117,812,150</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>117,812,150</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>유상증자</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>주식선택권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>79,250,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,415,027,785</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>947,476,574</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,441,754,359</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>전환상환우선주 전환</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>무상증자</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>지분의 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>자본 증가(감소) 합계</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="169">
<P>2022.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>6,922,984,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>101,263,129,602</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="138">
<P>2,597,450,326</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(64,612,836,952)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>46,170,726,976</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}CF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="681" BORDER="0">

<COLGROUP>
<COL WIDTH="672"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">현금흐름표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="30" AUPDATECONT="N">
<P>제 7 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="30" AUPDATECONT="N">
<P>제 6 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="30" AUPDATECONT="N">
<P>제 5 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="681" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="682" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="274"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="283">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 7 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 6 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 5 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>영업활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,237,339,664)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,841,509,209)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,284,664,239)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　영업활동으로부터 창출된 현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,407,475,151)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,948,850,657)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,388,926,071)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　이자수취(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>447,297,846</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>84,648,898</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>110,674,292</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　법인세납부(환급)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>13,095,170</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>22,692,550</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,412,460)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　이자지급(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(290,257,529)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>투자활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,435,922,734</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(48,112,781,288)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,501,429,506</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　투자활동으로 인한 현금유입액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>57,350,748,570</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>25,762,278,941</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>17,796,851,114</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　단기금융상품의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>25,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,748,476,051</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>9,700,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　장기금융상품의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>30,504,438</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　기타투자자산의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>32,029,295,045</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>21,012,302,890</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,089,236,322</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　보증금의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>259,046,111</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　유형자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>31,902,976</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　기계장치 취득관련 보조금 수령액</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,500,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,614,792</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　투자활동으로 인한 현금유출액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(48,914,825,836)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(73,875,060,229)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(14,295,421,608)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　장단기금융상품의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(20,000,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(25,001,608,238)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(8,776,769,898)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　기타투자자산의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(25,300,160,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(31,032,317,701)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(5,010,383,956)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　장기선급금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(47,689,198)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(253,733,726)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　유형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,411,243,783)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,449,276,204)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(396,884,691)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　무형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(134,846,855)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(105,912,360)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(12,149,700)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　보증금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(20,886,000)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　기타비유동자산의 증가</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(32,212,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(99,233,363)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>재무활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>661,834,710</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>56,826,245,460</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,917,932,472</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　재무활동으로 인한 현금유입액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>735,557,600</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>59,753,540,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,064,150,352</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　상환기술료 관련 보조금 수령액</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>12,727,272</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　전환상환우선주 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　주식선택권의 행사</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>735,557,600</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>753,540,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>55,050,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　유상증자</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>51,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,996,373,080</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　장기차입금의 증가</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,000,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　재무활동으로 인한 현금유출액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(73,722,890)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,927,294,540)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(146,217,880)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　리스부채의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(73,722,890)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(103,420,140)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(102,162,240)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　무상증자비용</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(44,055,640)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>　　주식발행비용</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,823,874,400)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>현금및현금성자산에 대한 환율변동효과</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>208,602,349</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>28,396,299</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>456,993</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>현금및현금성자산의순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,930,979,871)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,900,351,262</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,135,154,732</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>기초현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,441,591,400</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,541,240,138</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,406,085,406</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="283">
<P>기말현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,510,611,529</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,441,591,400</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,541,240,138</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 7 기 당기 : 2022년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 6 기 전기 : 2021년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">주식회사 큐라클</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>1. 일반사항</P>
<P>주식회사 큐라클(이하 "당사"라고 함)은 2016년 5월 12일 설립되어, 의학 및 약학 연구개발업을 주요 사업으로 영위하고 있으며, 2021년 7월 22일자로 코스닥시장에 주식을 상장한 공개법인입니다. 당사의 본점은 서울 서초구 효령로 23-1에 소재하고 있으며, 대표이사는 유재현입니다.</P>
<P>당기말 현재 당사의 주요 주주 현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="277"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="162"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="286" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주주명</TH>
<TH COLSPAN="2" WIDTH="343" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식수(주)</TH>
<TH WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">권영근</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,809,047</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13.07</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">이인규</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,353,780</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9.78</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">장덕수</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">474,873</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.43</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">김태윤</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">470,880</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.40</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">박광락</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,800</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">김명화</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">260,000</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.88</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">넥시드-어니스트 제1호투자조합</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,716</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">스마트혁신산업단지제1호투자조합</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">151,420</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.09</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">우제태</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,580</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.09</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,596,872</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">62.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,845,968</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>2. 중요한 회계정책2.1 재무제표 작성기준</P>
<P>당사는 주식회사 등의 외부감사에 관한 법률 제5조 1항 1호에서 규정하고 있는 국제회계기준위원회의 국제회계기준을 채택하여 정한 회계처리기준인 한국채택국제회계기준(이하 "기업회계기준")에 따라 재무제표를 작성하였습니다. </P>
<P> 재무제표는 다음을 제외하고는 역사적 원가에 기초하여 작성하였습니다.- 특정 금융자산과 금융부채- 확정급여제도와 공정가치로 측정하는 사외적립자산기업회계기준은 재무제표 작성시 중요한 회계추정의 사용을 허용하고 있으며, 회계정책을 사용함에 있어 경영진의 판단을 요구하고 있습니다. 보다 복잡하고 높은 수준의 판단이 필요한 부분이나 중요한 가정 및 추정이 필요한 부분은 주석 3에서 설명하고 있습니다.</P>
<P>당기 재무제표의 작성에 적용된 중요한 회계정책은 아래에서 설명하는 기준서의 도입과 관련된 영향을 제외하고는 전기재무제표 작성 시 채택한 회계정책과 동일합니다</P>
<P></P>
<P>2.2 회계정책과 공시의 변경2.2.1 당사가 채택한 제ㆍ개정 기준서 및 해석서당사는 2022년 1월 1일 이후 개시하는 회계기간부터 다음의 주요 제ㆍ개정 기준서를신규로 적용하였습니다.</P>
<P>(1) 기업회계기준서 제1116호 '리스'  - COVID-19 관련 임차료 면제ㆍ할인ㆍ유예   (21년 6월 30일 이후)개정사항은 코로나19 관련 임차료 면제ㆍ할인ㆍ유예가 아래의 조건을 충족하는 경우, 리스의 변경인지 평가하는 것을 면제할 수 있도록 하였습니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.- 리스료감면이 2022년 6월 30일 이전에 지급하여야 할 리스료에만 영향을 미침</P>
<P>- 리스료의 변동으로 수정된 리스대가가 변경 전 리스대가와 실질적으로 동일하거나 그보다 작음</P>
<P>- 그 밖의 실질적인 조건의 변경이 없음</P>
<P></P>
<P>(2) 기업회계기준서 제1016호 '유형자산' - 의도된 사용 전 생산된 재화의 매각금액과 관련원가의 회계처리 명확화</P>
<P>개정사항은 경영진이 의도한 방식으로 유형자산을 가동될 수 있는 장소와 상태에 이르기 전에 생산된 재화(예: 시제품)의 판매에서 발생하는 매각금액과 그 재화의 원가는 유형자산의 취득원가의 차감으로 인식하지 않고 당기손익으로 인식한다는 것을 주된 내용으로 하고 있습니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.</P>
<P>(3) 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' 개정 - 손실부담계약: 계약이행원가개정사항은 손실부담계약의 회피불가능 원가를 구성하는 계약이행원가가, 그 계약을이행하는데 드는 증분원가와 계약을 이행하는데 직접 관련되는 그 밖의 원가 배분액으로 구성됨을 명확히 하고 있습니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.(4) 한국채택국제회계기준 연차개선 2018-2020</P>
<P>한국채택국제회계기준 2018-2020연차개선은 다음과 같으며, 해당 기준서의 개정이재무제표에 미치는 중요한 영향은 없습니다.</P>
<P>- 기업회계기준서 제1101호 '한국채택국제회계기준의 최초 채택': 최초채택기업인 종속기업</P>
<P>- 기업회계기준서 제1109호 '금융상품': 금융부채 제거 목적의 10% 테스트 관련 수수료</P>
<P>- 기업회계기준서 제1116호 '리스': 리스 인센티브</P>
<P>- 기업회계기준서 제1041호 '농림어업': 공정가치 측정</P>
<P></P>
<P>(5) 기업회계기준서 제1103호 '사업결합' 개정 - 개념체계의 인용개정사항은 사업결합 시 인식할 자산과 부채는 개정된 재무보고를 위한 개념체계의 자산과 부채의 정의를 참조하도록 하되, 기준서 제1037호 '충당부채, 우발부채 및 우발자산' 및 해석서 제2121호 '부담금'의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서에서 정의한 과거사건, 현재의무 및 의무발생사건 등의 기준을 적용하도록 기준서 제1103호 인식 예외를 추가하고, 취득자는 취득일에 우발자산을 인식하지 않는다는 점을 포함하고 있습니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.</P>
<P>2.2.2 당사가 적용하지 않은 제ㆍ개정 기준서 및 해석서제정 또는 공표되었으나 시행일이 도래하지 않아 적용하지 아니한 제ㆍ개정 기준서 및 해석서는 다음과 같습니다.</P>
<P>(1) 기업회계기준서 제1001호 '재무제표 표시'(개정): 유동부채와 비유동부채의 분류</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">개정사항은 보고기간말 현재 존재하는 실질적인 권리에 따라 유동 또는 비유동으로 분류되며, 부채의 결제를 연기할 수 있는 권리의 행사가능성이나 경영진의 기대는 고려하지 않으며 부채의 결제에 자기지분상품의 이전도 포함되나, 복합금융상품에서 자기지분상품으로 결제하는 옵션이 지분상품의 정의를 충족하여 부채와 분리하여 인식된 경우는 제외됨을 명확히 하고 있습니다. 한편, 2022년 10월 국제회계기준위원회에서는 본 개정사항을 추가로 수정하고 시행일도 2024년 1월 1일 이후 시작하는 회계연도부터 적용(조기적용 허용)하는 것으로 연기함에 따라 한국채택국제회계기준의 개정절차가 진행중입니다. 당사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</SPAN>
</P>
<P>(2) 기업회계기준서 제1001호 '재무제표 표시'(개정): 중요한 회계정책 공시, 리픽싱 조건 금융부채 공시</P>
<P>개정사항은 유의적인 회계정책이 아닌 중요한 회계정책을 공시하고, 중요하지 않은 회계정책을 공시하는 경우에는 그 정보가 중요한 회계정책 정보를 불분명하게 하지 않도록 하고 있습니다. 또한, 발행자의 주가 변동에 따라 행사가격이 조정되는 조건(리픽싱 조건)이 있는 금융상품의 전부나 일부가 금융부채로 분류되는 경우에는 그 전환권이나 신주인수권에 대해 보고기간에 발생한 평가손익을 제외한 법인세비용차감전계속사업손익을 주석으로 공시하도록 2022년 12월 추가 개정되었습니다. 개정사항은 2023년 1월 1일 이후 시작하는 회계연도부터 적용하며 조기적용이 허용됩니다.당사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</P>
<P>(3) 기업회계기준서 제1008호 '회계정책, 회계추정치 변경 및 오류'(개정): 회계추정치 정의</P>
<P>개정사항은 '회계추정의 변경'에 대한 정의를 삭제하고 '회계추정치'에 대한 정의를 추가하여, 회계정책에서 측정불확실성을 고려하여 회계추정치를 개발하도록 하는 경우 추정치 개발 시 사용한 측정기법과 투입변수는 회계추정치에 포함되어 측정기법이나 투입변수의 변경이 전기오류수정으로 인한 것이 아닌 한 회계정책의 변경이 아닌 회계추정치의 변경임을 명확히 하고 있습니다. 개정사항은 2023년 1월 1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 당사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</P>
<P USERMARK=" 0X0000FF"> </P>
<P>(4) 기업회계기준서 제1012호 '법인세'(개정): 이연법인세 최초 인식 예외 규정의 요건 추가개정사항은 이연법인세의 최초 인식 예외 규정에 '거래 당시 동일한 금액으로 가산할일시적차이와 차감할 일시적차이가 생기지는 않는다'는 요건을 추가하여, 단일 거래에서 자산과 부채를 최초 인식할 때 동일한 금액의 가산할 일시적차이와 차감할 일시적차이가 생기는 경우에는 이연법인세 자산과 부채를 모두 인식해야 함을 명확히 하고 있습니다. 개정사항은2023년 1월 1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 당사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</P>
<P></P>
<P>(5) 기업회계기준서 제1117호 '보험계약'(제정): 기준서 제1104호 '보험계약’ 대체</P>
<P>기준서 제1117호 '보험계약'은 보험계약의 인식과 측정을 다룬 종전 기준서 제1104호 '보험계약'을 대체합니다. 해당 기준서는 보험계약을 발행한 기업의 유형과 관계없이 모든 보험계약에 포괄적이고 일반적인 모형을 제시합니다. 동 기준서는2023년1월 1일 이후 최초로 시작하는 회계연도부터 적용되며, 기준서 제1109호 '금융상품'을 적용한 기업은 조기적용이 허용됩니다. 당사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</P>
<P></P>
<P>(6) 기업회계기준서 제1001호 '재무제표 표시' - 행사가격 조정 조건이 있는 금융부채 평가손익 공시발행자의 주가 변동에 따라 행사가격이 조정되는 조건이 있는 금융상품의 전부나 일부가 금융부채로 분류되는 경우 그 금융부채의 장부금액과 관련 손익을 공시하도록 하였습니다. 동 개정사항은 2023년 1월 1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 당사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</P>
<P></P>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">2.3 외화환산</SPAN>
</P>
<P>(1) 기능통화와 표시통화 당사는 재무제표에 포함되는 항목들을 영업활동이 이뤄지는 주된 경제환경에서의 통화("기능통화")를 적용하여 측정하고 있습니다. 당사의 기능통화는 대한민국 원화이며, 재무제표는 대한민국 원화로 표시되어 있습니다.</P>
<P></P>
<P>(2) 외화거래와 보고기간말의 환산 기능통화 외의 통화(외화)로 이루어진 거래는 거래일의 환율을 적용하여 기록하고 있습니다. 매 보고기간 말에 화폐성 외화항목은 보고기간 말의 마감환율로 환산하고 있습니다. 공정가치로 측정하는 비화폐성 외화항목은 공정가치가 결정된 날의 환율로 환산하고, 역사적원가로 측정하는 비화폐성항목은 거래일의 환율로 환산하고 있습니다.</P>
<P>화폐성항목의 결제시점에 생기는 외환차이와 해외사업장순투자 환산차이 또는 현금흐름위험회피로 지정된 금융부채에서 발생한 환산차이를 제외한 화폐성항목의 환산으로 인해 발생한 외환차이는 모두 당기손익으로 인식하고 있습니다. 비화폐성항목에서 발생한 손익을 기타포괄손익으로 인식하는 경우에는 그 손익에 포함된 환율변동효과도 기타포괄손익으로 인식하고, 당기손익으로 인식하는 경우에는 환율변동효과도 당기손익으로 인식하고 있습니다.</P>
<PGBRK></PGBRK>
<P>2.4 금융자산</P>
<P>(1) 분류</P>
<P>당사는 다음의 측정 범주로 금융자산을 분류합니다.</P>
<P>- 당기손익공정가치측정금융자산</P>
<P>- 기타포괄손익공정가치측정금융자산</P>
<P>- 상각후원가측정금융자산</P>
<P></P>
<P>금융자산은 금융자산의 관리를 위한 사업모형과 금융자산의 계약상 현금흐름 특성에근거하여 분류합니다.</P>
<P></P>
<P>공정가치로 측정하는 금융자산의 손익은 당기손익 또는 기타포괄손익으로 인식합니다. 채무상품에 대한 투자는 해당 자산을 보유하는 사업모형에 따라 그 평가손익을 당기손익 또는 기타포괄손익으로 인식합니다. 당사는 금융자산을 관리하는 사업모형을 변경하는 경우에만 채무상품을 재분류합니다.</P>
<P></P>
<P>단기매매항목이 아닌 지분상품에 대한 투자는 최초 인식시점에 후속적인 공정가치 변동을 기타포괄손익으로 표시할 것을 지정하는 취소불가능한 선택을 할 수 있습니다. 지정되지 않은 지분상품에 대한 투자의 공정가치 변동은 당기손익으로 인식합니다.</P>
<P>(2) 측정당사는 최초 인식시점에 금융자산을 공정가치로 측정하며, 당기손익공정가치측정 금융자산이 아닌 경우에 해당 금융자산의 취득과 직접 관련되는 거래원가는 공정가치에 가산합니다. 당기손익공정가치측정금융자산의 거래원가는 당기손익으로 비용처리합니다. 내재파생상품을 포함하는 복합계약은 계약상 현금흐름이 원금과 이자로만 구성되어 있는지를 결정할 때 해당 복합계약 전체를 고려합니다.</P>
<P></P>
<P>① 채무상품금융자산의 후속적인 측정은 금융자산의 계약상 현금흐름 특성과 그 금융자산을 관리하는 사업모형에 근거합니다. 당사는 채무상품을 다음의 세 범주로 분류합니다.</P>
<PGBRK></PGBRK>
<P>(가) 당기손익공정가치측정금융자산상각후원가 측정이나 기타포괄손익공정가치 측정 금융자산이 아닌 채무상품은 당기손익공정가치로 측정됩니다. 위험회피관계가 적용되지 않는 당기손익공정가치 측정 채무상품의 손익은 당기손익으로 인식하고 발생한 기간에 포괄손익계산서에 '금융수익 또는 금융비용'으로 표시합니다.(나) 기타포괄손익공정가치측정금융자산계약상 현금흐름의 수취와 금융자산의 매도 둘 다를 통해 목적을 이루는 사업모형 하에서 금융자산을 보유하고, 계약상 현금흐름이 원리금만으로 구성되어 있는 금융자산은 기타포괄손익공정가치로 측정합니다. 손상차손(환입)과 이자수익 및 외환손익을 제외하고는, 공정가치로 측정하는 금융자산의 평가손익은 기타포괄손익으로 인식합니다. 금융자산을 제거할 때에는 인식한 기타포괄손익누계액을 자본에서 당기손익으로 재분류합니다. 유효이자율법에 따라 인식하는 금융자산의 이자수익은  '금융수익'에 포함됩니다. 외환손익 및 손상차손(환입)은 '금융비용 또는 금융수익'으로 표시합니다.</P>
<P>(다) 상각후원가측정금융자산계약상 현금흐름을 수취하기 위해 보유하는 것이 목적인 사업모형 하에서 금융자산을 보유하고, 계약상 현금흐름이 원리금만으로 구성되어 있는 자산은 상각후원가로 측정합니다. 상각후원가로 측정하는 금융자산으로서 위험회피관계의 적용 대상이 아닌 금융자산의 손익은 해당 금융자산이 제거되거나 손상될 때 당기손익으로 인식합니다. 유효이자율법에 따라 인식하는 금융자산의 이자수익은 '금융수익'에 포함됩니다.</P>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">② 지분상품 </SPAN>
</P>
<P>당사는 모든 지분상품에 대한 투자를 후속적으로 공정가치로 측정합니다. 공정가치 변동을 기타포괄손익으로 표시할 것을 선택한 장기적 투자목적 또는 전략적 투자목적의 지분상품에 대해 기타포괄손익으로 인식한 금액은 해당 지분상품을 제거할 때에도 당기손익으로 재분류하지 않습니다. 이러한 지분상품에 대한 배당수익은 당사가 배당을 받을 권리가 확정되는 시점에 당기손익으로 인식하고 있습니다. </P>
<P>당기손익공정가치로 측정하는 금융자산의 공정가치 변동은 포괄손익계산서에 '금융수익 또는 금융비용'으로 표시합니다. 기타포괄손익공정가치로 측정하는 지분상품에대한 손상차손(환입)은 별도로 구분하여 인식하지 않습니다.</P>
<P>(3) 손상 </P>
<P>① 금융상품과 계약자산당사는 다음 자산의 기대신용손실에 대해 손실충당금을 인식합니다.- 상각후원가로 측정하는 금융자산- 기타포괄손익공정가치로 측정하는 채무상품- 기업회계기준서 제1115호에서 정의된 계약자산</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">당사는 12개월 기대신용손실로 측정되는 다음의 금융자산을 제외하고는 전체기간 기대신용손실에 해당하는 금액으로 손실충당금을 측정합니다.- 보고기간말에 신용이 위험이 낮다고 결정된 채무증권- 최초 인식 이후 신용위험(즉, 금융자산의 기대존속기간동안에 걸쳐 발생할 채무불이행 위험)이 유의적으로 증가하지 않은 기타 채무증권과 은행예금매출채권과 계약자산에 대한 손실충당금은 항상 전체기간 기대신용손실에 해당하는 금액으로 측정됩니다.금융자산의 신용위험이 최초 인식 이후 유의적으로 증가했는지를 판단할 때와 기대신용손실을 추정할 때, 당사는 과도한 원가나 노력 없이 이용할 수 있고 합리적이고 뒷받침될 수 있는 정보를 고려합니다. 여기에는 미래지향적인 정보를 포함하여 당사의 과거 경험과 알려진 신용평가에 근거한 질적, 양적인 정보 및 분석이 포함됩니다.</SPAN>
</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">당사는 다음과 같은 경우 금융자산에 채무불이행이 발생했다고 고려합니다.- 채무자가 당사가 소구활동을 하지 않으면, 당사에게 신용의무를 완전하게 이행하지 않을 것 같은 경우- 금융자산의 연체일수가 90일을 초과한 경우전체기간 기대신용손실은 금융상품의 기대존속기간에 발생할 수 있는 모든 채무불이행 사건에 따른 기대신용손실입니다.12개월 기대신용손실은 보고기간 말 이후 12개월 이내(또는 금융상품의 기대존속기간이 12개월 보다 적은 경우 더 짧은 기간)에 발생 가능한 금융상품의 채무불이행 사건으로 인한 기대신용손실을 나타내는 전체기간 기대신용손실의 일부입니다.기대신용손실을 측정할 때 고려하는 가장 긴 기간은 당사가 신용위험에 노출되는 최장 계약기간입니다.</SPAN>
</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">② 기대신용손실의 측정기대신용손실은 신용손실의 확률가중추정치입니다. 신용손실은 모든 현금부족액(즉,계약에 따라 지급받기로 한 모든 계약상 현금흐름과 수취할 것으로 예상하는 모든 계약상 현금흐름의 차이)의 현재가치로 측정됩니다. 기대신용손실은 해당 금융자산의 유효이자율로 할인됩니다.③ 신용이 손상된 금융자산매 보고기간말에, 당사는 상각후원가로 측정되는 금융자산과 기타포괄손익공정가치로 측정되는 채무증권의 신용이 손상되었는지 평가합니다.  금융자산의 추정미래현금흐름에 악영향을 미치는 하나 이상의 사건이 발생한 경우에 해당 금융자산은 신용이 손상된 것입니다.</SPAN>
</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">금융자산의 신용이 손상된 증거는 다음과 같은 관측 가능한 정보를 포함합니다.- 발행자나 차입자의 유의적인 재무적 어려움- 채무불이행과 같은 계약 위반- 차입자의 재무적 어려움에 관련된 경제적이나 계약상 이유로 당초 차입조건의 불가피한 완화- 차입자의 파산가능성이 높아지거나 그 밖의 재무구조조정 가능성이 높아짐- 재무적 어려움으로 인해 해당 금융자산에 대한 활성시장 소멸④ 재무상태표상 신용손실충당금의 표시상각후원가로 측정하는 금융자산에 대한 손실충당금은 해당 자산의 장부금액에서 차감합니다. </SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">⑤ 제각금융자산의 계약상 현금흐름 전체 또는 일부의 회수에 대한 합리적인 기대가 없는 경우 해당 자산을 제거합니다. 당사는 제각한 금액이 유의적으로 회수할 것이라는 기대를 갖고 있지 않습니다. 그러나 제각된 금융자산은 당사의 만기가 된 금액의 회수 절차에 따라 회수활동의 대상이 될 수 있습니다.</SPAN>
</P>
<P></P>
<P>(4) 인식과 제거</P>
<P>금융자산의 정형화된 매입 또는 매도는 매매일에 인식하거나 제거합니다. 금융자산은 현금흐름에 대한 계약상 권리가 소멸하거나 금융자산을 양도하고 소유에 따른 위험과 보상의 대부분을 이전한 경우에 제거됩니다.</P>
<P>당사가 금융자산을 이전하는 거래를 하였지만, 이전되는 자산의 소유에 따른 대부분의 위험과 보상을 보유하고 있는 경우에는 이전된 자산을 제거하지 않습니다.</P>
<P>(5) 금융상품의 상계</P>
<P>금융자산과 부채는 인식한 자산과 부채에 대해 법적으로 집행가능한 상계권리를 현재 보유하고 있고, 순액으로 결제하거나 자산을 실현하는 동시에 부채를 결제할 의도를 가지고 있을 때 상계하여 재무상태표에 순액으로 표시합니다. 법적으로 집행가능한 상계권리는 미래사건에 좌우되지 않으며, 정상적인 사업과정의 경우와 채무불이행의 경우 및 지급불능이나 파산의 경우에도 집행가능한 것을 의미합니다.</P>
<P></P>
<P>2.5 파생상품 </P>
<P>파생상품은 최초 인식 시에 공정가치로 측정합니다. 최초 인식 이후에 공정가치로 측정하고 그 변동은 일반적으로 손익으로 인식합니다.</P>
<P>2.6 유형자산</P>
<P>유형자산은 최초에 원가로 측정하여 인식하고 있습니다. 유형자산의 원가에는 경영진이 의도하는 방식으로 자산을 가동하는데 필요한 장소와 상태에 이르게 하는데 직접 관련되는 원가 및 자산을 해체, 제거하거나 부지를 복구하는데 소요될 것으로 추정되는 원가가 포함됩니다.</P>
<P>유형자산은 최초 인식 후에 원가에서 감가상각누계액과 손상차손누계액을 차감한 금액을 장부금액으로 하고 있습니다.</P>
<PGBRK></PGBRK>
<P>유형자산 중 토지는 감가상각을 하지 않으며, 그 외 유형자산은 자산의 취득원가에서잔존가치를 차감한 금액에 대하여 아래에 제시된 내용연수에 걸쳐 해당 자산에 내재되어 있는 미래 경제적 효익의 예상 소비 형태를 가장 잘 반영한 정액법으로 상각하고 있습니다.</P>
<P>유형자산을 구성하는 일부의 원가가 당해 유형자산의 전체 원가와 비교하여 유의적이라면, 해당 유형자산을 감가상각할 때, 그 부분은 별도로 구분하여 감가상각하고 있습니다.</P>
<P>유형자산의 제거로 인하여 발생하는 손익은 순매각금액과 장부금액의 차이로 결정되고 그 차액은 당기손익으로 인식하고 있습니다.</P>
<P>당기 및 전기의 추정 내용연수는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="289"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="298" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="332" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추정내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30" ALIGN="CENTER">건         물</TD>
<TD WIDTH="332" HEIGHT="30" ALIGN="CENTER">40년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30" ALIGN="CENTER">기 계 장 치</TD>
<TD WIDTH="332" HEIGHT="30" ALIGN="CENTER">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30" ALIGN="CENTER">비         품</TD>
<TD WIDTH="332" HEIGHT="30" ALIGN="CENTER">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30" ALIGN="CENTER">시 설 장 치</TD>
<TD WIDTH="332" HEIGHT="30" ALIGN="CENTER">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30" ALIGN="CENTER">사용권자산</TD>
<TD WIDTH="332" HEIGHT="30" ALIGN="CENTER">1-10년</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당사는 매 보고기간말에 자산의 잔존가치와 내용연수 및 감가상각방법을 재검토하고재검토 결과 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 처리하고 있습니다.</P>
<P>후속지출은 해당 지출과 관련된 미래 경제적 효익이 당사로 유입될 가능성이 높은 경우에만 자본화하고 있습니다.</P>
<P></P>
<PGBRK></PGBRK>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">2.7 정부보조금</SPAN>
</P>
<P>정부보조금은 보조금의 수취와 정부보조금에 부가된 조건의 준수에 대한 합리적인 확신이 있을 때 공정가치로 인식됩니다. 자산관련보조금은 자산의 장부금액을 계산할 때 차감하여 표시되며, 수익관련보조금은 이연하여 정부보조금의 교부 목적과 관련된 비용에서 차감하여 표시됩니다.</P>
<P USERMARK=" 0X0000FF"></P>
<P>2.8 무형자산 무형자산은 역사적원가로 최초 인식되고, 원가에서 상각누계액과 손상차손누계액을차감한 금액으로 표시됩니다. </P>
<P>무형자산은 무형자산의 정의를 충족하는 소프트웨어를 포함하고 있으며, 사용이 가능한 시점부터 추정내용연수 동안 정액법에 따라 상각하고 있습니다. 회원권은 이용가능 기간에 대하여 예측가능한 제한이 없으므로 내용연수가 한정되지 않아 상각되지 않습니다.한정된 내용연수를 가지는 다음의 무형자산은 추정내용연수동안 정액법으로 상각됩니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="307"></COL>
<COL WIDTH="306"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="316" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">과   목</TH>
<TH WIDTH="315" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추정내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30" ALIGN="CENTER">특   허   권</TD>
<TD WIDTH="315" HEIGHT="30" ALIGN="CENTER">7년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30" ALIGN="CENTER">전용실시권</TD>
<TD WIDTH="315" HEIGHT="30" ALIGN="CENTER">7년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30" ALIGN="CENTER">소프트웨어</TD>
<TD WIDTH="315" HEIGHT="30" ALIGN="CENTER">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30" ALIGN="CENTER">상   표   권</TD>
<TD WIDTH="315" HEIGHT="30" ALIGN="CENTER">5년</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">내용연수가 유한한 무형자산의 상각기간과 상각방법은 매 보고기간말에 재검토하고 내용연수가 비한정인 무형자산에 대해서는 그 자산의 내용연수가 비한정이라는 평가가 계속하여 정당한 지를 매 보고기간말에 재검토하며, 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 처리하고 있습니다.</SPAN>
</P>
<P>①  연구 및 개발 </P>
<P>연구 또는 내부프로젝트의 연구단계에 대한 지출은 발생시점에 비용으로 인식하고 있습니다. 개발단계의 지출은 자산을 완성할 수 있는 기술적 실현가능성, 자산을 완성하여 사용하거나 판매하려는 기업의 의도와 능력 및 필요한 자원의 입수가능성, 무형자산의 미래 경제적 효익을 모두 제시할 수 있고, 관련 지출을 신뢰성 있게 측정할 수 있는 경우에 무형자산으로 인식하고 있으며, 기타 개발관련 지출은 발생시점에 비용으로 인식하고 있습니다. </P>
<P> </P>
<P>② 후속지출 </P>
<P>후속지출은 관련되는 특정자산에 속하는 미래의 경제적 효익이 증가하는 경우에 한하여 자본화하며, 내부적으로 창출한 영업권 및 상표명 등을 포함한 다른 지출은 발생 즉시 비용화하고 있습니다. </P>
<P></P>
<P>2.9 비금융자산의 손상 </P>
<P>고객과의 계약에서 생기는 수익에 따라 인식하는 계약자산과 계약을 체결하거나 이행하기 위해 든 원가에서 생기는 자산, 종업원급여에서 발생한 자산, 생물자산, 재고자산, 이연법인세자산, 공정가치로 평가하는 투자부동산 및 매각예정으로 분류되는 비유동자산을 제외한 모든 비금융자산에 대해서는 매 보고기간말마다 자산손상을 시사하는 징후가 있는지를 검토하며, 만약 그러한 징후가 있다면 당해 자산의 회수가능액을 추정하고 있습니다. 단, 사업결합으로 취득한 영업권 및 내용연수가 비한정인 무형자산, 아직 사용할 수 없는 무형자산에 대해서는 자산손상을 시사하는 징후와 관계없이 매년 회수가능액과 장부금액을 비교하여 손상검사를 하고 있습니다. </P>
<P> </P>
<P>회수가능액은 개별 자산별로, 또는 개별 자산의 회수가능액을 추정할 수 없다면 그 자산이 속하는 현금창출단위 별로 회수가능액을 추정하고 있습니다. 회수가능액은 사용가치와 순공정가치 중 큰 금액으로 결정하고 있습니다. 사용가치는 자산이나 현금창출단위에서 창출될 것으로 기대되는 미래현금흐름을 화폐의 시간가치 및 미래현금흐름을 추정할 때 조정되지 아니한 자산의 특유위험에 대한 현행 시장의 평가를 반영한 적절한 할인율로 할인하여 추정합니다. </P>
<P> </P>
<P>자산이나 현금창출단위의 회수가능액이 장부금액에 미달하는 경우 자산의 장부금액을 감소시키며 즉시 당기손익으로 인식하고 있습니다. </P>
<P> </P>
<P>사업결합으로 취득한 영업권은 사업결합으로 인한 시너지효과의 혜택을 받게 될 것으로 기대되는 각 현금창출단위에 배분합니다. 현금창출단위에 대한 손상차손은 현금창출단위에 배분된 영업권의 장부금액을 우선 감소시키고, 그 다음 현금창출단위에 속하는 다른 자산 각각의 장부금액에 비례하여 자산의 장부금액을 감소시키고 있습니다. 영업권에 대해 인식한 손상차손은 후속기간에 환입할 수 없습니다. 매 보고기간말에 영업권을 제외한 자산에 대해 과거기간에 인식한 손상차손이 더 이상 존재하지 않거나 감소된 것을 시사하는 징후가 있는지를 검토하고 직전 손상차손의 인식시점 이후 회수가능액을 결정하는 데 사용된 추정치에 변화가 있는 경우에만 환입합니다. 손상차손환입으로 증가된 장부금액은 과거에 손상차손을 인식하기 전 장부금액의 감가상각 또는 상각 후 잔액을 초과할 수 없습니다. </P>
<P USERMARK=" 0X0000FF"></P>
<P>2.10 매입채무와 기타 채무</P>
<P>매입채무와 기타 채무는 당사가 보고기간말 전에 재화나 용역을 제공받았으나 지급되지 않은 부채입니다. 매입채무와 기타 채무는 지급기일이 보고기간 후 12개월 후가 아니라면 유동부채로 표시되었습니다. 해당 채무들은 최초에 공정가치로 인식되고 후속적으로 유효이자율법을 적용한 상각후원가로 측정됩니다.</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">2.11 금융부채</SPAN>
</P>
<P>(1) 분류 및 측정 </P>
<P>당사의 당기손익공정가치측정금융부채는 단기매매목적의 금융상품입니다. 주로 단기간 내에 재매입할 목적으로 부담하는 금융부채는 단기매매금융부채로 분류됩니다.또한, 위험회피회계의 수단으로 지정되지 않은 파생상품이나 금융상품으로부터 분리된 내재파생상품도 단기매매금융부채로 분류됩니다.</P>
<P></P>
<P>당기손익공정가치측정금융부채, 금융보증계약, 금융자산의 양도가 제거조건을 충족하지 못하는 경우에 발생하는 금융부채를 제외한 모든 비파생금융부채는 상각후원가로 측정하는 금융부채로 분류되고 있으며, 재무상태표상 '매입채무', '차입금' 및 '기타금융부채' 등으로 표시됩니다. </P>
<P>특정일에 의무적으로 상환해야 하는 우선주는 부채로 분류됩니다. 이러한 우선주에 대한 유효이자율법에 따른 이자비용은 다른 금융부채에서 인식한 이자비용과 함께 포괄손익계산서상 '금융원가'로 인식됩니다.</P>
<PGBRK></PGBRK>
<P>(2) 제거 금융부채는 계약상 의무가 이행, 취소 또는 만료되어 소멸되거나 기존 금융부채의 조건이 실질적으로 변경된 경우에 재무상태표에서 제거됩니다. 소멸하거나 제3자에게 양도한 금융부채의 장부금액과 지급한 대가(양도한 비현금자산이나 부담한 부채를 포함)의 차액은 당기손익으로 인식합니다.2.12 복합금융상품 당사가 발행한 복합금융상품은 보유자의 선택에 의해 지분상품으로 전환될 수 있는 전환상환우선주로, 발행할 주식수는 보통주의 공정가치에 따라 변동될 수 있습니다.</P>
<P></P>
<P>2.13 충당부채</P>
<P>충당부채는 과거사건의 결과로 존재하는 현재의무(법적의무 또는 의제의무)로서, 당해 의무를 이행하기 위하여 경제적효익을 갖는 자원이 유출될 가능성이 높으며  그 의무의 이행에 소요되는 금액을 신뢰성 있게 추정할 수 있는 경우에 인식하고 있습니다. 충당부채로 인식하는 금액은 관련된 사건과 상황에 대한 불가피한 위험과 불확실성을 고려하여 현재의무를 보고기간말에 이행하기 위하여 소요되는 지출에 대한 최선의 추정치입니다. 화폐의 시간가치 효과가 중요한 경우 충당부채는 의무를 이행하기위하여 예상되는 지출액의 현재가치로 평가하고 있습니다.</P>
<P>충당부채를 결제하기 위해 필요한 지출액의 일부 또는 전부를 제3자가 변제할 것이 예상되는 경우 이행한다면 변제를 받을 것이 거의 확실하게 되는 때에 한하여 변제금액을 인식하고 별도의 자산으로 회계처리하고 있습니다.</P>
<P>매 보고기간말마다 충당부채의 잔액을 검토하고, 보고기간말 현재 최선의 추정치를반영하여 조정하고 있습니다. 의무이행을 위하여 경제적효익이 내재된 자원이 유출될 가능성이 더 이상 높지 아니한 경우에는 관련 충당부채를 환입하고 있습니다.</P>
<P USERMARK=" 0X0000FF"></P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">충당부채는 최초 인식과 관련 있는 지출에만 사용하고 있습니다.</SPAN>
</P>
<PGBRK></PGBRK>
<P>2.14 법인세</P>
<P>법인세비용은 당기법인세와 이연법인세로 구성되어 있으며, 기타포괄손익이나 자본에 직접 인식되는 거래나 사건 또는 사업결합에서 발생하는 세액을 제외하고는 당기손익으로 인식하고 있습니다. </P>
<P>법인세와 관련된 이자와 벌금은 법인세에 해당하는지 판단하고 법인세에 해당한다면기업회계기준서 제1012호 '법인세'를 적용하고 법인세에 해당하지 않는다면 기업회계기준서 제1037호 '충당부채, 우발부채, 우발자산'을 적용하고 있습니다.</P>
<P>① 당기법인세</P>
<P>당기법인세는 당기의 과세소득을 기초로 산정하고 있습니다. 과세소득은 포괄손익계산서상의 법인세비용차감전순이익에서 다른 과세기간에 가산되거나 차감될 손익 및 비과세항목이나 손금불인정항목을 제외하므로 포괄손익계산서상 손익과 차이가 있습니다. 당사의 당기법인세와 관련된 미지급법인세는 제정되었거나 실질적으로 제정된 세율을 사용하여 계산하고 있습니다. </P>
<P>당기법인세자산과 당기법인세부채는 다음의 조건을 모두 충족하는 경우에만 상계합니다. - 인식된 금액에 대한 법적으로 집행가능한 상계권리를 가지고 있음 - 순액으로 결제하거나, 자산을 실현하는 동시에 부채를 결제할 의도가 있음</P>
<P>② 이연법인세이연법인세부채와 이연법인세자산을 측정할 때에는 보고기간말에 기업이 관련 자산과 부채의 장부금액을 회수하거나 결제할 것으로 예상되는 방식에 따른 세효과를 반영하고 있습니다.</P>
<P>차감할 일시적차이로 인하여 발생하는 이연법인세자산은 일시적차이가 예측가능한 미래에 소멸 가능할 가능성이 높고, 일시적차이가 사용될 수 있는 과세소득이 발생할가능성이 높은 경우에 인식하고 있습니다. 미사용 세무상결손금과 세액공제, 차감할 일시적 차이가 사용될 수 있는 미래 과세소득의 발생가능성이 높은 경우 그 범위 안에서 이월된 미사용 세무상결손금과 세액공제, 차감할 일시적차이에 대하여 이연법인세자산을 인식합니다.</P>
<PGBRK></PGBRK>
<P>미래 과세소득은 관련 가산할 일시적차이의 소멸에 의해 결정됩니다. 가산할 일시적차이가 이연법인세자산을 완전히 인식하기에 충분하지 않다면, 현재 일시적차이들의소멸을 미래 과세소득에 고려합니다.</P>
<P>이연법인세자산의 장부금액은 매 보고기간말에 검토하고, 이연법인세자산으로 인한해택이 사용되기에 충분한 과세소득이 발생할 가능성이 더 이상 높지 않은 경우 이연법인세자산의 장부금액을 감소시키고 있습니다.</P>
<P USERMARK=" 0X0000FF"> </P>
<P>이연법인세자산과 부채는 보고기간말 제정되었거나 실질적으로 제정된 세법에 근거하여 당해 자산이 실현되거나 부채가 지급될 보고기간에 적용될 것으로 기대되는 세율을 사용하여 측정하고 있습니다. 이연법인세자산과 이연법인세부채를 측정할 때에는 보고기간말 현재 당사가 관련 자산과 부채의 장부금액을 회수하거나 결제할 것으로 예상되는 방식에 따라 법인세효과를 반영하고 있습니다.</P>
<P>이연법인세자산과 부채는 동일 과세당국이 부과하는 법인세이고, 당사가 인식된 금액을 상계할 수 있는 법적 권한을 가지고 있으며 당기 법인세부채와 자산을 순액으로결제할 의도가 있는 경우에만 상계하고 있습니다. </P>
<P></P>
<P>배당금 지급에 따라 추가적으로 발생하는 법인세비용이 있다면 배당금 지급과 관련한 부채가 인식되는 시점에 인식하고 있습니다.</P>
<P>2.15 종업원 급여(1) 퇴직급여당사의 퇴직연금제도는 확정급여제도입니다. 확정급여제도는 확정기여제도를 제외한 모든 퇴직연금제도입니다. 일반적으로 확정급여제도는 연령, 근속연수나 급여수준 등의 요소에 의하여 종업원이 퇴직할 때 지급받을 퇴직연금급여의 금액이 확정됩니다. 확정급여제도와 관련하여 재무상태표에 계상된 부채는 보고기간말 현재 확정급여채무의 현재가치에서 사외적립자산의 공정가치를 차감한 금액입니다. 확정급여채무는 매년 독립된 보험계리인에 의해 예측단위적립방식에 따라 산정되며, 확정급여채무의 현재가치는 그 지급시점과 만기가 유사한 우량회사채의 이자율로 기대미래현금유출액을 할인하여 산정됩니다. 한편, 순확정급여부채(자산)과 관련한 재측정요소는 기타포괄손익으로 인식됩니다.  제도개정, 축소 또는 정산이 발생하는 경우에는과거근무원가 또는 정산으로 인한 손익은 당기손익으로 인식됩니다. (2) 주식기준보상</P>
<P>종업원에게 부여한 주식결제형 주식기준보상은 부여일에 지분상품의 공정가치로 측정되며, 가득기간에 걸쳐 종업원 급여비용으로 인식됩니다. 가득될 것으로 예상되는 지분상품의 수량은 매 보고기간말에 비시장성과조건을 고려하여 재측정되며, 당초 추정치로부터의 변동액은 당기손익과 자본으로 인식됩니다. 주식선택권의 행사시점에 신주를 발행하며 직접적으로 관련되는 거래비용을 제외한 순유입액은 자본금(명목가액)과 주식발행초과금으로 인식됩니다.</P>
<P>(3) 단기종업원급여종업원이 관련 근무용역을 제공한 보고기간말부터 12개월 이내에 결제될 단기종업원급여는 근무용역과 교환하여 지급이 예상되는 금액을, 근무용역이 제공된 때에 당기손익으로 인식하고 있습니다. 단기종업원급여는 할인하지 않은 금액으로 측정하고있습니다.</P>
<P>(4) 해고급여당사는 해고급여의 제안을 더 이상 철회할 수 없을 때와 해고급여의 지급을 수반하는구조조정에 대한 원가를 인식할 때 중 이른 날에 해고급여에 대한 비용을 인식합니다.해고급여의 지급일이 12개월이 지난 후에 도래하는 경우에는 현재가치로 할인하고 있습니다.</P>
<P>2.16 수익인식 </P>
<P>(1) 수행의무의 식별당사는 기술이전계약에서 수행의무를 식별하며, 각 수행의무를 이행하는 시점 혹은 기간에 따라 이행하는 대로 수익을 인식하고 있습니다. 기술이전으로 인한 수익은 계약체결시점에 수령하는 계약금(Upfront payment), 일정요건 달성시점에 수령하는 마일스톤 금액(Milestone payment) 및 이전된 기술과 관련된 매출액의 일정비율을 수령하는 로열티로 구성되어 있습니다. 계약금은 반환 의무가 없고 기술이전 시점 이후에 수행할 추가적인 의무가 없는 경우, 기술에 대한 사용권을 부여한 것으로 보아관련 수익을 일시에 인식하고 있습니다. 또한, 추가적인 수행의무가 존재하는 경우 수행의무의 구별 여부를 판단합니다. 추가적인 수행의무가 단일 수행의무라면 라이선스와 관련된 수익인식기준을 적용하지 않습니다. 추가적인 수행의무가 구별되는 수행의무인 경우 라이선스 부여의 접근권 혹은 사용권 여부를 판단하고, 다른 수행의무는 그 이행시점에 따라 수익인식시기를 결정합니다.(2) 변동대가</P>
<P>당사는 변동대가와 관련하여 불확실성이 나중에 해소될 때, 이미 인식한 누적 수익 금액 중 유의적인 부분을 되돌리지 않을 가능성이 매우 높은 정도까지만 변동대가를 거래가격에 포함하여 수익으로 인식합니다.</P>
<P></P>
<P>2.17 리스리스계약은 일반적으로 고정기간으로 체결되지만 아래에서 설명하는 연장선택권 또는 종료선택권이 있을 수 있습니다. 리스조건은 개별적으로 협상되며 다양한 계약조건을 포함합니다. 리스계약에 따라 부과되는 다른 제약은 없지만 리스자산을 차입금의 담보로 제공할 수는 없습니다.</P>
<P>당사는 계약이 집행가능한 기간 내에서 해지불능기간에 리스이용자가 연장선택권을 행사할 것이 상당히 확실한 경우의 그 대상기간과 종료선택권을 행사하지 않을 것이 상당히 확실한 경우의 그 대상기간을 포함하여 리스기간을 산정합니다. 당사는 리스이용자와 리스제공자가 각각 다른 당사자의 동의 없이 종료할 수 있는 권리가 있는 경우 계약을 종료할 때 부담할 경제적 불이익을 고려하여 집행가능한 기간을 산정합니다.</P>
<P>리스에서 생기는 자산과 부채는 최초에 현재가치기준으로 측정합니다. 리스부채는 다음 리스료의 순현재가치를 포함합니다.- 받을 리스 인센티브를 차감한 고정리스료(실질적인 고정리스료 포함)- 지수나 요율(이율)에 따라 달라지는 변동리스료- 잔존가치보증에 따라 당사(리스이용자)가 지급할 것으로 예상되는 금액- 매수선택권을 행사할 것이 상당히 확실한 경우 매수선택권의 행사가격, 연장선택권을 행사할 것이 상당히 확실한 경우 연장기간의 리스료, 리스기간이 종료선택권 행사를 반영하는 경우에 리스를 종료하기 위하여 부담하는 금액</P>
<P>리스의 내재이자율을 쉽게 산정할 수 있는 경우 그 이자율로 리스료를 할인합니다. 내재이자율을 쉽게 산정할 수 없는 경우에는 리스이용자가 비슷한 경제적 환경에서 비슷한 기간에 걸쳐 비슷한 담보로 사용권자산과 가치가 비슷한 자산을 획득하는 데 필요한 자금을 차입한다면 지급해야 할 이자율인 리스이용자의 증분차입이자율을 사용합니다.</P>
<P>당사는 지수나 요율에 따라 달라지는 변동리스료의 경우 지수나 요율이 유효할 때까지 리스부채에 포함하지 않는 변동리스료의 잠재적 미래 증가 위험에 노출되어 있습니다. 지수나 요율에 따라 달라지는 리스료의 조정액이 유효한 시점에서 리스부채를 재평가하고 사용권자산을 조정합니다.</P>
<P>각 리스료는 리스부채의 상환과 금융원가로 배분합니다. 금융원가는 각 기간의 리스부채 잔액에 대하여 일정한 기간 이자율이 산출되도록 계산된 금액을 리스기간에 걸쳐 당기손익으로 인식합니다. </P>
<P> </P>
<P>사용권자산은 다음 항목들로 구성된 원가로 측정합니다.- 리스부채의 최초 측정금액- 받은 리스 인센티브를 차감한 리스개시일이나 그 전에 지급한 리스료- 리스이용자가 부담하는 리스개설직접원가- 복구원가의 추정치사용권자산은 리스개시일부터 사용권자산의 내용연수 종료일과 리스기간 종료일 중 이른 날까지의 기간동안 감가상각합니다. 당사가 매수선택권을 행사할 것이 상당히 확실한(reasonably certain) 경우 사용권자산은 기초자산의 내용연수에 걸쳐 감가상각합니다. </P>
<P> 리스요소를 포함하는 계약의 개시일이나 변경유효일에 당사는 계약대가를 상대적 개별 가격에 기초하여 각 리스요소에 배분합니다. 다만, 당사는 부동산 리스에 대하여 비리스요소를 분리하지 않는 실무적 간편법을 적용하여 리스요소와 관련된 비리스요소를 하나의 리스요소로 회계처리합니다. </P>
<P>당사는 리스기간이 12개월 이내인 단기리스와 소액 기초자산 리스에 대하여 사용권자산과 리스부채를 인식하지 않는 실무적 간편법을 선택하였습니다. 당사는 이러한 리스에 관련된 리스료를 리스기간에 걸쳐 정액법에 따라 비용으로 인식합니다. </P>
<P>당사는 리스계약에 연장선택권 및 종료선택권을 포함하고 있습니다. 이러한 조건들은 계약 관리 측면에서 운영상의 유연성을 극대화하기 위해 사용됩니다. 보유하고 있는 대부분의 연장선택권 및 종료선택권은 해당 리스제공자가 아니라 당사가 행사할 수 있습니다.</P>
<P>당사는 이자율지표개혁으로 인해 미래 리스료의 산정 기준이 변경되는 경우, 대체 이자율 지표의 변경을 반영하는 개정 할인율을 적용한 수정 리스료를 할인하여 리스부채를 재측정합니다. </P>
<P>2.18 현금및현금성자산당사는 보유현금과 요구불예금, 유동성이 매우 높고 확정된 금액의 현금으로 전환이 용이하고 가치변동의 위험이 경미한 단기 투자자산을 현금및현금성자산으로 분류하고 있습니다. 지분상품은 현금성자산에서 제외하고 있으나, 상환일이 정해져 있고 취득일로부터 상환일까지의 기간이 단기인 우선주와 같이 실질적인 현금성자산인 경우에는 현금성자산에 포함하고 있습니다. </P>
<P>2.19 주당이익당사는 보통주에 대해 기본주당이익을 당기순손익에 대하여 계산하고 포괄손익계산서에 표시하고 있습니다. 기본주당이익은 보통주에 귀속되는 당기순손익을 보고기간동안에 유통된 보통주식수를 가중평균한 주식수로 나누어 계산하고 있습니다. </P>
<P>2.20 재무제표 승인당사의 재무제표는 2023년 2월 13일 이사회에서 승인되었으며, 2023년 3월 30일자 정기주주총회에서 최종 승인될 예정입니다.</P>
<P></P>
<PGBRK></PGBRK>
<P>3. 중요한 회계추정 및 가정재무제표 작성에는 미래에 대한 가정 및 추정이 요구되며 경영진은 당사의 회계정책을 적용하기 위해 판단이 요구됩니다. 추정 및 가정은 지속적으로 평가되며, 과거 경험과 현재의 상황에 비추어 합리적으로 예측가능한 미래의 사건을 고려하여 이루어집니다. 회계추정의 결과가 실제 결과와 동일한 경우는 드물 것이므로 중요한 조정을유발할 수 있는 유의적인 위험을 내포하고 있습니다.</P>
<P>다음 회계연도에 자산 및 부채 장부금액의 조정에 영향을 미칠 수 있는 경영진 판단과 유의적 위험에 대한 추정 및 가정은 다음과 같습니다. 일부 항목에 대한 유의적인 판단 및 추정에 대한 추가적인 정보는 개별 주석에 포함되어 있습니다.</P>
<P>(1) 법인세당사의 과세소득에 대한 법인세는 세법 및 과세당국의 결정을 적용하여 산정되므로 최종 세효과를 산정하는 데에는 불확실성이 존재합니다(주석19 참조).(2) 금융상품의 공정가치활성시장에서 거래되지 않는 금융상품의 공정가치는 원칙적으로 평가기법을 사용하여 결정됩니다. 당사는 보고기간말 현재 중요한 시장상황에 기초하여 다양한 평가기법의 선택 및 가정에 대한 판단을 하고 있습니다(주석6 참조). (3) 순확정급여부채(자산)순확정급여부채(자산)의 현재가치는 보험수리적방식에 의해 결정되는 다양한 요소들특히 임금상승률 및 할인율의 변동에 영향을 받습니다(주석17 참조).(4) 금융자산의 손상금융자산의 손실충당금은 부도위험 및 기대손실률 등에 대한 가정에 기초하여 측정됩니다. 당사는 이러한 가정의 설정 및 손상모델에 사용되는 투입변수의 선정에 있어서 당사의 과거 경험, 현재 시장 상황, 재무보고일 기준의 미래전망정보 등을 고려하여 판단합니다.</P>
<PGBRK></PGBRK>
<P>4. 재무위험관리4.1 재무위험관리요소당사는 여러 활동으로 인하여 시장위험(환위험 등), 신용위험 및 유동성위험과 같은 다양한 재무위험에 노출되어 있습니다. 당사의 전반적인 위험관리정책은 금융시장의변동성에 초점을 맞추고 있으며 재무성과에 미치는 부정적 영향을 최소화하는데 중점을 두고 있습니다.</P>
<P></P>
<P>4.1.1 시장위험(1) 외환위험 관리외환 위험은 인식된 외화표시 자산 및 부채와 관련하여 발생하고 있습니다.</P>
<P>당기말과 전기말 현재 외환 위험에 노출되어 있는 금융자산ㆍ부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="6" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위 : USD, GBP, 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD ROWSPAN="2" WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>통화</P>
</TD>

<TD COLSPAN="2" WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD COLSPAN="2" WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>외화금액</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>원화환산액</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>외화금액</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>원화환산액</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="6" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">
<P>금융자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">
<P> 외화예금</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>USD</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,663,292</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,642,490</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,862,748</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,764,788</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">USD</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">701,263</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">888,710</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="6" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">
<P>금융부채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="60" ROWSPAN="2">
<P> 미지급금</P>
</TD>

<TD WIDTH="106" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">
<P>USD</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">136,285</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">172,714</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,450</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,994</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="106" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">GBP</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">325,551</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">497,334</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>당기말과 전기말 현재 다른 모든 변수가 일정하고 미국 달러화 및 영국 파운드화에 대한 원화의 환율이 10% 변동 시 당사의 세전 이익 및 자본에 미치는 영향은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="68"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="6" WIDTH="632" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="2" WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD COLSPAN="2" WIDTH="240" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>세전 이익에 대한 영향</P>
</TD>

<TD COLSPAN="2" WIDTH="238" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>자본에 대한 영향</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>

<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="77" VALIGN="MIDDLE" HEIGHT="60">
<P>USD/원</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" HEIGHT="30">
<P>상승시</P>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">535,849</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">570,379</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">535,849</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">570,379</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" HEIGHT="30">
<P>하락시</P>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(535,849)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(570,379)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(535,849)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(570,379)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="77" VALIGN="MIDDLE" HEIGHT="60">
<P>GBP/원</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" HEIGHT="30">
<P>상승시</P>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(49,733)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(49,733)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" HEIGHT="30">
<P>하락시</P>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,733</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,733</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(2) 이자율위험 관리당사의 현금흐름 이자율위험은 장단기차입금에서 비롯됩니다. 변동이자율로 발행된차입금으로 인하여 당사는 현금흐름 이자율위험에 노출되어 있으며 동 이자율위험의일부는 변동이자부현금성자산으로부터의 이자율위험과 상쇄됩니다.당사는 이자율위험에 대한 노출에 대해 재융자, 기존 차입금의 갱신, 대체적인 융자 및 위험회피 등을 고려한 다각적인 분석을 실시하고 있습니다.당기말과 전기말 현재 다른 변수가 일정하고 차입금에 대한 이자율 1% 변동이 변동금리부차입금에 대한 이자비용의 영향은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="632" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구분</TD>
<TD COLSPAN="2" WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당기</TD>
<TD COLSPAN="2" WIDTH="252" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">1% 상승시</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">1% 하락시</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">1% 상승시</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">1% 하락시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">이자비용</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(80,000)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(80,000)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>4.1.2 신용위험신용위험은 당사의 통상적인 거래 및 투자활동에서 발생하며 거래상대방이 계약조건상 의무사항을 지키지 못하여 당사에 재무적 손실을 미칠 위험을 의미합니다. (1) 위험관리금융상품은 채무불이행위험이 낮고 단기간내에 계약상 현금흐름을 지급할 수 있는 발행자의 충분한 능력이 있는 경우 신용위험이 낮은 것으로 간주합니다. 신용위험은 재무적 손실의 최소화를 목적으로 당사 차원에서 관리되고 있습니다. 이러한 신용위험을 관리하기 위하여 당사는 거래시 재무상태와 과거 경험 및 기타 요소들을 포함한거래상대방의 신용도를 고려하고 있습니다. 신용위험은 보유하고 있는 수취채권에 대한 신용위험뿐 아니라 현금및현금성자산, 은행 및 금융기관 예치금으로부터 발생할 수 있습니다. 이러한 위험을 줄이기 위하여 당사는 신용도가 높은 금융기관들과 거래를 하고 있습니다.(2) 금융자산의 손상상각후원가로 측정하는 금융자산은 단기금융상품, 상각후원가금융자산, 계약자산, 미수수익과 보증금 등으로 구성되어 있습니다. 당기와 전기 중 상각후원가로 측정하는 기타금융자산에 대해 당기손익으로 인식한 손실충당금은 없습니다. 상각후원가로측정하는 금융자산은 모두 신용위험이 낮은 것으로 판단되며, 따라서 손실충당금은 12개월 기대신용손실로 인식하였습니다.당기말과 전기말 현재 당사가 보유한 금융상품과 관련하여 신용위험 최대노출액은 장부금액과 동일합니다.</P>
<P>4.1.3 유동성 위험당사는 영업 자금 수요를 충족시키기위해 약정을 위반하는 일이 없도록 유동성에 대한 예측을 항시 모니터링하고 있습니다. 유동성을 예측하는데 있어 당사의 자금조달 계획, 약정 준수, 당사 내부의 목표재무비율 및 통화에 대한 제한과 같은 외부 법규나법률 요구사항도 고려하고 있습니다. 당사는 상기에서 언급한 예측을 통해 결정된 대로 여유있는 유동성이 확보될 수 있도록 적절한 만기나 충분한 유동성을 제공해주는 금융상품을 선택하여 잉여자금을 투자하고 있습니다. 당기말과 전기말 현재 당사는 유동성 위험을 관리할 수 있도록 즉시 출금이 가능한 보통예금 등에 8,510,611천원(전기말 10,395,846천원)을 예치하고 있습니다. 당사의 유동성 위험 분석 내역은 다음과 같습니다. 아래 표시된 금액은 현금흐름을 할인하지 아니한 금액이며, 예상이자비용이 포함된 금액입니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="799">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="6" WIDTH="799" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>장부금액</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>계약상 현금흐름</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>1년이내</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>1년초과 5년이내</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>5년초과</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">차입금</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,467,200</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">233,600</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,233,600</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">유동리스부채</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,043</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,820</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,820</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">기타유동금융부채</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,258,802</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">1,258,802</SPAN>
</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,258,802</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">비유동리스부채</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">106,719</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">130,558</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">130,558</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="799">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="6" WIDTH="799" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P> (단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>장부금액</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>계약상 현금흐름</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>1년이내</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>1년초과 5년이내</P>
</TD>

<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>5년초과</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">차입금</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,700,800</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">233,600</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,467,200</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">유동리스부채</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">82,705</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,733</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,733</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">기타유동금융부채</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,293,551</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,293,551</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,293,551</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">비유동리스부채</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">128,152</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">134,468</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">134,468</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>상기 분석에 포함된 금융부채는 보고기간말로부터 계약 만기일까지의 잔여 기간에 따라 만기별로 구분되었습니다. 만기별 구분에 포함된 현금흐름은 현재가치로 할인하지 아니한 금액으로서 지급을 요구받을 수 있는 기간 중 가장 빠른일자를 기준으로작성되었습니다.</P>
<P>4.2 자본위험관리당사의 자본 관리 목적은 계속기업으로서 주주 및 이해당사자들에게 이익을 지속적으로 제공할 수 있는 능력을 보호하고 자본 비용을 절감하기 위해 최적의 자본 구조를 유지하는 것입니다. 자본 구조를 유지 또는 조정하기 위해 당사는 주주에게 지급되는 배당을 조정하고, 부채 감소를 위한 신주 발행 및 자산 매각 등을 실시하고 있습니다. 당사는 자본조달비율에 기초하여 자본을 관리하고 있습니다. 자본조달비율은 순부채를 총자본으로 나누어 산출하고 있습니다. 순부채는 총차입금(재무상태표의  리스부채 포함)에서 현금및현금성자산을 차감한 금액이며 총자본은 재무상태표의    "자본"에 순부채를 가산한 금액입니다. 당기말과 전기말 현재 당사의 자본조달비율은다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="620" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>총차입금</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                 8,150,762</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,210,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>차감:현금및현금성자산</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,510,612)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,441,591)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>순부채(A)</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(359,850)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,230,735)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>자본총계(B)</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               46,170,727</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,016,753</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>총자본(C=A+B)</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              45,810,877</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,786,018</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>자본조달비율(A/C)(*)</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">(*) 현금및현금성자산이 총차입금을 초과하여 자본조달비율을 표시하지 않았습니다.</SPAN>
</P>
<PGBRK></PGBRK>
<P>5. 원가기준 투입법 적용 계약(1) 당기 및 전기 중 당사의 계약잔액 및 영업수익 등의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="715" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">당기</TH>

<TH WIDTH="139" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">
<P>기초</P>
<P>계약잔액</P>
</TH>
<TH WIDTH="139" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">증감액</TH>

<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" USERMARK=" B">

<P USERMARK=" B">
<SPAN USERMARK=" !B">영업수익</SPAN>
</P>
</TH>

<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" USERMARK=" B">

<P USERMARK=" B">
<SPAN USERMARK=" !B">기말</SPAN>
</P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">계약잔액(*)</SPAN>
</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE">CU06-RE 임상시험</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">850,715</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">2,732,144</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">3,582,859</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 임상 2상 시험 용역 제공 수행의무를 통해 수행의무 결과를 합리적으로 측정할 수없는 상황에서 투입되는 원가만큼 회수가 가능할 것으로 예상하고 있기 때문에, 계약잔액이 존재하지 않습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="715" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">전기</TH>

<TH WIDTH="139" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">
<P>기초</P>
<P>계약잔액</P>
</TH>
<TH WIDTH="139" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">증감액</TH>

<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" USERMARK=" B">

<P USERMARK=" B">
<SPAN USERMARK=" !B">영업수익</SPAN>
</P>
</TH>

<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" USERMARK=" B">

<P USERMARK=" B">
<SPAN USERMARK=" !B">기말</SPAN>
</P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">계약잔액</SPAN>
</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE">CU06-RE 임상시험</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">1,081,319</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">230,604</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">850,715</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>
<P>(2) 당기말 및 전기말 현재 진행중인 용역과 관련된 누적원가 등의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="714">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="714" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="139" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">누적원가</TH>
<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">누적손익</TH>
<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계약자산</TH>
<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계약부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE">CU06-RE 임상시험</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">3,682,236</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">131,227</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">149,321</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="714">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="714" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전 기</TH>
<TH WIDTH="139" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">누적원가</TH>
<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">누적손익</TH>
<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계약자산</TH>
<TH WIDTH="138" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계약부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE">CU06-RE 임상시험</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">205,125</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">25,479</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">35,267</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">850,715</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>
<P>(3) 당기 및 전기의 계약수익금액이 전기 매출액의 5% 이상인 수행의무별 정보는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="807">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="807" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="8">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수행의무</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약일</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이행종료시점</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">진행률</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약수익</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약자산</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="91" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">CU06-RE임상시험</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임상 1상 시험</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-10</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022년</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">100%</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">850,715</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임상 2상 시험</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-10</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023년 이후</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-(*)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,732,144</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,321</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="413" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> 3,582,859</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,321</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="807">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="807" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="8">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
<TH WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수행의무</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약일</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이행종료시점</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">진행률</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약수익</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약자산</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="91" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">CU06-RE임상시험</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임상 1상 시험</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-10</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022년</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">18.7%</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">195,337</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">850,715</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임상 2상 시험</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-10</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023년 이후</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-(*)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,267</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,267</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="413" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">230,604</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,267</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">850,715</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 임상 2상 시험 용역에 대한 수행의무의 결과를 합리적으로 측정할 수 없으나, 수행의무를 이행하는 동안에 드는 원가는 회수될 것으로 예상하여 발생원가의 범위에서 수익을 인식하고 있습니다.</P>
<P>6. 금융상품 공정가치6.1 금융상품 종류별 공정가치당기말과 전기말 현재 금융상품의 종류별 장부금액 및 공정가치는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="253"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="632" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="262" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD COLSPAN="2" WIDTH="186" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD COLSPAN="2" WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>장부금액</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>공정가치</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>장부금액</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>공정가치</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="632" VALIGN="MIDDLE" HEIGHT="30">
<P>금융자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  현금및현금성자산(*1)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,510,612</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,510,612</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,441,591</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,441,591</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  매출채권(*1)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">888,710</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">888,710</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  장단기금융상품(*1)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000,000</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000,000</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,030,504</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,030,504</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  당기손익공정가치측정금융자산</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,073,467</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,073,467</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,020,500</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,020,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  기타포괄손익공정가치측정금융자산</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  상각후원가측정금융자산(*1)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,025,727</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,025,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  기타금융자산(*1)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">271,354</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">271,354</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,638</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,638</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="262" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,044,303</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,044,303</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,943,960</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,943,960</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="632" VALIGN="MIDDLE" HEIGHT="30">
<P>금융부채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  기타금융부채(*1)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,258,802</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">1,258,802</SPAN>
</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,293,551</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,293,551</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  리스부채(*1)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,762</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,762</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">210,856</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">210,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  장기차입금(*1)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="262" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,409,564 </TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,409,564 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,504,407</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,504,407</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 상각후원가로 측정되는 금융자산 및 금융부채로서 장부금액은 공정가치의 합리적인 근사치입니다.</P>
<PGBRK></PGBRK>
<P>6.2 공정가치 서열체계공정가치로 측정되는 금융상품의 공정가치 서열체계 구분은 다음과 같습니다.- 수준 1: 측정일에 동일한 자산이나 부채에 대한 접근가능한 활성시장의 조정되지 않은 공시가격- 수준 2: 수준 1의 공시가격 이외에 자산이나 부채에 대해 직접적으로 또는 간접적으로 관측가능한 투입변수- 수준 3: 자산이나 부채에 대한 관측가능하지 않은 투입변수</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="253"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="82"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="629" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당기말</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">수준 1</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">수준 2</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">수준 3</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">합계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="629" VALIGN="MIDDLE" HEIGHT="30">금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  당기손익공정가치측정금융자산</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 3,073,467</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,073,467</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  기타포괄손익공정가치측정금융자산</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="253"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="262" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>수준 1</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>수준 2</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>수준 3</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>합계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" VALIGN="MIDDLE" HEIGHT="30">  당기손익공정가치측정금융자산</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,020,500</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,020,500</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">6.3 공정가치 측정치의 서열체계 수준 간 이동당사는 공정가치 서열체계의 수준 간 이동을 보고기간말에 인식하며 각 공정가치 서열체계의 수준 간 이동 내역은 없습니다. </SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">6.4 공정가치 측정치의 수준 3의 변동 내역당기와 전기 중 공정가치 측정치의 수준 3의 변동 내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="216"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="630" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>기초금액</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,917,166</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">취득</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>전환</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(4,892,310)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>평가손실(이익) 인식액</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(24,856)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>기말금액</P>
</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>

<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>6.5 가치평가기법 및 투입변수(1) 당기말 및 전기말 현재 당사의 재무상태표에서 공정가치로 측정되는 자산, 부채 중 공정가치 서열체계 수준 2로 분류된 항목의 가치평가기법과 투입변수는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="717">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="717" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당기말</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">공정가치</TD>
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">수준</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">가치평가기법</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">투입변수</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">투입변수 범위</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="717" VALIGN="MIDDLE" HEIGHT="30">당기손익공정가치측정금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">  수익증권 및 펀드</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,073,467 </TD>
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시장접근법</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기초자산가격</TD>
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="717">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="717" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전기말</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">공정가치</TD>
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">수준</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">가치평가기법</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">투입변수</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">투입변수 범위</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="717" VALIGN="MIDDLE" HEIGHT="30">당기손익공정가치측정금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">  수익증권 및 펀드</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,020,500</TD>
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시장접근법</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기초자산가격</TD>
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당기말 현재 당사의 재무상태표에서 공정가치로 측정되는 자산, 부채 중 공정가치 서열체계 수준 3으로 분류된 항목의 가치평가기법과 투입변수는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="717">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="717" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당기말</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">공정가치</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="57" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">수준</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가치평가기법</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">투입변수</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">투입변수 범위</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="717" HEIGHT="30" COLSPAN="6" VALIGN="MIDDLE">기타포괄손익공정가치측정금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" VALIGN="MIDDLE">  비상장주식</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">300,160</TD>
<TD WIDTH="57" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">원가접근법</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기초자산가격</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>전기말 현재 수준 3으로 분류되는 기타포괄손익공정가치측정 금융자산은 존재하지 않습니다.6.6 수준 3으로 분류된 공정가치 측정치의 가치평가과정당사는 재무보고 목적의 공정가치 측정을 담당하는 담당자가 있으며, 이러한 공정가치 측정치는 수준 3으로 분류되는 공정가치 측정치를 포함하고 있습니다. 공정가치 측정 담당자는 당사의 재무담당이사와 감사에 직접 보고하며 매기 보고일정에 맞추어 공정가치 평가과정 및 그 결과에 대해 재무담당이사 및 감사와 협의합니다.</P>
<PGBRK></PGBRK>
<P>7. 범주별 금융상품(1) 당기말과 전기말 현재 당사의 금융자산 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="255"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="185"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="632" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="632" VALIGN="MIDDLE" HEIGHT="30">
<P>상각후원가측정금융자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">
<P> 현금및현금성자산 </P>
</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,510,612</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,441,591</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">888,710</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">
<P> 장단기금융상품</P>
</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000,000</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,030,504</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30"> 상각후원가측정금융자산</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,025,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30">
<P> 기타금융자산</P>
</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">271,354</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,638</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>소계</P>
</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,670,676</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,923,460</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="632" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">당기손익공정가치측정금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30"> 유동당기손익공정가치측정금융자산</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,073,467</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,020,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="632" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">기타포괄손익공정가치측정금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" HEIGHT="30"> 기타포괄손익공정가치측정금융자산</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="174" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,044,303</TD>
<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,943,960</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당기말과 전기말 현재 당사의 금융부채 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="633">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="188"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" HEIGHT="30">
<P>상각후원가측정금융부채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="238" VALIGN="MIDDLE" HEIGHT="30">
<P> 차입금</P>
</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" VALIGN="MIDDLE" HEIGHT="30"> 리스부채</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,762</TD>
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">210,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="238" VALIGN="MIDDLE" HEIGHT="30">
<P> 기타금융부채</P>
</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,258,802</TD>
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,293,551</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="238" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,409,564</TD>
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,504,407</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>
<PGBRK></PGBRK>
<P>(3) 당기와 전기의 금융상품 범주별 순손익 정보는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="633">

<COLGROUP>
<COL WIDTH="247"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="179"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" HEIGHT="30">
<P>당기손익공정가치측정금융자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 평가이익</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,569</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 평가손실</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,700)</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(24,846)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 처분이익</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,270</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,331</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 처분손실</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" HEIGHT="30">
<P>상각후원가측정금융자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 상각후원가측정금융자산처분손실</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(28,833)</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 이자수익</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">537,732</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">216,746</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 외환차익</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,268</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 외환차손</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(78,573)</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 외화환산이익</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">238,735</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 외화환산손실</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(58,622)</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" HEIGHT="30">
<P>당기손익공정가치측정금융부채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 전환상환우선주평가이익</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" HEIGHT="30">
<P>상각후원가측정 금융부채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 이자비용</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(299,895)</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,044)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 잡이익(임차료 할인)</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,998</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,617</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 외환차손</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,017)</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(27,674)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 외환차익</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">144,021</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,159</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 잡손실(리스변경)</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(24,629)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" VALIGN="MIDDLE" HEIGHT="30"> 외화환산이익</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,971</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">242</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>
<PGBRK></PGBRK>
<P>8. 현금및현금성자산 및 장단기금융상품(1) 당기말과 전기말 현재 당사의 현금및현금성자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="630" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="630" VALIGN="MIDDLE" HEIGHT="30">
<P>현금및현금성자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>  보통예금</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,510,612</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,441,591</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">(2) 당기말과 전기말 현재 당사의 장단기금융상품의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">
<P>단기금융상품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>  정기예적금</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 20,000,000</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">
<P>장기금융상품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>  장기성예금</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,504</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000,000</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,030,504</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">(3) 당기말과 전기말 현재 당사의 사용이 제한된 금융상품은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="632" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당기말</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">보통예금(*1)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,745</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">정기예금(*2)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,778</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 정부로부터 수령한 연구개발비 보조금으로 연구개발비 용도로 사용이 제한되어 있습니다(주석11 참조). (*2) 철거이행보증금의 담보로 제공되어 사용이 제한되어 있습니다.</P>
<P></P>
<PGBRK></PGBRK>
<P>9. 기타투자자산당기말과 전기말 현재 당사의 기타투자자산의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="245"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="179"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P>상각후원가측정금융자산</P>
</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,025,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P>당기손익공정가치측정금융자산</P>
</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,073,467</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,020,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">기타포괄손익공정가치측정금융자산</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,373,627</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,046,227</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>10. 기타금융자산 및 기타자산(1) 당기말과 전기말 현재 당사의 기타금융자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="630" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="630" VALIGN="MIDDLE" HEIGHT="30">
<P>유동항목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P> 미수금</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,104</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P> 미수수익</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">207,772</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,973</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P> 유동임차보증금</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,156</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">253,085</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">220,979</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">388,162</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="630" VALIGN="MIDDLE" HEIGHT="30">
<P>비유동항목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P> 비유동임차보증금</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,415</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P> 기타보증금</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,960</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,130</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,375</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,476</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">271,354</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425,638</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(2) 당기말과 전기말 현재 당사의 기타자산 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">
<P>유동항목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">

<P USERMARK=" 0X0000FF"> 
<SPAN USERMARK=" 0X000000">선급비용</SPAN>
</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">312,658</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">297,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P> 당기법인세자산</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">76,295</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,095</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P> 부가세대급금</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">174,517</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">299,986</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">563,470</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">610,937</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="631" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">
<P>비유동항목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P> 장기선급금</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">406,989</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">343,411</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">970,459</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">954,348</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>11. 정부보조금(1) 당기말 현재 수행 중인 개발과제 등과 관련된 정부보조금은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="856">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="222"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="856" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">과제명</TH>
<TH WIDTH="231" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수행기간</TH>
<TH WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">입금연도</TH>
<TH WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">입금액</TH>
<TH WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">총지원금</TH>
<TH WIDTH="162" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">정부기관</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="208" VALIGN="MIDDLE" HEIGHT="150">바이오의료기술개발사업</TD>
<TD ROWSPAN="5" WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">2018년4월1일~2022년12월31일</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018년</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140,000</TD>
<TD ROWSPAN="5" WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="150">693,000 </TD>
<TD ROWSPAN="5" WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">한국보건산업진흥원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019년</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020년</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021년</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="90" ROWSPAN="3">고경력연구인력채용지원사업</TD>
<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">2019년12월1일~2022년8월30일</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019년</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,900</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="90" ROWSPAN="3">137,225 </TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">한국산업기술진흥협회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020년</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,900</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021년(*)</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,425</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 2022년 8월 중도 종료되었습니다.</P>
<P>(2) 당기말과 전기말 현재 정부보조금의 미사용잔액의 세부내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="631" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">선수수익(*)</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,745</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 정부로부터 수령한 연구개발비 보조금으로 연구개발비 용도로 사용이 제한되어 있습니다(주석8 참조).</P>
<PGBRK></PGBRK>
<P>(3) 당기와 전기 중 정부보조금의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="851">

<COLGROUP>
<COL WIDTH="271"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="851" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="280" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기</TH>
<TH ROWSPAN="2" WIDTH="96" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">기초금액</TH>
<TH ROWSPAN="2" WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">수령금액</TH>
<TH ROWSPAN="2" WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">반환금액(*)</TH>
<TH COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">사용금액</TH>
<TH ROWSPAN="2" WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">기말금액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자산취득</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비용보전 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="280" HEIGHT="30">바이오의료기술개발사업</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="96" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">240,242</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(240,242)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="280" HEIGHT="30">고경력연구인력채용지원사업</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="96" HEIGHT="30">45,745</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">20</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(12,498)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(33,267)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="280" HEIGHT="30">합계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="96" HEIGHT="30">45,745</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">240,262</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(12,498)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(273,509)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 정부보조금의 중도 종료 및 이자수익 금액입니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="852">

<COLGROUP>
<COL WIDTH="270"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="852" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="279" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
<TH WIDTH="96" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초금액</TH>
<TH WIDTH="96" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수령금액</TH>
<TH WIDTH="96" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">반환금액(*)</TH>
<TH WIDTH="190" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용금액</TH>
<TH WIDTH="95" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말금액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산취득</TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비용보전 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="279" HEIGHT="30" VALIGN="MIDDLE">바이오의료기술개발사업</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">59,601</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,500)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(58,101)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="279" HEIGHT="30" VALIGN="MIDDLE">고경력연구인력채용지원사업</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,744</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,923</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(49,900)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,745</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="279" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,744</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">109,524</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,500)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(108,001)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,745</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 정부보조금에서 발생한 이자수익입니다.</P>
<PGBRK></PGBRK>
<P>12. 유형자산</P>
<P>(1) 당기말과 전기말 현재 당사의 유형자산 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="761">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="761" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득원가</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상각누계액</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">정부보조금</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,379,631</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,379,631</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,081,568</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(57,779)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,023,789</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,786,137</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(461,827)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,361)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,315,949</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">313,103</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(73,603)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">239,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">223,520</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(73,358)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,162</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">리스개량자산</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,068</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(828)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,240</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,500</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,847,527</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(667,395)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,361)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,171,771</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="761">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="761" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득원가</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상각누계액</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">정부보조금</TH>
<TH WIDTH="152" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,379,631</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,379,631</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">891,185</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(328,722)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,583)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">547,880</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,400</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(33,261)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,139</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">105,143</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,356)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">318,915</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(83,151)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">235,764</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">리스개량자산</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,068</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(215)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,853</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025,589</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,803,931</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(498,705)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,583)</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,290,643</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>
<P>(2) 당기 및 전기 중 당사의 유형자산 변동 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="906">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="906" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기초</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">처분</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감가상각비</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타(*)</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,379,631</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,379,631</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,814</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(57,779)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,027,754</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,023,789</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">562,463</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132,103</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(69,171)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(236,324)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">935,239</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,324,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">(정부보조금)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,583)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,324</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,898</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,361)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,139</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(40,439)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,700)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,787</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,539</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,002)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(35,708)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">180,884</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">239,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">235,764</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,003</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,934)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(105,793)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,878)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,162</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">리스개량자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,853</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(613)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,240</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025,589</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,178,788</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,143,877)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,290,643</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,439,247</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(115,222)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(438,019)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,878)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,171,771</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="907">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="907" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
<TH WIDTH="127" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기초</TH>
<TH WIDTH="127" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">처분</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감가상각비</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타(*)</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,379,631</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,379,631</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">720,236</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,293</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(175,066)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">562,463</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">(정부보조금)</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(18,191)</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,500)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,108</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,583)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,219</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,080)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,139</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,775</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,695</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(17,683)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">714,439</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">187,360</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(124,743)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(541,292)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">235,764</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">리스개량자산</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,068</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(215)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,853</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,405,220</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,379,631)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025,589</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,525,478</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,635,136</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(328,679)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(541,292)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,290,643</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">(*) 건설중인자산의 본계정대체 및 리스변경으로 구성되어 있습니다.</SPAN>
</P>
<P>(3) 당기말 현재 유형자산 담보제공내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="839">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="82"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="839" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보설정금액</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관련 계정과목</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관련 차입금</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보권자</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,379,631</TD>
<TD WIDTH="150" HEIGHT="60" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE">9,600,000</TD>
<TD WIDTH="149" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">차입금(주석15)</TD>
<TD WIDTH="149" HEIGHT="60" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE">8,000,000</TD>
<TD WIDTH="91" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">하나은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,023,789</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>13. 무형자산(1) 당기말과 전기말 현재 당사의 무형자산 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="784">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="7" WIDTH="784" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD COLSPAN="3" WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD COLSPAN="3" WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>취득원가</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>상각누계액</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>장부금액</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>취득원가</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>상각누계액</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>장부금액</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30">특허권</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">165,232</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(74,953)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,279</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,891</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(57,778)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,113</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30">전용실시권</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">292,983</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(163,107)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">129,876</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">227,976</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(126,631)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30">소프트웨어 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,119</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(21,335)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,784</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,619</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(12,195)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,424</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30">상표권</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,212</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,531)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,681</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,212</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,688)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30">회원권</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,000</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,000</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,000</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">584,546</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(262,926)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">321,620</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">449,698</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(198,292)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">251,406</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>
<P>(2) 당기 및 전기 중 당사의 무형자산 변동 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기초</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>취득</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>상각비</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">특허권</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,113</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,340</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(17,174)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,279</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">전용실시권</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,345</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,006</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(36,475)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">129,876</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,424</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,500</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,140)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,784</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">상표권</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,524</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,843)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,681</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">회원권</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">251,406</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">134,846</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(64,632)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">321,620</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기초</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>취득</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>상각비</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">특허권</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,947</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,311</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,145)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,113</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">전용실시권</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">107,856</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,815</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(32,326)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,428</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,400</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,404)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,424</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">상표권</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,213</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,689)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,524</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" HEIGHT="30">회원권</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">172,231</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132,739</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,564)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">251,406</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>14. 리스당사가 리스이용자인 경우의 리스에 대한 정보는 다음과 같습니다.(1) 재무상태표에 인식된 금액당기말과 전기말 현재 리스와 관련해 재무상태표에 인식된 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="633">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="633" VALIGN="MIDDLE" HEIGHT="30">
<P>사용권자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>  건물</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">57,516</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>  차량운반구</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,162</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,248</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,162</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">235,764</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="634">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="634" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="634" VALIGN="MIDDLE" HEIGHT="30">
<P>리스부채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30">
<P>  유동</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,043</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">82,704</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30">
<P>  비유동</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">106,719</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">128,152</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,762</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">210,856</TD>
</TR>
</TBODY>
</TABLE>
<P>당기 중 증가된 사용권자산은 28,003천원이며 전기 중 증가된 사용권자산은 187,360천원입니다.</P>
<P USERMARK=" 0X0000FF"></P>
<PGBRK></PGBRK>
<P>(2) 포괄손익계산서에 인식된 금액리스와 관련해서 포괄손익계산서에 인식된 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="321"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="632" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="330" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="632" VALIGN="MIDDLE" HEIGHT="30">
<P>사용권자산의 감가상각비</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P> 건물</P>
</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,583</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">94,036</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P> 차량운반구</P>
</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,210</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,707</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">105,793</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">124,743</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>리스부채에 대한 이자비용</P>
</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,942</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,456</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">단기리스료</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>단기리스가 아닌 소액자산리스료</P>
</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,451</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,834</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>리스부채 측정치에 포함되지 않은 변동리스료</P>
</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,838</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,186</TD>
</TR>
</TBODY>
</TABLE>
<P>당기 및 전기 중 선급리스료를 포함한 리스의 총 현금유출은 각각 96,012천원 및 103,420천원입니다. 한편, 당기 중 '코로나19'의 직접적인 영향으로 할인된 임차료를 당기손익으로 인식한 금액은 4,998천원입니다.</P>
<P USERMARK=" 0X0000FF"></P>
<PGBRK></PGBRK>
<P>15. 차입금(1) 당기말과 전기말 현재 당사의 차입금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="634">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="634" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="634" VALIGN="MIDDLE" HEIGHT="30">비유동항목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30">  장기차입금</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">상기 차입금과 관련하여 유형자산이 담보로 제공되어 있습니다(주석12 참조). (2) 당기말과 전기말 현재 차입금의 상세내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="629" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만기일</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율(%)</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="629" VALIGN="MIDDLE" COLSPAN="6" HEIGHT="30">장기차입금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30"> 원화대출</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">하나은행</TD>
<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2024-12-29</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.62%</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 당기말 현재 장기차입금의 상환일정은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="306"></COL>
<COL WIDTH="305"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="629" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="2">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="315" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상환연도</TH>
<TH WIDTH="314" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상환금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1년 이내</TD>
<TD WIDTH="314" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2년 이내</TD>
<TD WIDTH="314" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="314" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>16. 기타금융부채 및 기타부채(1) 당기말과 전기말 현재 당사의 기타금융부채 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="632" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="632" VALIGN="MIDDLE" HEIGHT="30">
<P>유동항목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P> 미지급금</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,039,466</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">145,314</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">

<P USERMARK=" 0X0000FF"> 
<SPAN USERMARK=" 0X000000">미지급비용</SPAN>
</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">219,335</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,148,237</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,258,801</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,293,551</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당기말과 전기말 현재 당사의 기타부채 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">
<P>유동항목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P> 선수수익(*)</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,745</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P> 예수금</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,833</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,833</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">115,469</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 전기말 현재 선수수익은 정부로부터 수령한 연구개발비 보조금으로 연구개발비 용도로 사용이 제한되어 있습니다(주석 8, 11 참조).</P>
<PGBRK></PGBRK>
<P>17. 퇴직급여(1) 당기말과 전기말 현재 당사의 재무상태표에 인식된 순확정급여부채(자산) 금액의산정내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="245"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="179"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P>확정급여채무의 현재가치</P>
</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">596,643</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629,150</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P>사외적립자산의 공정가치</P>
</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(587,295)</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(682,870)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">
<P>재무상태표상 순확정급여부채(자산)</P>
</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,348</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,720)</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당기와 전기 중 당사의 확정급여채무 현재가치의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="630" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>기초금액</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629,150</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">486,758</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>당기근무원가</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">297,957</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">215,078</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>이자비용</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,257</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,446</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>과거근무원가</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(48,320)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>재측정요소</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">(132,374)</TD>
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">184,282</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P> 1) 경험조정효과</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(38,613)</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">211,737</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P> 2) 인구통계적가정변경효과</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P> 3) 재무적가정변경효과</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(93,761)</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(27,455)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>급여지급액</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(215,347)</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(219,094)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">
<P>기말금액</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">596,643</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629,150</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 당기와 전기 중 당사의 사외적립자산 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>기초금액</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">682,870</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">432,897</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>기여금납입액</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">328,573</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">247,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">급여 지급액</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(428,417)</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>이자수익</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,830</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>재측정요소</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,561)</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(7,220)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>기말금액</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">587,295</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">682,870</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(4) 당기말과 전기말 현재 당사의 사외적립자산 구성요소는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="632" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>현금및현금성자산 등</P>
</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">587,295</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">682,870</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<P>(5) 당기말과 전기말 현재 당사의 주요 보험수리적 가정은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="631" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">할인율</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.33%</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.93%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">임금상승률</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.68%</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.56%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<P>(6) 주요 가정의 변동에 따른 대략적인 확정급여채무의 민감도 분석은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="632" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="4">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" ALIGN="CENTER" HEIGHT="60">구분</TH>
<TH COLSPAN="3" WIDTH="474" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">확정급여채무에 대한 영향</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가정의 변동폭</TH>
<TH WIDTH="158" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가정의 증가</TH>
<TH WIDTH="158" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가정의 감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">할인율</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1% 포인트</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(35,054)</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,270</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">임금상승률</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1% 포인트</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,291</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(36,483)</TD>
</TR>
</TBODY>
</TABLE>
<P>상기의 민감도 분석은 다른 가정은 일정하다는 가정하에 산정되었습니다. 주요 보험수리적가정의 변동에 대한 확정급여채무의 민감도는 재무상태표에 인식된 확정급여채무 산정 시 사용한 예측단위접근법과 동일한 방법을 사용하여 산정되었습니다.</P>
<PGBRK></PGBRK>
<P>18. 충당부채(1) 당기말과 전기말 현재 당사의 충당부채 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="131"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="630" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD COLSPAN="2" WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>유동</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>비유동</P>
</TD>

<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>유동</P>
</TD>

<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>비유동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30">
<P>복구충당부채</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,000</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">(2) 당기와 전기의 충당부채 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="630" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기초</P>
</TD>

<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>증가</P>
</TD>

<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>감소</P>
</TD>

<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30">
<P>복구충당부채</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,000</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(42,000)</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="5" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기초</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>증가</P>
</TD>

<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>감소</P>
</TD>

<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="141" VALIGN="MIDDLE" HEIGHT="30">
<P>복구충당부채</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,590</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,410</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>19. 법인세비용 및 이연법인세(1) 당기와 전기 중 법인세비용과 회계이익의 관계는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="306"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="632" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="315" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="158" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" HEIGHT="30">법인세비용차감전순손실</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,405,593)</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,677,789)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" HEIGHT="30">법인세율로 계산한 법인세수익</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,509,231)</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,469,114)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="632" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">조정사항;</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" HEIGHT="30">세무상 가감되지 않는 손익</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">247,093</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,031,020</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" HEIGHT="30">이연법인세가 인식되지 않은 이월결손금 등</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,262,138</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">438,094</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" HEIGHT="30">당기조정항목</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,509,231</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,469,114</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" VALIGN="MIDDLE" HEIGHT="30">법인세비용</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(2) 당기 및 전기 중 이연법인세자산(부채)의 증감내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="826">

<COLGROUP>
<COL WIDTH="286"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="826" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="295" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기</TH>
<TH COLSPAN="4" WIDTH="355" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">일시적차이</TH>
<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">법인세효과</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기초</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증가</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감소</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기말</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기초</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">확정급여부채</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629,151</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">182,840</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(215,347)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">596,644</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">138,413</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125,295</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">미지급비용(연차수당)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,396</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125,695</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(96,396)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125,695</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,207</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,396</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">복구충당부채</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,001</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(42,001)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,240</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">정부보조금(기계장치)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,584</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,222)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,362</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,208</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,756</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">정부보조금(선수금)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,745</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,262</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(286,007)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,064</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">임차보증금</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,287</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(20,328)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,959</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,343</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">831</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">리스부채</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">210,857</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(60,094)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,763</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,389</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">외화환산손실</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,622</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,622</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,311</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">유가증권평가손실</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,846</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,700</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(24,846)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,700</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,466</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">777</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">업무용승용차</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,464</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,464</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,777</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">차감할일시적차이</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,087,867</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">619,583</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(751,241)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">956,209</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">239,330</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">200,803</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">사외적립자산</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(629,150)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">428,418</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(386,563)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(587,295)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(138,413)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(123,332)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">유형자산</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,284)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,642</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,642)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,042)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(975)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(238,617)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">232,502</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(146,900)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(153,015)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(52,496)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(32,133)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">외화환산이익</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(28,639)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,639</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(261,706)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(261,706)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,301)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(54,958)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">유가증권평가이익</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(60,940)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,940</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(63,569)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(63,569)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13,407)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13,349)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">미수수익</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(207,772)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(207,772)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(43,632)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">가산할일시적차이</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(966,630)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">755,141</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,066,510)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,277,999)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(212,659)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(268,379)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">세무상결손금</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,978,029</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,725,471</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,703,500</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,615,166</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,657,735</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">이월세액공제</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,011,248</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">376,698</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,387,946</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,011,248</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,387,946</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="650" VALIGN="MIDDLE" COLSPAN="5" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,653,085</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,978,105</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="650" VALIGN="MIDDLE" COLSPAN="5" HEIGHT="30">이연법인세자산인식제외금액</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,653,085</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,978,105</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="650" VALIGN="MIDDLE" COLSPAN="5" HEIGHT="30">이연법인세자산인식대상금액</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="826">

<COLGROUP>
<COL WIDTH="286"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="826" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="295" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">전기</TH>
<TH COLSPAN="4" WIDTH="355" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">일시적차이</TH>
<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">법인세효과</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기초</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증가</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감소</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기말</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기초</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">확정급여부채</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">486,759</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(219,094)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">361,486</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629,151</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">107,087</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">138,413</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">미지급비용(연차수당)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,493</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(61,493)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,396</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,396</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,528</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,207</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">복구충당부채</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,591</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,410</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,001</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,090</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,240</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">정부보조금(기계장치)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,192</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,608)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,584</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,002</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,208</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">정부보조금(선수금)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,744</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(112,728)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">112,729</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,745</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,064</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,064</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">임차보증금</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,829</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,542)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,287</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,682</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,343</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">리스부채</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">674,753</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(463,896)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">210,857</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">148,446</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,388</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">외화환산손실</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">유가증권평가손실</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,846</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,846</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,466</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">차감할일시적차이</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,331,362</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(862,362)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">618,867</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,087,867</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">292,899</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">239,329</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">사외적립자산</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(432,897)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(196,253)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(629,150)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(95,237)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(138,413)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">유형자산</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13,926)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,642</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,284)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,064)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,043)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(714,439)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(517,500)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">993,322</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(238,617)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(157,177)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(52,496)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">외화환산이익</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(458)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(28,639)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">458</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(28,639)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(101)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,301)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">유가증권평가이익</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(60,940)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(60,940)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13,407)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">가산할일시적차이</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,161,720)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(803,332)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">998,422</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(966,630)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(255,579)</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(212,660)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">세무상결손금</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,161,122</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,816,907</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,978,029</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,115,447</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,615,166</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" VALIGN="MIDDLE" HEIGHT="30">이월세액공제</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">576,821</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">434,427</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,011,248</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">576,821</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,011,248</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="650" VALIGN="MIDDLE" COLSPAN="5" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,729,588</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,653,083</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="650" VALIGN="MIDDLE" COLSPAN="5" HEIGHT="30">이연법인세자산인식제외금액</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,729,588</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,653,083</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="650" VALIGN="MIDDLE" COLSPAN="5" HEIGHT="30">이연법인세자산인식대상금액</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(3) 당기말 현재 이연법인세자산으로 인식되지 않은 세무상결손금 및 이월세액공제의 소멸연도는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="631" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">소멸연도</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">세무상결손금</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">이월세액공제</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2026년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">115,092</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2027년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">153,418</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,649</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2028년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,185,021</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,530</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2029년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,539,655</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,369</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2030년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">337,273</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2031년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">434,427</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2032년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">376,698</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2035년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,167,936</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2036년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,816,907</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2037년</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,485,471</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,463,500</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,387,946</TD>
</TR>
</TBODY>
</TABLE>
<P>당사의 회계이익과 과세소득간의 일시적차이 및 이월결손금 등으로 인한 법인세효과가 당기말 현재 미래의 과세소득 규모 등을 고려할 때 실현가능성이 확실하지 않아 이연법인세자산으로 인식하지 않았으며, 미래 예상과세소득이 변경되는 경우에 이연법인세자산으로 인식될 수 있습니다.</P>
<PGBRK></PGBRK>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">20. 자본금과 자본잉여금(1) 당사가 발행할 주식의 총수는 50,000,000주이고, 발행한 주식수는 보통주식 13,845,968주(전기말: 13,687,468주)이며 1주당 액면금액은 500원입니다.(2) 당기와 전기 중 자본금 및 자본잉여금의 변동은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="703">

<COLGROUP>
<COL WIDTH="241"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="703" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="4">(단위: 주, 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="250" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">주식수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자본금</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">주식발행초과금</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">전기초</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,950,536</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,475,268</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,989,092</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">  2021-01-07 전환상환우선주전환</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">365,432</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">182,716</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,709,118</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">  2021-07-17 유상증자</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,040,000</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,020,000</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,161,772</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">  2021-09-02 주식선택권 행사</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">227,000</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">113,500</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,432,082</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">  2021-12-06 주식선택권 행사</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,500</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,250</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">556,038</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">전기말</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,687,468</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,843,734</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,848,102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">당기초</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,687,468</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,843,734</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,848,102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">  2022-04-11 주식선택권 행사</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">98,500</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,250</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">945,746</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">  2022-06-17 주식선택권 행사</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,000</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,034</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">  2022-11-30 주식선택권 행사</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,000</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,000</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">428,248</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30">당기말</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,845,968</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,922,984</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,263,130</TD>
</TR>
</TBODY>
</TABLE>
<P>21. 기타자본구성요소당기말과 전기말 현재 당사의 기타자본구성요소의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="630" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">주식선택권</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,597,450</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,649,974</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>22. 결손금(1) 당기말과 전기말 현재 당사의 결손금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="630" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">미처리결손금</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(64,612,838)</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,325,057)</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당기 및 전기 결손금처리계산서의 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="893">

<COLGROUP>
<COL WIDTH="223"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="156"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="893" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">구분</TH>
<TH WIDTH="331" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2" ALIGN="CENTER" HEIGHT="53">당기처리예정일 : 2023년 3월 30일</TH>
<TH WIDTH="330" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2" ALIGN="CENTER" HEIGHT="53">전기처리확정일 : 2022년 3월 30일</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" HEIGHT="30">I. 미처리결손금</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(64,612,838)</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,325,057)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" HEIGHT="30">기초미처리결손금</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,325,057)</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(46,455,765)</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" HEIGHT="30">당기순손실</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,405,593)</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,677,790)</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" HEIGHT="30">확정급여제도의 재측정요소</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">117,812</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(191,502)</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" HEIGHT="30">II. 결손금처리액</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" HEIGHT="30">III. 차기이월미처리결손금</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(64,612,838)</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,325,057)</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>23. 주식기준보상(1) 당사는 주주총회 결의에 의거하여 당사의 임직원에게 주식선택권을 부여하였으며, 당기말 현재 그 주요 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="850">

<COLGROUP>
<COL WIDTH="220"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="850" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 주, 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="229" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">구분</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">부여방법</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">잔여부여수량(*)</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">가득기간</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">행사가격(*)</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">부여일공정가치(*)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">3-1차 - 2019년 6월 30일 부여</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식교부형</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.0년</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2026-07-13</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,384</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,782</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">4차 - 2020년 3월 31일 부여</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식교부형</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.0년</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2027-04-01</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,200</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,793</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">5-1차 - 2021년 1월 5일 부여</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식교부형</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.0년</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2028-01-05</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,750</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,061</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">5-2차 - 2021년 1월 5일 부여</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식교부형</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.0년</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2028-01-05</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,720</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,669</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">6-1차 - 2021년 3월 29일 부여</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식교부형</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.0년</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2028-03-29</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,500</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">6-2차 - 2021년 3월 29일 부여</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식교부형</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.0년</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2028-03-29</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,720</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,376</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">7차 - 2022년 3월 30일 부여</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식교부형</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.0년</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2029-03-29</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,500</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,999</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">8차 - 2022년 11월 16일 부여</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식교부형</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.0년</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2029-11-15</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,700</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,985</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">(*) 당사는 2020년 12월 12일 100% 무상증자를 실시함에 따라 주식선택권 부여수량,행사가격 및 부여일 공정가치를 조정하였습니다.</SPAN>
</P>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">종업원 주식선택권은 행사시점에 당사의 주식으로 전환되며, 종업원이 주식선택권을부여받을 때 지급하였거나 지급할 금액은 없습니다. 주식선택권은 배당에 대한 권리나 의결권을 가지지 않으며, 가득일로부터 만기일까지의 기간 동안 행사될 수 있습니다.</SPAN>
</P>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">(2) 당기와 전기 중 당사의 주식선택권의 변동은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="633">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="633" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">기초 잔여주식</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">374,500</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">560,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">기중 부여수량</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">225,000</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">기중 권리상실분</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(24,000)</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">기중 행사분</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(158,500)</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(331,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">기말 잔여주식</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">417,000</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">374,500</TD>
</TR>
</TBODY>
</TABLE>
<P>당기말 현재 유효한 주식선택권의 가중평균 잔여만기는 5.73년이며, 가중평균 행사가격은 13,199원입니다.</P>
<P>(3) 당사는 부여된 주식선택권의 보상원가를 이항모형을 이용한 공정가치접근법을 적용하여 산정했으며, 보상원가를 산정하기 위한 제반 가정 및 변수는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="781">

<COLGROUP>
<COL WIDTH="164"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3-1차</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">4차</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">5-1차</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">5-2차</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">6-1차</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">6-2차</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">7차</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">8차</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE">주식선택권 공정가치</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,782원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,793원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,061원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,669원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,700원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,376원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,999원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,985원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE">주가</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,172원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,514원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,218원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,218원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,218원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,218원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,200원</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,900원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE">무위험이자율</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.54%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.22%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.50%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.50%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.73%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.73%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2.90%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.84%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE">연환산 예상주가변동성</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">43.82%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61.79%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">91.25%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">91.25%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">85.88%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">85.88%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86.26%</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">85.15%</TD>
</TR>
</TBODY>
</TABLE>
<P>(4) 당기 및 전기 비용으로 인식한 주식기준보상은 각각 1,706,196천원 및 1,337,229천원이며 전액 주식결제형 주식기준보상과 관련된 비용입니다.</P>
<PGBRK></PGBRK>
<P>24. 영업수익(1) 수익의 구성당기 중 당사의 영업수익은 프랑스 소재 기업인 Thea Open Innovation과 체결한 기술이전계약에서 발생하였습니다(주석33 참조).(2) 당기 및 전기 중 영업수익의 인식 시기에 대한 구분은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="707">

<COLGROUP>
<COL WIDTH="227"></COL>
<COL WIDTH="227"></COL>
<COL WIDTH="226"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="707" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="236" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구    분</TH>
<TH WIDTH="236" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="235" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" VALIGN="MIDDLE" HEIGHT="30">한 시점에 이행</TD>
<TD WIDTH="236" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="235" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,024,349</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" VALIGN="MIDDLE" HEIGHT="30">기간에 걸쳐 이행 </TD>
<TD WIDTH="236" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">             3,582,858</TD>
<TD WIDTH="235" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">230,604</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="236" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">             3,582,858</TD>
<TD WIDTH="235" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,254,953</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 당사가 고객과의 계약과 관련하여 인식한 자산, 부채는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="629" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당  기</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기초</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증가</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감소</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">계약자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,267</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,732,143</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,618,089</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149,321</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">계약부채</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">850,715</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">850,715</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> -</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="629" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전  기</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기초</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증가</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감소</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">계약자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,267</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,267</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">계약부채(*)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,046,052</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">195,337</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">850,715</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 전기 중 Thea Open Innovation과의 기술이전 대가로 수령한 계약금(Upfront payment)중 당기에 영업수익으로 인식한 금액을 제외한 잔액입니다. 당사는 해당 계약금에서 기술 사용권에 대한 대가를 제외한 금액에 대해서 원가 투입법기준 진행률에 따라 기간에 걸쳐 수익을 인식하고 있으며 해당 계약부채는 2022년 중 전액 수익으로 인식되었습니다.(4) 당기 중 당사 영업수익의 10%이상을 차지하는 주요 고객은 1개 거래처로 영업수익은 3,582백만원입니다.</P>
<PGBRK></PGBRK>
<P>25. 영업비용당기와 전기 중 발생한 당사의 영업비용의 내용은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="634">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="634" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">종업원 급여</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,288,626</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,662,383</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">퇴직급여</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">296,383</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">168,001</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">복리후생비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">109,414</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">48,918</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">주식보상비용</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,706,197</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,337,229</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">여비교통비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">132,990</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">48,964</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">접대비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">104,879</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">108,284</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">세금과공과</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">239,282</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">55,313</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">감가상각비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">438,019</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">328,679</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">경상개발활동비용</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">873,098</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">607,265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">소모품비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">74,387</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,060</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">지급수수료</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,165,027</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,857,286</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">광고선전비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">75,142</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">143,988</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">건물관리비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,900</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,534</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">무형자산상각비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">64,633</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">53,564</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">위탁용역비</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,901,506</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,651,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,588</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,680</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,565,071</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,124,548</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>26. 기타수익 및 기타비용당기와 전기 중 발생한 당사의 기타수익 및 기타비용의 내용은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="630" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="630" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">기타수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30"> 잡이익</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,710</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,196</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30"> 유형자산처분이익</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">587</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,297</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,196</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="630" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">기타비용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30"> 기부금</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30"> 유형자산처분손실</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,669</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30"> 잡손실</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">935</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,604</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164,629</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>27. 금융수익 및 금융비용당기와 전기 중 발생한 당사의 금융수익 및 금융비용의 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="156"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="632" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="301" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="632" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">금융수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 이자수익</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">537,732</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">216,746</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 당기손익공정가치측정금융자산처분이익</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,270</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,331</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 당기손익공정가치측정금융자산평가이익</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,569</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 전환상환우선주평가이익</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 외화환산이익</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">261,706</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,639</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 외환차익</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">181,289</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,504</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,097,566</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">363,016</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="632" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">금융비용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 이자비용</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">299,895</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,044</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 외화환산손실</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,622</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 당기손익공정가치측정금융자산처분손실</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,213</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 당기손익공정가치측정금융자산평가손실</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,700</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,846</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 상각후원가금융자산처분손실</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,833</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" HEIGHT="30"> 외환차손</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">79,590</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,674</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">470,640</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,777</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>28. 주당순손실기본주당순손실은 당사의 보통주당기순손실을 해당 기간의 가중평균유통보통주식수로 나누어 산정하였습니다.(1) 보통주당기순손실</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="629" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 주, 원/주, 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="209" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">당기순손실</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,405,593)</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,677,789)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">가중평균유통보통주식수(*)</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,766,061</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,331,616</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" HEIGHT="30">기본주당순손실</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(829)</TD>
<TD WIDTH="209" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(542)</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당기와 전기 중 가중평균유통보통주식수의 산정내역은 다음과 같습니다.</P>
<P>① 당기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="178"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="715" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위: 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="187" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기준일</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">유통보통주식수</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가중치(일)</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">적수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30">기초</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022-01-01</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,687,468</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">365</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,995,925,820</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30">주식선택권행사(1차)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022-04-11</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">98,500</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">265</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,102,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30">주식선택권행사(2차)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022-06-17</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,000</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">198</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">792,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30">주식선택권행사(3차)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022-11-30</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,000</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,792,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계(*)</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">　</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,845,968</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,024,612,320</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당기 가중평균유통보통주식수 = 5,024,612,320주 ÷ 365일 = 13,766,061주</P>
<P>② 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="176"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="715" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="185" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기준일</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유통보통주식수</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중치(일)</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">적수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-01-01</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,950,536</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">365</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,996,945,640</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE">전환상환우선주 전환</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-01-07</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">365,432</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">359</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">131,190,088</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE">유상증자</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-07-17</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,040,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">168</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">342,720,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE">주식선택권행사(1차)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-09-02</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">227,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">121</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,467,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE">주식선택권행사(2차)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-12-06</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">104,500</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,717,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계(*)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,687,468</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,501,039,728</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 전기 가중평균유통보통주식수 = 4,501,039,728주 ÷ 365일 = 12,331,616주</P>
<P>(2) 희석주당순손실당기 및 전기 손실발생으로 인하여 희석효과가 없습니다. 따라서 희석주당손익은 기본주당손익과 동일합니다. 잠재적으로 미래의 기본주당이익을 희석할 수 있는 항목은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="632" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">주식선택권</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">417,000</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">374,500</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<PGBRK></PGBRK>
<P>29. 영업으로부터 창출된 현금(1) 영업으로부터 창출된 현금</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="778">

<COLGROUP>
<COL WIDTH="317"></COL>
<COL WIDTH="217"></COL>
<COL WIDTH="217"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="778" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="326" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="226" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="226" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">당기순손실</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,405,593)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,677,789)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">조정</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,094,621</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,573,694</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  감가상각비</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">438,020</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">328,679</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  무형자산상각비</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">64,633</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,564</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  주식보상비용</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,706,197</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,337,229</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  퇴직급여</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">296,383</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">168,001</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  유형자산처분손실</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,669</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  접대비</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,662</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,664</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  이자비용</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">299,895</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,044</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  전환상환우선주평가손실(이익)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(24,856)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  외화환산손실</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,622</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  이자수익</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(537,732)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(216,746)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  당기손익공정가치측정금융자산처분이익</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,270)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,331)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  당기손익공정가치측정금융자산처분손실</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,213</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  당기손익공정가치측정금융자산평가이익</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(48,700)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(60,940)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  당기손익공정가치측정금융자산평가손실</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,700</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,846</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  외화환산이익</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(261,706)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(28,639)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  잡이익</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,998)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(69,663)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  잡손실</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  유형자산처분이익</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(587)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  상각후원가금융자산처분손실</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,833</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">영업활동으로 인한 자산 부채의 변동</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,096,503)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,155,245</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  매출채권</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,109,502</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  미수금</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,053</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,055</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  계약자산</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,140,754)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(35,267)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  선수수익</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(45,745)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  예수금</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,891)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,869</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  미지급금</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">917,123</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">103,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  미지급비용</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(932,597)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,011,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  선급비용</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(52,353)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(141,895)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  당기법인세자산</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(68,092)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13,095)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  부가세대급금</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125,469</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(211,430)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  계약부채</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(850,715)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">850,715</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  유동복구충당부채</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(42,000)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  퇴직금의 지급</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(215,347)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(219,094)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">  사외적립자산</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,844</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(247,990)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">영업활동으로부터 창출된 현금흐름</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,407,475)</TD>
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,948,850)</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(2) 현금의 유출ㆍ입이 없는 거래 중 중요한 사항</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="781">

<COLGROUP>
<COL WIDTH="317"></COL>
<COL WIDTH="219"></COL>
<COL WIDTH="218"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="781" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="326" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="228" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="227" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">복구추정에 따른 복구충당부채 설정</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,410</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">건설중인자산 대체</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,143,877</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">사용권자산 취득(*)</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,003</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">187,360</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">리스부채 감소</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,398</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">535,247</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">전환상환우선주부채의 평가</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(24,856)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">전환상환우선주부채의 전환</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,892,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30">주식선택권의 행사</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">758,720</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,405,102</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">(*) 현금 지출된 선급리스료분(현금흐름표 참조)을 제외한 사용권자산 증가분을 기재하였습니다.</SPAN>
</P>
<P>(3) 재무활동에서 생기는 부채의 조정내용</P>
<P>재무활동에서 생기는 부채의 조정내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="779" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="779" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="468" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무활동으로인한부채</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환상환우선주부채</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장기차입금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리스부채</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">전기초</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">4,917,166</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">674,752</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">5,591,918</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">  현금흐름</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">8,000,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">(103,420)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">7,896,580</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">  공정가치변동</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">(24,856)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">(24,856)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">  기타변동</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">(4,892,310)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">(360,476)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">(5,252,786)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">전기말 순부채</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">8,000,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">210,856</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">8,210,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">당기초 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">8,000,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">210,856</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">8,210,856</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">  현금흐름</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">(73,723)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">(73,723)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">  공정가치변동</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">  기타변동</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">13,629</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">13,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30">당기말 순부채</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">8,000,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">150,762</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30">8,150,762</TD>
</TR>
</TBODY>
</TABLE>
<P>30. 우발부채와 약정사항(1) 당기말 현재 당사가 피소되어 계류중인 소송사건은 없습니다.(2) 당기말 현재 금융기관과 체결한 약정한도는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="632" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금융기관</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">약정한도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시설대출</TD>
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">하나은행</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>31. 연구개발관련 약정사항(1) 당기말 현재 당사가 타기관과 공동연구를 진행 중인 계약 현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="846">

<COLGROUP>
<COL WIDTH="224"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="846" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="233" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">품목</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계약상대방</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계약체결일</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계약종료일</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">총계약금액</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기지급금액</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">미지급액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">후보물질 효능 및 기전분석 연구</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연세대산학협력단</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021-10-25</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022-10-24</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">200,000</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">160,000</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="233" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">후보물질 효능 및 기전분석 연구</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연세대산학협력단</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022-10-25</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023-10-24</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">200,000</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">200,000</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 당기말 현재 당사가 진행중인 연구개발 현황 및 각 파이프라인별 개발 진행단계는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="851">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="213"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ROWSPAN="2" WIDTH="161" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구분</TH>
<TH ROWSPAN="2" WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">품 목</TH>
<TH ROWSPAN="2" WIDTH="222" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">적응증</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" ALIGN="CENTER" HEIGHT="60">연구시작일</TH>
<TH COLSPAN="2" WIDTH="294" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">현재 진행단계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">단계(국가)</TH>
<TH WIDTH="130" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">승인일</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">화학합성</TD>
<TD ROWSPAN="6" WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">신약 개발</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU01</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">당뇨병성 신증</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016년</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 2b상(한국)</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 7월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU02</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비알콜성 지방간염</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017년</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">후보물질 최적화 중</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU03</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">습성 황반변성</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016년</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 2a상(한국) 종료</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019년12월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU04</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">면역항암</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017년</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">선도물질 탐색 중</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU05</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">폐암</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017년</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">후보물질 최적화 중</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU06</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈관손상과 관련된 다양한 질환</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017년</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상 2a상(미국)</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 9월</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 당기와 전기 중 파이프라인별로 발생한 경상연구개발비 등의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="630" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU01</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">511,157</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">534,435</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU02</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,065</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,015</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU03</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">634,249</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">492,278</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU04</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">216,807</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">95,364</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU05</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135,759</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,350</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CU06</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,890,221</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,036,050</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타공통비</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,963,649</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,799,712</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,374,907</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,040,204</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<PGBRK></PGBRK>
<P>32. 특수관계자거래(1) 당기와 전기 중 특수관계자와의 수익 및 비용 거래 내역은 아래와 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="785">

<COLGROUP>
<COL WIDTH="277"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="785" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="286" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분(*)</TH>
<TH WIDTH="250" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환상환우선주평가이익</TH>
<TH WIDTH="249" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환상환우선주평가손실</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" HEIGHT="30">산은캐피탈주식회사</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,856</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당사의 주식이 전기 중 한국거래소가 개설한 코스닥시장에 상장됨에 따라 유의적인 영향력을 행사하는 자로 분류한 산은캐피탈주식회사와의 특수관계가 해소되었습니다.</P>
<P>(2) 전기 중 특수관계자에 대한 채무금액의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="879" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="879" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="144" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가손익</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환(*)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">전환상환우선주부채</TD>
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">산은캐피탈주식회사</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="144" HEIGHT="30">4,917,166</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30">(24,856)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30">(4,892,310)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 산은캐피탈이 보유하고 있는 전환상환우선주부채는 2021년 1월 7일 전액 보통주로 전환되었습니다.(3) 당기와 전기 중 특수관계자와의 자금거래 내역은 없습니다.</P>
<P>(4) 주요 경영진에 대한 보상주요 경영진은 등기 및 비등기임원에 해당하며, 종업원 용역의 대가로서 주요 경영진에게 지급됐거나 지급될 보상금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="631" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">급여 및 기타 단기종업원 급여</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,843,251</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,652,187</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">퇴직 급여</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">127,859</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">74,935</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">주식기준보상</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,766,918</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,054,536</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합     계</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,738,028</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,781,658</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(5) 지급보증 및 담보제공 내역당사가 특수관계자로부터 제공받거나 특수관계자에게 제공한 지급보증 및 담보제공 내역은 없습니다.</P>
<PGBRK></PGBRK>
<P>33. 기술이전계약</P>
<P>(1) 당사는 2021년 10월 27일자로 프랑스에 소재한 Thea Open Innovation과 당뇨병성 황반부종 및 습성 황반변성 치료제 CU06-RE에 대한 기술이전 계약을 체결하였습니다. 당사는 반환조건 없는 계약금(Upfront payment) USD 6,000,000과 관련된 수행의무 및 임상 2상 시험 용역 제공에 대한 수행의무를 식별하였습니다.</P>
<P>한편, 당사는 향후 임상 2상 시험 성공 및 규제당국의 허가 등 일정요건을 달성하는 경우 최대 USD 157,500,000 규모의 마일스톤 금액을 수령할 수 있으며, 고객이 인식하는 해당 기술과 관련된 순매출액의 일정 부분을 로열티로 수령할 수 있습니다.(2) 기술이전계약과 관련된 불확실성 및 기타사항당사의 향후 마일스톤 및 로열티 수익은 임상시험, 관계당국의 허가 등 개발의 성공 여부에 따라 달라질 수 있으므로 발생가능성에 불확실성이 내포되어 있습니다. </P>
<P>34. 보고기간 후 사건당사는 2023년 3월 6일 기존에 CU06-RE 관련 임상 2상 시험에 대해서만 비용을 보전 받기로 계약하였던 Thea Open Innovation과의 기술이전계약의 조건을 비임상시험에 대한 비용까지 보전 받는 것으로 변경 계약하였습니다. </P>
</SECTION-2>
</LIBRARY>


<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 배당에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 배당에 관한 회사의 정책</SPAN>당사는 누적 결손에 따라 상법상 배당가능이익 산정이 불가능하여 배당을 집행할 수 없습니다. 상법상 배당가능재원 확보시, 당사 정관에 의거하여 회사의 성장을 위한 투자와 주주가치 증대, 이익규모 및 미래성장을 위한 투자재원 확보, 기업의 재무구조 건전성 유지 등의 요인을 종합적으로 고려하여 배당정책을 결정할 예정입니다. 당사의 정관상 배당에 관한 사항은 아래와 같습니다.
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" HEIGHT="812">
<P>제12조(동등 배당) 회사는 배당 기준일 현재 발행(전환된 경우를 포함한다)된 동종 주식에 대하여 발행일에 관계 없이 모두 동등하게 배당한다.</P>
<P>제57조(이익금의 처분) 회사는 매사업연도의 처분전 이익잉여금을 다음과 같이 처분한다.</P>
<P>1.  이익준비금</P>
<P>2.  기타의 법정준비금</P>
<P>3.  배당금</P>
<P>4.  임의적립금</P>
<P>5.  기타의 이익잉여금처분액</P>
<P>제58조(이익배당)① 이익배당은 금전 또는 금전 외의 재산으로 할 수 있다.</P>
<P>② 이익의 배당을 주식으로 하는 경우 회사가 종류주식을 발행한 때에는 각각 그와 같은 종류의 주식으로 할 수 있다.</P>
<P>③ 제1항의 배당은 제16조 제1항에서 정한 기준일 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게 지급한다.</P>
<P>④ 이익배당은 주주총회의 결의로 정한다. </P>
<P>제59조(분기배당) ① 회사는 이사회의 결의로 사업연도 개시일부터 3월.6월 및 9월의 말일(이하 “분기배당 기준일”이라 한다)의 주주에게 「자본시장과 금융투자업에 관한 법률」 제165조의12에 따라 분기배당을 할 수 있다. 분기배당은 금전으로 한다.</P>
<P>② 제1항의 이사회 결의는 분기배당 기준일 이후 45일 내에 하여야 한다.</P>
<P>③ 분기배당은 직전결산기의 대차대조표상의 순자산액에서 다음 각호의 금액을 공제한 액을 한도로 한다.</P>
<P>1. 직전결산기의 자본금의 액 </P>
<P>2. 직전결산기까지 적립된 자본준비금과 이익준비금의 합계액</P>
<P>3. 직전결산기의 정기주주총회에서 이익배당하기로 정한 금액</P>
<P>4. 직전결산기까지 정관의 규정 또는 주주총회의 결의에 의하여 특정목적을 위해 적립한 임의준비금</P>
<P>5. 「상법 시행령」제19조에서 정한 미실현이익 </P>
<P>6. 분기배당에 따라 당해 결산기에 적립하여야 할 이익준비금의 합계액</P>
<P>7. 당해 영업년도 중에 분기배당이 있었던 경우 그 금액의 합계액</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">나. 주요배당지표 </P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제7기(2022년)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제6기(2021년)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제5기(2020년)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">500</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">-11,406</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">-6,678</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">-28,610</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">-829</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">-542</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-3,969</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<LIBRARY>
<P USERMARK=" B">다. 과거 배당 이력</P>

<TABLE-GROUP ACLASS="DIVIDEND_BCK" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_QUA" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_END" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_THR" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="149" HEIGHT="30" ACODE="DIV_FIV" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 당사는 최근 5년간 누적결손에 따라 상법상 배당가능이익 산정이 불가능하여 과거 배당내역이 없습니다.</P>
</LIBRARY>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-0">7. 증권의 발행을 통한 자금조달에 관한 사항</TITLE>
<P></P>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-1">7-1. 증권의 발행을 통한 자금조달 실적</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">[지분증권의 발행 등과 관련된 사항]</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">가. 증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="771" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="465"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="474" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="768" BORDER="1">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="518" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="203" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160512">2016.05.12</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">설립자본금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160912">2016.09.12</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">2,408</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">415,000</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160930">2016.09.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">1,204</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">415,000</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20161013">2016.10.13</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">481</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">415,000</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170607">2017.06.07</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">330,435</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">1주당 13.715주 배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180714">2018.07.14</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">11,820</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">84,600</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180718">2018.07.18</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">11,820</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">84,600</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180829">2018.08.29</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">12,170</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">84,600</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180921">2018.09.21</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">23,640</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">84,600</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20181006">2018.10.06</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">41,370</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">84,600</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20181027">2018.10.27</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">11,820</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">84,600</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20181130">2018.11.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">17,730</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">84,600</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20191026">2019.10.26</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="35" ACODE="INC_STK_KND">우선주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="35" ACODE="INC_CNT">
<P>258,065</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">15,500</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="35" ALIGN="CENTER">주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20191030">2019.10.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="35" ACODE="INC_STK_KND">우선주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="35" ACODE="INC_CNT">
<P>109,678</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">15,500</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="35" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20191130">2019.11.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="35" ACODE="INC_STK_KND">우선주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="35" ACODE="INC_CNT">
<P>129,032</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">15,500</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="35" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="35" AUNIT="INC_DT" AUNITVALUE="20191213">2019.12.13</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="35" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="35" ACODE="INC_STK_KND">우선주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="35" ACODE="INC_CNT">
<P>64,516</P>
</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="35" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="35" ACODE="INC_SL_AMT">15,500</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="35" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201031">2020.10.31</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">149,213</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">26,800</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201102">2020.11.02</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">2,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">2,820</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201102">2020.11.02</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">96,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">500</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201116">2020.11.16</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">전환상환우선주 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201201">2020.12.01</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">전환상환우선주 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201212">2020.12.12</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">3,872,993</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">1주당 1주 배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201212">2020.12.12</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">1,784,991</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">1주당 1주 배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201223">2020.12.23</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">365,432</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">전환상환우선주 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201224">2020.12.24</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">1,229,474</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">전환상환우선주 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201228">2020.12.28</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">803,432</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">전환상환우선주 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201229">2020.12.29</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">548,148</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">전환상환우선주 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201230">2020.12.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">258,064</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">전환상환우선주 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210107">2021.01.07</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">365,432</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">전환상환우선주 보통주전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210719">2021.07.19</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="01">유상증자(일반공모)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">2,040,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">25,000</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">신규상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210902">2021.09.02</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">53,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">500</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210902">2021.09.02</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">154,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">3,384</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210902">2021.09.02</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">1,410</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20211206">2021.12.06</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">11,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">500</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20211206">2021.12.06</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">43,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">3,384</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20211206">2021.12.06</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">50,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">500</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20220411">2022.04.11</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">30,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">3,384</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20220411">2022.04.11</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">68,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">6,200</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20220617">2022.06.17</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">6,200</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20221130">2022.11.30</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">56,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">3,384</TE>
<TD VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 2019.07.29 액면분할 : 5,000원 → 500원을 반영하였습니다. </P>

<P></P>

<P>
<SPAN USERMARK=" B">나. 미상환 전환사채 발행현황</SPAN>보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">다. 미상환 신주인수권부사채 등 발행현황</SPAN>보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">라. 미상환 전환형 조건부자본증권 등 발행현황</SPAN>보고서 작성기준일 현재 해당사항이 없습니다.
</P>

<P>
<SPAN USERMARK=" B">마. 채무증권 발행 실적 등</SPAN>보고서 작성기준일 현재 해당사항이 없습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">[채무증권의 발행 등과 관련된 사항]</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="1">(단위 : 원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="748" BORDER="1">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급(평가기관)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환여부</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

</SECTION-3><SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-2">7-2. 증권의 발행을 통해 조달된 자금의 사용실적</TITLE>

<LIBRARY>
<P USERMARK=" B">가. 공모자금의 사용내역 </P>

<TABLE-GROUP ACLASS="FUND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="761" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="452"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="461" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="750" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="186" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증권신고서 등의 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">코스닥시장 상장</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20210716">2021.07.16</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">11,082</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">8,500</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">코스닥시장 상장</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20210716">2021.07.16</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">연구개발자금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">37,028</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">연구개발자금</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">12,727</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P>주1) 증권신고서 제출 당시 기재한 공모 자금의 사용 목적에 따른 유형자산 취득을 위해 동 자금을 사용하였습니다.  </P>

<LIBRARY>
<P USERMARK=" B">나. 사모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND_SA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="847" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="538"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="547" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="846" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="40"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="49" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">주요사항보고서의 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="248" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">1회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20180714">2018.07.14</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT">
<P USERMARK="F-GL11">1,000</P>
</TE>

<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">
<P USERMARK="F-GL11">운영 및 개발자금</P>
</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">2회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20180718">2018.07.18</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT">1,000</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">1,000</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">3회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20180829">2018.08.29</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,030</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,030</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">4회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20180921">2018.09.21</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">2,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">2,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">5회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20181006">2018.10.06</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">3,500</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">3,500</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">6회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20181027">2018.10.27</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">7회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20181130">2018.11.30</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,500</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,500</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">8회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20191026">2019.10.26</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">4,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">4,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">9회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20191030">2019.10.30</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,700</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,700</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">10회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20191130">2019.11.30</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">2,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">2,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">11회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20191213">2019.12.13</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT">
<P USERMARK="F-GL11">1,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">12회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20201031">2020.10.31</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">3,999</P>
</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">3,999</P>
</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="34" ACODE="PO_TYPE" VALIGN="MIDDLE">유상증자</TE>
<TE ALIGN="CENTER" WIDTH="49" HEIGHT="34" ACODE="MO_SEQ" VALIGN="MIDDLE">13회</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="34" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20201102">2020.11.02</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="PLA_USE" VALIGN="MIDDLE">운영 및 연구개발자금</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="34" ACODE="PLA_AMT" VALIGN="MIDDLE">55</TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="34" ACODE="BRK_CON" VALIGN="MIDDLE">운영 및 연구개발자금</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="BRK_AMT" VALIGN="MIDDLE">55</TE>
<TE ALIGN="CENTER" WIDTH="132" HEIGHT="34" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<LIBRARY>
<P USERMARK=" B">다. 미사용자금의 운용내역 </P>

<TABLE-GROUP ACLASS="UNS_HIY" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="598" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="231"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="240" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="592" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="138" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금융상품명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">운용금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">실투자기간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="138" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">MMF</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">3,045</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="138" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">정기예금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">5,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202209-202301" VALIGN="MIDDLE">2022년 09월 ~ 2023년 01월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="138" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">정기예금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">5,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202209-202301" VALIGN="MIDDLE">2022년 09월 ~ 2023년 01월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="138" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">정기예금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">5,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202209-202301" VALIGN="MIDDLE">2022년 09월 ~ 2023년 01월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="138" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">정기예금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">5,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202209-202301" VALIGN="MIDDLE">2022년 09월 ~ 2023년 01월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">3개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="138" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">정기예금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">3,000</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202211-202302" VALIGN="MIDDLE">2022년 11월 ~ 2023년 02월</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">2개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="138" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">보통예금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">838</TE>
<TU ALIGN="CENTER" WIDTH="205" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="216" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="UNS_MNY_SUM" VALIGN="MIDDLE">26,883</TE>
<TD ALIGN="CENTER" WIDTH="298" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" AUPDATECONT="N">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-8-0">8. 기타 재무에 관한 사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 재무제표 재작성 등의 유의사항</SPAN>(1) 재무제표 재작성당사는 보고서 작성기준일 현재 해당사항이 없습니다.(2) 합병, 분할, 자산양수도, 영업양수도 
</P>
<P></P>
<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.</P>
<P></P>

<P>(3) 자산유동화와 관련한 자산매각의 회계처리 및 우발채무 등에 관한 사항당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">나. 대손충당금 설정현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">다. 재고자산 현황 등 </SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">라. 수주계약 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">마. 공정가치평가 내역</SPAN>공정가치 평가방법 및 내역은 「Ⅲ. 재무에 관한 사항 → 5. 재무제표 주석」 을 참조하시기 바랍니다.  
</P>
<P></P>

<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>

<P>
<SPAN USERMARK=" B">가. 예측정보에 대한 주의사항</SPAN>당사가 동 사업보고서에서 기재한 예측은 당해 공시서류 작성시점의 재무성과에대한 당사의 견해를 반영한 것입니다. 동 예측정보는 미래의 경영환경과 관련된 여러가정에 기초하고 있으며, 동 가정들은 실제결과와 차이가 있을 수 있습니다. 이러한 차이를 초래할 수 있는 요인에는 당사 경영성과 등 내부환경에 관련된 요인과 외부환경에 관한 요인 및 기타 요인이 포함되어 있습니다.당사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다. 결론적으로 이러한 주의문구는 모든 예측정보에 대하여 적용되며, 당사가 예상한 결과가 실현되거나 실현되지 않는다는 확신을 제공할 수 없습니다.동 보고서에 기재된 예측정보는 동 보고서 작성시점을 기준으로 작성한 것이며, 당사가 이러한 위험요인이나 예측정보를 추가로 기재할 의무는 없습니다.
<SPAN USERMARK=" B">나. 개요</SPAN>
</P>
<P></P>

<P>당사는 세계 최초로 혈관내피기능장애 차단제(Endothelial Dysfunction Blocker, ED Blocker) 개발에 특화된 신개념 플랫폼 기술인 SOLVADYS®를 활용하여 혈관누수 및 염증 차단을 특징으로 하는 ED Blocker 물질, CU06-1004를 개발하였습니다. CU06-1004는 2021년 10월에 기술수출을 통해 아시아를 제외한 전세계 지역에 대한 판권을 떼아오픈이노베이션(Thea Open Innovation)에 이전하였습니다. 떼아오픈이노베이션에 이전한 판권은 당뇨황반부종 및 습성 황반변성에 국한되며, 그 외의 적응증에 대한 권리는 당사가 소유하고 있습니다. CU06은 2022년 6월 건강인을 대상으로 임상1상을 완료하고, 9월 미국 FDA로 부터 당뇨병성 황반부종에 대한 임상2a상  IND를 승인 받았으며
<SPAN>, </SPAN>
<SPAN>미국에서 임상시험을 진행하고 있습니다.</SPAN>
<SPAN> 또한</SPAN> 대표적인 ED 질환 중 하나인 당뇨병성 신증치료제 CU01은 2022년 7월 국내 2b상을 승인받아 환자 모집을 준비하고 있으며, 경구용 습성 황반변성치료제 CU03 은 2021년 1월 국내 임상 2a상이 완료되었습니다. 또한 당사는 2021년10월 떼아오픈이노베이션(Thea Open Innovation, 프랑스)에 당뇨황반부종 및 습성황반변성 치료제 ‘CU06’의 아시아를 제외한 전세계 지역 기술 수출 성과를 거두었습니다.
</P>
<P></P>

<P>
<SPAN USERMARK=" B">다. 재무상태 및 영업실적</SPAN>
</P>
<P>(1) 재무상태</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="796" BORDER="0">

<COLGROUP>
<COL WIDTH="303"></COL>
<COL WIDTH="475"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="796" HEIGHT="34" ALIGN="CENTER">   재   무   상   태   표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="796" HEIGHT="31" ALIGN="CENTER">제 7 기 기말 2022년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="796" HEIGHT="31" ALIGN="CENTER">제 6 기 기말 2021년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="312" HEIGHT="31">주식회사 큐라클</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="484" HEIGHT="31">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="796">

<COLGROUP>
<COL WIDTH="264"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="273" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과목</TH>
<TH WIDTH="269" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 7 (당)기말</TH>
<TH WIDTH="254" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 6 (전)기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자      산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">I. 유동자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,406,557,981</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,522,184,069</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   현금및현금성자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,510,611,529</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,441,591,400</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   단기금융상품</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,000,000,000</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,000,000,000</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   매출채권</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">888,710,035</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   기타투자자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,073,466,867</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,046,226,730</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   기타유동금융자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">220,978,801</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">388,161,597</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   기타유동자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">563,470,010</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">610,937,042</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   계약자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,320,739</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,267,300</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">II.비유동자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,250,914,726</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,007,160,825</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   장기금융상품</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,504,438</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   유형자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,171,770,923</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,290,643,010</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   무형자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">321,619,982</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">251,406,066</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   순확정급여자산 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">53,720,290</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   기타포괄손익공정가치측정금융자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">300,160,000</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   기타비유동금융자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,374,936</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">37,476,371</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   기타비유동자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">406,988,885</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">343,410,650</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자산총계</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">55,657,472,707</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">65,529,344,894</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">부      채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">I.유동부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,370,678,057</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,384,440,244</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   유동리스부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,043,015</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">82,704,554</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   기타유동부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">67,833,320</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">115,469,487</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   기타유동금융부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,258,801,722</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,293,551,403</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   계약부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">850,714,800</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   유동복구충당부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">42,000,000</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">II.비유동부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,116,067,674</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,128,151,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   장기차입금</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,000,000,000</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,000,000,000</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   순확정급여부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,348,328</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">   비유동리스부채</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">106,719,346</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">128,151,654</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">부채총계</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,486,745,731</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,512,591,898</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자      본</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">I.자본금</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,922,984,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,843,734,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">II.자본잉여금</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">101,263,129,602</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">99,848,101,817</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">III.기타자본구성요소</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,597,450,326</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,649,973,752</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">IV.결손금</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">   (64,612,836,952)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(53,325,056,573)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자본총계</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,170,726,976</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">55,016,752,996</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">부채및자본총계</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">55,657,472,707</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">65,529,344,894</TD>
</TR>
</TBODY>
</TABLE>
<P>당사의 2022년말 총자산 55,657백만원, 총부채 9,487백만원, 총자본 46,171백만원입니다. 자산총계는 본점이전에 따른 유형자산 취득 및 운영자금 사용 등으로 이한 현금성자산의 감소로인하여 전기말 대비 약18% 감소하였습니다. 부채총계는 전기말 미지급비용으로 계상되어 있던 서초사옥 매매 취득세 납부등으로 인하여 감소하였으며, 전기말 대비 약11% 감소하였습니다. 자본총계는 당기순손실 증가로 결손금이 증가하면서 전기말 대비 약 19% 감소하였습니다.</P>
<P>(2) 영업실적</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="761">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="441"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="761" HEIGHT="31" COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER"> 포  괄  손  익  계  산  서</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="761" HEIGHT="31" COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">제 7 기 2022년 1월 1일부터 2022년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="761" HEIGHT="31" COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">제 6 기 2021년 1월 1일부터 2021년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="31" VALIGN="BOTTOM">주식회사 큐라클</TD>
<TD WIDTH="450" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="761">

<COLGROUP>
<COL WIDTH="414"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="423" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과목</TH>
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 7 (당)기</TH>
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 6 (전)기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">I.영업수익</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,582,858,972</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,254,952,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">II.영업비용</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(15,565,070,430)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(13,124,547,681)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">III.영업손실</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(11,982,211,458)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,869,595,181)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">IV.기타수익</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">34,297,105</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">84,196,028</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">V.기타비용</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(84,604,318)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(164,628,880)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">VI.금융수익</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,097,566,202</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">363,016,332</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">VII.금융비용</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(470,640,060)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(90,777,162)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">VIII.법인세비용차감전순손실</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(11,405,592,529)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,677,788,863)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">IX.법인세비용</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">X.당기순손실</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(11,405,592,529)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,677,788,863)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">XI.기타포괄손익</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">117,812,150</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(191,502,433)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="761" HEIGHT="30" COLSPAN="3">후속적으로 당기손익으로 재분류되지 않는 기타포괄손익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">   확정급여제도의 재측정요소</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">117,812,150</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(191,502,433)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">XII.총포괄손익</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(11,287,780,379)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,869,291,296)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">   주당손실</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="423" HEIGHT="30">   기본 및 희석주당손실</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(829)</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(542)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>당사는 경상연구개발비 및 인력 증가에 따라 영업비용이 전년대비 16% 증가하였고, 2021년 10월 떼아오픈이노베이션(Thea Open Innovation) 에 당뇨황반부종 및 습성 황반변성 치료제 'CU06' 기술 수출을 통해 수취한 계약금(Upfront) 6백만불을 수익인식기준에 따라 2021년도와 2022년도에 나누어 수익으로 인식하였습니다. 또한 CU06 임상2a상에 대한  임상연구비용 및 제반비용 등을 수익으로 인식하였습니다.</SPAN>
<SPAN USERMARK=" B">라. 유동성 및 자금조달과 지출</SPAN>(1) 유동성에 관한 사항
<SPAN>당기말과 전기말 현재 당사의 현금및현금성자산의 내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="630" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>구분</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>당기말</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="630" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">
<P>현금및현금성자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">
<P>  현금</P>
</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">443</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">
<P>  보통예금</P>
</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,510,612</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,441,591</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>합계</P>
</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,510,612</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,441,591</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>당기말과 전기말 현재 당사의 장단기금융상품의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">
<P>단기금융상품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>  정기예적금</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 20,000,000</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" HEIGHT="30">
<P>장기금융상품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" HEIGHT="30">
<P>  장기성예금</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,504</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 20,000,000</TD>
<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,030,504</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>당기말과 전기말 현재 당사의 사용이 제한된 금융상품은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="632" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당기말</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">  보통예금(*1)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,745</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="211" HEIGHT="30" VALIGN="MIDDLE">  정기예금(*2)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,778</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 정부로부터 수령한 연구개발비 보조금으로 연구개발비 용도로 사용이 제한되어 있습니다(주석11,31 참조). </P>
<P>(*2) 철거이행보증금의 담보로 제공되어 사용이 제한되어 있습니다.</P>
<P>당기말과 전기말 현재 당사의 기타투자자산 및 기타포괄손익공정가치측정금융자산의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="264"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="170"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="631" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>(단위: 천원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="273" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>당기말</P>
</TD>

<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>전기말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="273" VALIGN="MIDDLE" HEIGHT="30">
<P>  상각후원가측정 금융자산</P>
</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,025,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="273" VALIGN="MIDDLE" HEIGHT="30">
<P>  당기손익공정가치측정 금융자산</P>
</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,073,467</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,020,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" VALIGN="MIDDLE" HEIGHT="30">  기타포괄손익공정가치측정 금융자산</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">300,160</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="273" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,373,627</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,046,227</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 자금의 조달</P>
<P>당기말과 전기말 현재 차입금의 상세내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="629" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만기일</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율(%)</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="629" VALIGN="MIDDLE" COLSPAN="6" HEIGHT="30">장기차입금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">  원화대출</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">하나은행</TD>
<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2024-12-29</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.62%</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 자금지출</P>

<TABLE BORDER="1" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="205"></COL>
<COL WIDTH="204"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="630" VALIGN="MIDDLE" ALIGN="RIGHT" COLSPAN="3" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="214" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제7기</TH>
<TH WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제6기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기초 현금 및 현금성자산</TD>
<TD WIDTH="214" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,441,591</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,541,240</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>영업활동으로 인한 현금흐름</P>
</TD>
<TD WIDTH="214" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,237,339)</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,841,509)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>투자활동으로 인한 현금흐름</P>
</TD>
<TD WIDTH="214" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,435,923</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(48,112,781)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>재무활동으로 인한 현금흐름</P>
</TD>
<TD WIDTH="214" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">661,835</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,826,245</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>환율변동효과</P>
</TD>
<TD WIDTH="214" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">208,602</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,396</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기말 현금 및 현금성자산</P>
</TD>
<TD WIDTH="214" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,510,612</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,441,591</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN USERMARK=" B">마. 부외거래</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">바. 중요한 회계정책 및 추정에 관한 사항</SPAN>중요한 회계정책 및 추정에 관한 사항은 Ⅲ.재무에 관한 사항을 참조하여 주시기 바랍니다.
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 회계감사인의 감사의견 등</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-1-0">1. 외부감사에 관한 사항</TITLE>
<P></P>
<LIBRARY>
<P USERMARK=" B">가. 회계감사인의 명칭 및 감사의견</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="668" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="262"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="271" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제7기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR1" VALIGN="MIDDLE">삼정회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT1" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="OPN_EMP1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="271" HEIGHT="30" ACODE="OPN_POT1" VALIGN="MIDDLE">연구개발비의 실제성과 정확성 검토</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제6기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR2" VALIGN="MIDDLE">삼정회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="OPN_EMP2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="271" HEIGHT="30" ACODE="OPN_POT2" VALIGN="MIDDLE">라이선스 수익인식의 적정성</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제5기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR3" VALIGN="MIDDLE">삼일회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="OPN_EMP3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="271" HEIGHT="30" ACODE="OPN_POT3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나. 감사용역 체결현황 </P>

<TABLE ACLASS="NORMAL" WIDTH="617" BORDER="0">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="617" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="617" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="45"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="54" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제7기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="SIGK_AUR1" VALIGN="MIDDLE">삼정회계법인</TE>
<TE ALIGN="CENTER" WIDTH="168" HEIGHT="53" ACODE="SIGK_CNT1" VALIGN="MIDDLE">재무제표 검토 및 감사분,반기검토</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">55,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="53" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">590</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">55,000</TE>
<TE ALIGN="RIGHT" WIDTH="54" HEIGHT="53" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">599</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">제6기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="SIGK_AUR2" VALIGN="MIDDLE">삼정회계법인</TE>
<TE ALIGN="CENTER" WIDTH="168" HEIGHT="53" ACODE="SIGK_CNT2" VALIGN="MIDDLE">재무제표 검토 및 감사분,반기검토</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">55,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="53" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">590</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">55,000</TE>
<TE ALIGN="RIGHT" WIDTH="54" HEIGHT="53" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">591</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">제5기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="SIGK_AUR3" VALIGN="MIDDLE">삼일회계법인</TE>
<TE ALIGN="CENTER" WIDTH="168" HEIGHT="53" ACODE="SIGK_CNT3" VALIGN="MIDDLE">재무제표감사</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">99,000</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="53" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">700</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">99,000</TE>
<TE ALIGN="RIGHT" WIDTH="54" HEIGHT="53" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">712</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">다. 회계감사인과의 비감사용역 계약체결 현황</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR1" VALIGN="MIDDLE" ROWSPAN="2">제7기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" ROWSPAN="2">제6기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="2">제5기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<LIBRARY>
<P USERMARK=" B">라. 재무제표 중 이해관계자의 판단에 상당한 영향을 미칠 수 있는 사항에 대해     내부감사기구가 회계감사인과 논의한 결과</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="862" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="496" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="76" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="DIS_DATE" AUNITVALUE="20230102" VALIGN="MIDDLE">2023년 01월 02일</TU>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="76" ACODE="DIS_ATT" VALIGN="MIDDLE">감사 및 대표이사</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="76" ACODE="DIS_WAY" VALIGN="MIDDLE">서면</TE>
<TE WIDTH="496" HEIGHT="76" ACODE="DIS_CONT" VALIGN="MIDDLE">- 감사계획단계의 지배기구 협의- 핵심감사항목 선정- 감사팀의 구성, 재무제표 감사의 목적, 책임구분, 감사계획, 독립성 등</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20230322" VALIGN="MIDDLE">2023년 03월 22일</TU>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">감사 및 대표이사</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면</TE>
<TE WIDTH="496" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">- 감사종결단계의 지배기구 협의- 책임구분, 감사진행상황, 감사결과, 독립성 등</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>


<P USERMARK=" B">마. 감사인의 변경
<SPAN USERMARK=" !B">당사는 보고서 작성기준일 현재 해당사항 없습니다.</SPAN>
</P>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-2-0">2. 내부통제에 관한 사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 내부회계관리제도</SPAN>(1) 내부회계관리제도에 대한 회계감사인의 의견경영자의 내부회계관리제도 운영실태보고서에 대한 우리의 검토결과 중요성의 관점에서 내부회계관리제도모범규준에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였습니다.(2) 내부회계관리자가 제시한 내부회계관리제도에 대한 문제점 또는 개선방안당사는 보고서  작성기준일 현재 해당사항이 없습니다. 
</P>

<P>
<SPAN USERMARK=" B">나. 내부회계관리제도 이외 내부통제구조에 대한 회계감사인으로부터 평가</SPAN>당사는 보고서  작성기준일 현재 해당사항이 없습니다. 
</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P>가. 이사회 구성개요(1) 이사회 구성 현황당사의 이사회는 보고서 작성기준일 현재 사내이사 1인, 기타비상무이사 3인, 사외이사 2인, 총 6인의 이사로 구성되어있습니다. 이사회 의장은 권영근 기타비상무이사가 수행하고 있으며 이사회 내 위원회는 설치되어 있지 않습니다. 각 이사의 주요 이력 및 담당업무는 「VIII. 임원 및 직원 등의 관한 사항」을 참조하시기 바랍니다.</P>
<P>사외이사 및 그 변동현황</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">6</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">2</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>(2) 이사회의 권한 내용당사의 이사회는 법령 또는 정관에 정해진 사항, 주주총회로부터 위임 받은 사항, 회사 경영의 기본방침 및 업무 집행에 관한 중요 사항을 의결하고 있습니다. 이사회는 이사의 직무 집행을 감독합니다.(3) 이사회 운영규정의 주요 내용</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="945">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="781"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="790" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>세부내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제1조 (적용범위)</P>
</TD>

<TD WIDTH="790" VALIGN="MIDDLE" HEIGHT="53">
<P>회사의 이사회에 관한 사항은 법령이나 정관에서 다른 정함이 있는 경우를 제외하고는 이 규정에 따른다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>제2조</P>
<P>(이사회의 구성)</P>
</TD>

<TD WIDTH="790" VALIGN="MIDDLE" HEIGHT="76">
<P>1. 이사회는 주주총회에서 선임 된 이사 전원(사외이사, 기타비상무이사를 포함)으로 한다.</P>
<P>2. 감사는 이사회에 출석하여 의견을 진술할 수 있다.</P>
<P>3. 이사회의 업무처리를 위하여 1명의 간사를 둘 수 있다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제5조</P>
<P>(이사회의 성립)</P>
</TD>

<TD WIDTH="790" VALIGN="MIDDLE" HEIGHT="53">
<P>이사회는 이사 전원의 과반의 출석에 의하여 성립한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>제6조</P>
<P>(이사회의 결의방법)</P>
</TD>

<TD WIDTH="790" HEIGHT="168">
<P>1. 이사는 각1개의 의결권을 가진다.</P>
<P>2. 이사회의 결의는 재적이사 과반수의 출석과 출석이사 과반수로 결정한다. 다만, 상법 제397조의 2(회사기회유용금지) 및 제398조(자기거래금지)에 해당하는 사안에 대한 이사회의 결의는 3분의 2이상의 수로 한다.</P>
<P>3. 이사회는 이사의 전부 또는 일부가 직접 회의에 출석하지 아니하고 모든 이사가 음성을 동시에 송,수신하는 원격통신수단에 의하여 결의에 참가하는 것을 허용할 수 있으며, 이 경우 당해 이사는 이사회에 직접 출석한 것으로 본다.</P>
<P>4. 이사회 결의에 관하여 특별한 이해관계가 있는 자는 의결권을 행사하지 못하며 의결권의 수에 산입하지 않는다.</P>
<P>5. 이사회의 의결권은 대리하지 못한다.</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">나. 중요의결사항</SPAN>(1) 이사회 주요 활동내역 
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1441">

<COLGROUP>
<COL WIDTH="59"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="433"></COL>
<COL WIDTH="37"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="90">회차</TH>
<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="90">개최일자</TH>
<TH ROWSPAN="2" WIDTH="442" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="90">의안내용</TH>
<TH WIDTH="46" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" ALIGN="CENTER" HEIGHT="90">가결여부</TH>
<TH COLSPAN="6" WIDTH="792" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">이사의 성명</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="132" HEIGHT="60">권영근(출석률: 100%)</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="132" HEIGHT="60">유재현(출석률: 100%)</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="132" HEIGHT="60">김영명(출석률: 100%)</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="132" HEIGHT="60">추연성(출석률: 78%)</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="132" HEIGHT="60">최동훈(출석률: 100%)</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="132" HEIGHT="60">조상헌(출석률: 44%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="68" HEIGHT="60">1차</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="60">2022-02-15</TD>
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">내부회계관리제도 운영실태보고의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">재무제표 승인의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="68" HEIGHT="30">2차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="30">2022-03-15</TD>
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">내부회계관리제도 운영실태 평가 보고의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="68" HEIGHT="30">3차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="30">2022-03-15</TD>
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">정기주주총회 소집 결의의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="68" HEIGHT="30">4차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="30">2022-04-13</TD>
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">주식매수선택권 부여 취소의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="68" HEIGHT="30">5차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="30">2022-06-09</TD>
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">임시주주총회 소집 결의의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="68" HEIGHT="30">6차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="30">2022-06-09</TD>
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">주식매수선택권 부여 취소의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="68" HEIGHT="150">7차</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="150">2022-11-16</TD>
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">타법인 주식 취득의 건</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="150">가결</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="150">찬성</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="150">찬성</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="150">찬성</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="150">-</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="150">찬성</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="150">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">주식매수선택권 부여의 건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">주식매수선택권 부여 취소의 건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">규정 일부 변경의 건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">CU01 임상시험수탁기관 계약 체결의 건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="68" HEIGHT="60">8차</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="60">2022-12-28</TD>
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">내부회계관리규정 개정의 건</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="46" HEIGHT="60">가결</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="60">찬성</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="60">찬성</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="60">찬성</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="60">찬성</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="60">찬성</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="132" HEIGHT="60">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="442" HEIGHT="30">CU06-1004의 생식발생독성시험 계약 체결의 건</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 사외이사 현황</P>

<TABLE BORDER="1" WIDTH="674" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="313"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>성 명</P>
</TH>

<TH WIDTH="322" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>주 요 경 력</P>
</TH>

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>최대주주등과의이해관계</P>
</TH>

<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>결격요건 여부</P>
</TH>

<TH WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>비 고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">최동훈</TD>

<TD WIDTH="322" VALIGN="MIDDLE" HEIGHT="99">
<SPAN>연세대학교 의학 박사연세대학교 내과학교실 교수('10~현재)</SPAN>
<SPAN>용인세브란스병원 병원장('19~'22)신촌세브란스병원 교수('22~현재)</SPAN>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>해당사항없음</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>부</P>
</TD>

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">조상헌</TD>
<TD WIDTH="322" VALIGN="MIDDLE" HEIGHT="76">서울대학교 내과학 박사서울대학교 내과학교실 교수('92~현재)서울대학교병원 알레르기내과교수('93~현재)</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>해당사항없음</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>부</P>
</TD>

<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">다. 이사회내 위원회 구성 현황</SPAN>당사는 보고서 작성기준일 현재 이사회 내 위원회를 구성하고 있지 않습니다.
<SPAN USERMARK=" B">라. 이사의 독립성</SPAN>(1) 이사 선출에 대한 독립성 기준 운영 여부당사의 이사는 주주총회에서 선임하며, 이사 후보자는 상법 등 관련 법령상 자격 기준을 준수함은 물론, 전문성, 독립성 등의 선정 기준에 따라 이사회에서 선정하여 주주총회에 제출할 의안으로 확정하고 있습니다.(2) 이사의 독립성 검토
</P>

<TABLE BORDER="1" WIDTH="1018" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="47"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추천인</TH>
<TH WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">선임사유</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">선임일</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">활동분야(담당업무)</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사와의거래</TH>
<TH WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최대주주 또는주요주주와의 관계</TH>
<TH WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연임여부</TH>
<TH WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연임횟수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">사내이사(대표이사)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">유재현</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이사회</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">다양한 국가에서 글로벌신약의 사업화 및 시장 성장에 크게 기여한 전문가</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2021.11.26</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">대표이사</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">해당없음</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">해당없음</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기타비상무이사</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">권영근</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">혈관질환분야 전문가이자 큐라클의 창업자</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019.03.22</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구개발자문</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당없음</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">본인</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연임</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타비상무이사</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김영명</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이사회</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈관연구분야 전문가</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.03.22</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구개발자문</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연임</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타비상무이사</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">추연성</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이사회</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해외사업개발분야 전문가</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.03.29</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구개발자문</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해당없음</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사외이사</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">최동훈</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사 경영의 투명성을 제고할 적임자로 판단됨</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.01.05</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구개발자문</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당없음</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당없음</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사외이사</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">조상헌</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사 경영의 투명성을 제고할 적임자로 판단됨</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.11.26</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구개발자문</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당없음</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당없음</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="56" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>
</TBODY>
</TABLE>

<P>주1) 자세한 사항은 「VIII. 임원 및 직원 등의 관한 사항」을 참고하여 주시기 바랍니다.(3) 사외이사 후보 추천위원회당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">마. 사외이사의 전문성</SPAN>당사는 사외이사의 직무수행을 위한 별도의 지원조직은 없으나, 사외이사가 이사회에서 전문적인 직무수행이 가능하도록 경영지원본부가 이를 보조하고 있습니다. 당사의 사외이사는 관련분야 전문가로서 직무 수행에 있어 전문성을 갖추고 있습니다. 또한 이사회 전에 해당 안건 내용을 충분히 검토할 수 있도록 사전에 자료를 제공하고 기타 사내 주요 현안에 대해서도 수시로 정보를 제공하고 있습니다.
</P>

<LIBRARY>
<P USERMARK=" B">바. 사외이사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ODRT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="76" ACODE="ODRT_EDU_NOT_DTL">사외이사의 경력상 충분한 자격 요건으로 미실시하였으나 추후 전문성을 높이기 위한 교육이 필요할 경우 실시할 예정입니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 감사위원회 위원의 인적사항 및 사외이사 여부</SPAN>당사는 보고서 작성기준일 현재 감사위원회를 설치하고 있지 않으며 주주총회에서 선임된 비상근감사 1인이 감사업무를 수행하고 있습니다.
<SPAN USERMARK=" B">나. 감사의 인적사항</SPAN>
</P>

<TABLE BORDER="1" WIDTH="995" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="609"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P> 성 명</P>
</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">상근여부</TH>

<TH WIDTH="618" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>주요 경력</P>
</TH>

<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>결격요건 여부</P>
</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">최대주주등과의이해관계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">서규영</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">비상근</TD>

<TD WIDTH="618" VALIGN="MIDDLE" HEIGHT="122">

<P>
<SPAN>고려대 법학 학사, 법과대학원 박사금융감독원 기업공시제도실·금융투자국 부국장('15~'17)금융감독원 공보국장, 인재교육원 실장, 자산운용검사국장, 인적자원개발실 국장('17~'21)금융감독원 금융교육국 선임교수('22)</SPAN>
</P>

<P>
<SPAN>금융채권자조정위원회 사무국장('22∼현재)</SPAN>
</P>
</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">해당없음</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">없음</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">다. 감사의 독립성</SPAN>
</P>

<P>감사는 이사회에 참석하여 독립적으로 이사의 업무를 감독할 수 있으며, 제반업무와 관련하여 관련장부 및 관계서류를 해당부서에 제출을 요구할 수 있습니다. 또한 필요시 회사로부터 영업에 관한 사항을 보고받을 수 있으며, 적절한 방법으로 경영정보에 접근할 수 있습니다.
<SPAN USERMARK=" B">라. 감사의 주요 활동내역 </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="770">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="330"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83">회차</TH>
<TH ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83">개최일자</TH>
<TH ROWSPAN="2" WIDTH="339" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83">의안내용</TH>
<TH ROWSPAN="2" WIDTH="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83">가결 여부</TH>
<TH COLSPAN="2" WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">이사의 성명</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="112" HEIGHT="53">고민석(출석률: 86%)</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="53">서 규 영(출석률: 100%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="60">1차</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="60">2022-02-15</TD>
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">내부회계관리제도 운영실태보고의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="112" HEIGHT="30">찬성</TD>
<TD ROWSPAN="7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="210">주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">재무제표 승인의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="112" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">2차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="30">2022-03-15</TD>
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">내부회계관리제도 운영실태 평가 보고의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="112" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">3차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="30">2022-03-15</TD>
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">정기주주총회 소집 결의의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="112" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">4차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="30">2022-04-13</TD>
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">주식매수선택권 부여 취소의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="112" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">5차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="30">2022-06-09</TD>
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">임시주주총회 소집 결의의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="112" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="30">6차</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="30">2022-06-09</TD>
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">주식매수선택권 부여 취소의 건</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="30">가결</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="112" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="150">7차</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="150">2022-11-16</TD>
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">타법인 주식 취득의 건</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="150">가결</TD>
<TD ROWSPAN="7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="112" HEIGHT="210">주1)</TD>
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="150">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">주식매수선택권 부여의 건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">주식매수선택권 부여 취소의 건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">규정 일부 변경의 건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">CU01 임상시험수탁기관 계약 체결의 건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="60">8차</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="60">2022-12-28</TD>
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">내부회계관리규정 개정의 건</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="60">가결</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="60">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="339" HEIGHT="30">CU06-1004의 생식발생독성시험 계약 체결의 건</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주1) </SPAN>
<SPAN>고민석 감사는 2022년 7월 22일 </SPAN>
<SPAN>일신상의 사유로 사임하여 출석률 계산시 사임이후 이사회는 제외하였습니다.주2) </SPAN>
<SPAN>서규영 감사는 2022년 7월 22일</SPAN>
<SPAN> 정기주주총회에</SPAN>서 신규 선임되었습니다.
</P>

<LIBRARY>
<P USERMARK=" B">마. 감사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ADT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="99" ACODE="ADT_EDU_NOT_DTL">경영상의 중요한 내용이 있을 경우 실시간 커뮤니케이션을 하고 있어 별도 교육은 실시하지 않았습니다. 감사의 교육내용등에 대해서는 검토중이며 필요할 경우 논의하여 교육을 실시할 예정입니다. </TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>


<P>
<SPAN USERMARK=" B">바. 감사 지원조직 현황</SPAN>당사는 보고서 작성기준일 현재 감사 지원조직을 별도로 두고 있지 않습니다. 다만 경영지원본부가 감사의 전문적인 직무수행이 가능하도록 보조하고 있습니다.
<SPAN USERMARK=" B">사. 준법지원인에 관한 사항</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
</P>

<LIBRARY>
</LIBRARY><LIBRARY>
<P></P>
</LIBRARY>

</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주총회 등에 관한 사항</TITLE>
<P></P>
<P USERMARK=" B">가. 투표제도 현황</P>

<TABLE-GROUP ACLASS="VOTE_CON" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="359"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="368" HEIGHT="30" AUPDATECONT="N">)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">투표제도 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">집중투표제</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">서면투표제</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전자투표제</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">도입여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="JVOTE_DYN" AUNITVALUE="N">배제</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="SVOTE_DYN" AUNITVALUE="Y">도입</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="DVOTE_DYN" AUNITVALUE="N">미도입</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">실시여부</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="JVOTE_SYN">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="SVOTE_SYN">실시</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="DVOTE_SYN">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주1) 당사는 정관32조에 의거 서면에 의한 의결권 행사를 채택하고 있습니다.
<SPAN USERMARK=" B">나. 소수주주권의 행사여부</SPAN>당사는 보고서 작성기준일 현재까지 소수주주권이 행사된 경우가 없습니다.
<SPAN USERMARK=" B">다. 경영권 경쟁여부</SPAN>당사는 보고서 작성기준일 현재까지 경영권과 관련하여 경쟁 사실이 없습니다. 
</P>
<P USERMARK=" B">라. 의결권 현황</P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK"> 13,845,968</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">기타 법률에 의하여의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권을 행사할 수 있는 주식수(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK"> 13,845,968</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK=" B">마. 주식사무</SPAN>
</P>

<TABLE BORDER="1" WIDTH="740" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="272"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="651">제10조(신주인수권)</TD>

<TD COLSPAN="3" WIDTH="604" HEIGHT="651">
<P>① 주주는 그가 소유한 주식의 수에 비례하여 신주의 배정을 받을 권리를 갖는다.</P>
<P>② 회사는 제1항의 규정에도 불구하고 다음 각 호의 어느 하나에 해당하는 경우 이사회의 결의로 주주 외의 자에게 신주를 배정할 수 있다</P>
<P>1. 발행주식총수의 100분의 30을 초과하지 않는 범위 내에서 「자본시장과 금융 투자업에 관한 법률」제165조의6에 따라 일반 공모증자방식으로 신주를 발행하는 경우</P>
<P>2. 발행하는 주식총수의 100분의 20 범위 내에서 우리사주조합원에게 신주를 우선  배정하는 경우</P>
<P>3. 「상법」 제542조의3에 따른 주식매수선택권의 행사로 인하여 신주를 발행하는 경우</P>
<P>4. 「근로복지기본법」 제39조의 규정에 의한 우리사주매수선택권의 행사로 인하여 신주를 발행하는 경우</P>
<P>5. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 주식예탁증서(DR)발 행에 따라 신주를 발행하는 경우</P>
<P>6. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 회사가 경영상 필요로 외국인 투자를 위하여 신주를 우선 배정하는 경우</P>
<P>7. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 기술신용보증기금법에 관한 법률에 의한 신기술사업금융회사와 신기술투자조합, 중소기업 창업지원법에 의한 중소기업창업투자회사와 중소기업창업투자조합 및 법인세법규정에 의한 기관 투자자에게 배정하는 경우</P>
<P>8. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 기술도입, 연구개발, 생산·판매·자본제휴를 위하여  그 제휴회사에게 신주를 배정하는 경우</P>
<P>9. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 경영상 목적을 위 하여 국내외 금융기관, 국내법인 또는 국내외 개인에게 신주를 배정하는 경우</P>
<P>10. 발행주식총수의 100분의 50을 초과하지 않는 범위내에서 주권을 코스닥시장에 상장하기 위하여 신주를 모집하거나 인수인에게 인수하게  하는 경우.</P>
<P>③ 제2항 각 호 중 어느 하나의 규정에 의해 신주를 발행할 경우 발행할 주식의 종류와 수 및 발행가격 등은 이사회의 결의로 정한다. </P>
<P>④ 신주인수권의 포기 또는 상실에 따른 주식과 신주배정에서 발생한 단 주에 대한 처리방법은 이사회의 결의로 정한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">결산일</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월31일</TD>
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">정기주주총회</TD>
<TD WIDTH="281" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매 영업년도 종료 후 3개월 이내</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주주명부 폐쇄시기</TD>
<TD COLSPAN="3" WIDTH="604" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이사회 결의로 정한 기준일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주권의 종류</TD>
<TD COLSPAN="3" WIDTH="604" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기명식 보통주식, 기명식 종류주식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">명의개서대리인</TD>
<TD COLSPAN="3" WIDTH="604" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국예탁결제원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공고방법</TD>
<TD COLSPAN="3" WIDTH="604" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회사의 인터넷 홈페이지(www.curacle.com) 또는 매일경제신문</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">바. 주주총회 의사록 요약</SPAN>공시대상기간(최근 3사업연도)동안 개최된 주주총회의 내용은 아래와 같습니다. 
</P>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="187"></COL>
<COL WIDTH="303"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주총일자</TH>
<TH WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">안 건</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">결 의 내 용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제5기 임시주주총회 (1차)(2021.01.05)</TD>
<TD WIDTH="312" VALIGN="MIDDLE" HEIGHT="53">1. 임원 증원의 건2. 스톡옵션부여의 건</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">1. 원안가결2. 원안가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>제5기 정기주주총회(2021.03.29)</P>
</TD>

<TD WIDTH="312" VALIGN="MIDDLE" HEIGHT="168">
<P>1. 제5기 재무제표 승인의 건</P>
<P>2. 정관 일부 변경의 건</P>
<P>3. 이사 선임의 건</P>
<P>4. 감사 선임의 건</P>
<P>5. 주식매수선택권 부여의 건</P>
<P>6. 이사 보수한도액 승인의 건</P>
<P>7. 감사 보수한도액 승인의 건</P>
</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">1. 원안가결2. 원안가결3. 원안가결4. 원안가결5. 원안가결6. 원안가결7. 원안가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제6기 임시주주총회(2021.11.26)</TD>
<TD WIDTH="312" VALIGN="MIDDLE" HEIGHT="53">1. 이사 선임의 건(사내이사 유재현, 사외이사 조상헌)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">1. 원안가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>제6기 정기주주총회(2022.03.30)</P>
</TD>

<TD WIDTH="312" VALIGN="MIDDLE" HEIGHT="145">
<P>1. 제6기 재무제표 승인의 건</P>
<P>2. 정관 일부 변경의 건</P>
<P>3. 이사 선임의 건</P>
<P>4. 주식매수선택권 부여의 건</P>
<P>5. 이사 보수한도액 승인의 건</P>
<P>6. 감사 보수한도액 승인의 건</P>
</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">1. 원안가결2. 원안가결3. 원안가결4. 원안가결5. 원안가결6. 원안가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제7기 임시주주총회(2022.07.22)</TD>
<TD WIDTH="312" VALIGN="MIDDLE" HEIGHT="53">1. 감사 선임의 건</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">1. 원안가결</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P></P>
<P USERMARK=" B">가. 최대주주 및 특수관계인의 주식소유 현황</P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="619" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="308" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="618" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="315" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="152" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">권영근</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">최대주주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">1,809,047 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">13.22</TE>
<TE ALIGN="RIGHT" WIDTH="89" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">1,809,047 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">13.07 </TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김영명</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">40,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.29</TE>
<TE ALIGN="RIGHT" WIDTH="89" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">40,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.29 </TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">곽현정</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">34,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.25</TE>
<TE ALIGN="RIGHT" WIDTH="89" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">50,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.36 </TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">표정인</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">20,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.15</TE>
<TE ALIGN="RIGHT" WIDTH="89" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">10,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.07 </TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">황 용</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">0 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="89" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">18,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.13 </TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김명화</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">직원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">220,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">1.61</TE>
<TE ALIGN="RIGHT" WIDTH="89" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">260,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">1.88 </TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">2,123,047</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">15.51</TE>
<TE ALIGN="RIGHT" WIDTH="89" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">2,187,047</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">15.80</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="89" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 기초의 발행주식 총수는 13,687,468주 입니다.주2) 기말의 발행주식 총수는 13,845,968주 입니다. 2022년 4월, 6월, 11월 주식매수선택권 행사를 통해 158,500주가 증가하였습니다. </P>
<P USERMARK=" B">나. 최대주주의 주요경력 및 개요</P>
<P></P>

<TABLE BORDER="1" WIDTH="581" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="416"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">명 칭</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">직 책</TH>
<TH WIDTH="425" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">학력 및 경력</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">권영근</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">이사회의장</TD>
<TD WIDTH="425" VALIGN="MIDDLE" HEIGHT="122">서울대학교 화학교육과 학사State University of New York at Buffalo, 이학 석/박사(생화학)연세대학교 생화학과 교수 ('04~현재)연세대학교 생명시스템대학 학장 ('20~'22.01)(주)큐라클 ('16~현재)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">다. 사업현황 등 회사 경영 안정성에 영향을 미칠 수 있는 주요 내용</SPAN>당사는 보고서 작성기준일  현재 해당사항이 없습니다.
</P>

<P>
<SPAN USERMARK=" B">라. 최대주주 변동내역</SPAN>당사는 설립이후 현재까지 최대주주 변동내역이 없습니다.
</P>
<P USERMARK=" B">마. 주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율(%)</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">권영근</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">        1,809,047 </TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">13.07</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">이인규</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">        1,353,780 </TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">9.78</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<LIBRARY>
<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">소액주주현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="231" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="108" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율(%)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액주식수</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행주식수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNT">37,936 </TE>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNTT">37,945 </TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_RT">99.98</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNT">8,596,872 </TE>
<TE WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNTT">13,845,968 </TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_RT">62.09</TE>
<TE WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 소액주주는 발행주식총수 1%에 미달하는 주식을 소유한 주주입니다.</P>
</LIBRARY>

<P></P>

<P>
<SPAN USERMARK=" B">바. 주가 및 주식거래실적</SPAN>당사는 기업공시서식 작성기준에 따른 소규모기업에 해당하여 '주가 및 주식거래실적' 을 기재를 생략합니다. 
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>
<P USERMARK=" B">가. 임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1384" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="1035"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1044" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1389" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="410"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="419" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="122" ACODE="SH5_NM_T" VALIGN="MIDDLE">유재현</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="122" AUNIT="SH5_BIH" AUNITVALUE="197208" VALIGN="MIDDLE">1972.08</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="122" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="122" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="122" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="122" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">총괄</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="122" ACODE="SH5_SKL" VALIGN="MIDDLE">서울대학교 약학 학사 한국얀센 Immunology사업부 총괄이사('11~'14)  한국얀센 Specialty사업부 총괄상무('14~'18)  얀센북아시아 Specialty사업부 총괄전무('18~'20)  (주)큐라클 대표이사 ('21.11~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="122" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="122" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="122" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="122" ACODE="SH5_PER" VALIGN="MIDDLE">1년 2개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="122" AUNIT="SH5_FIH" AUNITVALUE="20241126" VALIGN="MIDDLE">2024.11.26</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="70" ACODE="SH5_NM_T" VALIGN="MIDDLE">권영근</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="70" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="70" AUNIT="SH5_BIH" AUNITVALUE="196404" VALIGN="MIDDLE">1964.04</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="70" ACODE="SH5_LEV" VALIGN="MIDDLE">이사회의장</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="70" AUNIT="SH5_REG_DRCT" AUNITVALUE="5" VALIGN="MIDDLE">기타비상무이사</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="70" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="70" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">이사회 의장</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="70" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">State University of New York at Buffalo 생화학 박사 연세대학교 생화학과 교수('04.03~현재) (주)큐라클 이사회의장('16.05~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="70" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">1,809,047</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="70" ACODE="SH5_RLTN" VALIGN="MIDDLE">본인</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="70" ACODE="SH5_PER" VALIGN="MIDDLE">6년 8개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="70" AUNIT="SH5_FIH" AUNITVALUE="20250330" VALIGN="MIDDLE">2025.03.30</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">김영명</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="195605" VALIGN="MIDDLE">1956.05</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">기타비상무이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="5" VALIGN="MIDDLE">기타비상무이사</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">기타 비상무 이사</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">미국 Utah 주립대학교 생화학 박사 강원대학교 의학과 교수('97.03~현재) 강원대학교 혈관연구센터장('01.01~현재) (주)큐라클 기타비상무이사('19.03~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">40,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">3년 10개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="20250330" VALIGN="MIDDLE">2025.03.30</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">추연성</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="195603" VALIGN="MIDDLE">1956.03</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">기타비상무이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="5" VALIGN="MIDDLE">기타비상무이사</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">기타 비상무 이사</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">미국 Univ Illinois at Chicago 약학 박사 LG생명과학 부사장 및 고문('00.07~'18.03) (주)바이오파트너즈 대표이사('19.07~현재) (주)큐라클 기타비상무이사('20.03~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">2년 10개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="20240329" VALIGN="MIDDLE">2024.03.29</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">최동훈</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="196306" VALIGN="MIDDLE">1963.06</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="4" VALIGN="MIDDLE">사외이사</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">사외 이사</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">연세대학교 의학 박사 연세대학교 내과학교실 교수('10.03~현재) 용인세브란스병원 병원장('19.03~현재) (주)큐라클 사외이사('21.01~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">2년</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="20240329" VALIGN="MIDDLE">2024.03.29</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">조상헌</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="195912" VALIGN="MIDDLE">1959.12</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="4" VALIGN="MIDDLE">사외이사</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">사외 이사</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">서울대학교 내과학 박사 서울대학교 내과학교실 교수('92~현재) 서울대학교병원 알레르기내과교수('93~현재) (주)큐라클 사외이사('21.11~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">1년 2개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="20241126" VALIGN="MIDDLE">2024.11.26</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="133" ACODE="SH5_NM_T" VALIGN="MIDDLE">서규영</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="133" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="133" AUNIT="SH5_BIH" AUNITVALUE="196612" VALIGN="MIDDLE">1966.12</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="133" ACODE="SH5_LEV" VALIGN="MIDDLE">감사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="133" AUNIT="SH5_REG_DRCT" AUNITVALUE="6" VALIGN="MIDDLE">감사</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="133" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="133" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">감사</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="133" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">고려대 법학 학사, 법과대학원 박사 금융감독원 기업공시제도실·금융투자국 부국장('15~'17) 금융감독원 공보국장, 인재교육원 실장, 자산운용검사국장, 인적자원개발실 국장('17~'21) 금융감독원 금융교육국 선임교수('22) 금융채권자조정위원회 사무국장('22∼현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="133" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="133" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="133" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="133" ACODE="SH5_PER" VALIGN="MIDDLE">6개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="133" AUNIT="SH5_FIH" AUNITVALUE="20250722" VALIGN="MIDDLE">2025.07.22</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="135" ACODE="SH5_NM_T" VALIGN="MIDDLE">박종현</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="135" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="135" AUNIT="SH5_BIH" AUNITVALUE="196602" VALIGN="MIDDLE">1966.02</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="135" ACODE="SH5_LEV" VALIGN="MIDDLE">부사장</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="135" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="135" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="135" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">CFO</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="135" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">서울대학교 국제경제학 학사 우리투자증권 리서치센터장('05.05~'11.02) 우리투자증권 법인영업그룹장('11.03~'14.12) NH투자증권 에퀴티세일즈본부장('15.01~'19.12) NH투자증권 프라임브로커리지본부장('20.01~'20.12) (주)큐라클 부사장('22.09~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="135" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="135" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="135" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="135" ACODE="SH5_PER" VALIGN="MIDDLE">4개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="135" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">김정한</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="197404" VALIGN="MIDDLE">1974.04</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">사업 개발 총괄</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">University of california,Berkeley, Marketing&Global business MBA 동화약품 BD, Global&ETC Marketing 총괄임원 ('12.12~'20.09) (주)큐라클 사업개발본부 본부장('21.04~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">1년 9개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">최재진</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="196902" VALIGN="MIDDLE">1969.02</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">전략 기획 총괄</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">서강대학교 마케팅 석사 한독 Commercial Excellence 부서장 ('15.05~19.05) 아이큐비아코리아 Strategic Consultant ('20.12~21.12) (주)큐라클 상무이사 ('21.12~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">1년 1개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="156" ACODE="SH5_NM_T" VALIGN="MIDDLE">김수정</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="156" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="156" AUNIT="SH5_BIH" AUNITVALUE="197301" VALIGN="MIDDLE">1973.01</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="156" ACODE="SH5_LEV" VALIGN="MIDDLE">상무 이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="156" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="156" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="156" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">임상 개발 총괄</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="156" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">한양대학교 의학 박사 아모레퍼시픽기술 연구원 책임연구원 ('97.10 ~'09.05) 코미팜 의약사업부 이사('09.05~'19.01) 한양대학교 의생명공학전문대학원 겸임교수('11.03~'14.03) 크리스탈지노믹스 RA/임상개발본부 이사('19.03~'19.09) 파마리서치 연구소장 ('19.11~'22.05) (주)큐라클 임상개발본부 상무('22.05~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="156" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="156" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="156" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="156" ACODE="SH5_PER" VALIGN="MIDDLE">8개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="156" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="135" ACODE="SH5_NM_T" VALIGN="MIDDLE">이원일</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="135" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="135" AUNIT="SH5_BIH" AUNITVALUE="197509" VALIGN="MIDDLE">1975.09</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="135" ACODE="SH5_LEV" VALIGN="MIDDLE">상무 이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="135" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="135" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="135" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">신약 연구소 총괄</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="135" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">서울대학교 약학박사 C&C신약연구소 신약연구 책임연구원('01.01~'15.01) 젬백스앤카엘 연구개발 이사('15.02~'16.07) 제일약품 신약연구 책임연구원('16.08~'17.06) (주)대원제약 신약연구 이사('17.06~'22.07) (주)큐라클 신약연구본부 상무('22.08~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="135" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="135" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="135" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="135" ACODE="SH5_PER" VALIGN="MIDDLE">5개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="135" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="112" ACODE="SH5_NM_T" VALIGN="MIDDLE">곽현정</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="112" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="112" AUNIT="SH5_BIH" AUNITVALUE="197101" VALIGN="MIDDLE">1971.01</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="112" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="112" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="112" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="112" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">전임상 후보물질 발굴</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="112" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">충남대학교, 화학과 이학박사 (주)SK 바이오팜 사업부 책임연구원('00.08~'10.12) 한국화학연구원 선임연구원('11.02~'16.11) (주)큐라클 신약연구소 이사('17.03~'22.04) (주)큐라클 전락기획실 이사('22.05~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="112" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">34,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="112" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="112" ACODE="SH5_PER" VALIGN="MIDDLE">5년 10개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="112" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="133" ACODE="SH5_NM_T" VALIGN="MIDDLE">표정인</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="133" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="133" AUNIT="SH5_BIH" AUNITVALUE="197711" VALIGN="MIDDLE">1977.11</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="133" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="133" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="133" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="133" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">중앙 연구소 총괄</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="133" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">연세대학교, 이학박사(의약화학) 한국과학기술연구원(KIST) 연구원('03.06~'14.12) 삼육대학교 특임교수/비전임('11.09~'14.07) iNtRON Biotechnology 신약연구 팀장('15.01~'17.07) (주)큐라클 연구개발본부 수석연구원('17.08~'20.11) (주)큐라클 연구개발본부 이사('20.12~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="133" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">20,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="133" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="133" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="133" ACODE="SH5_PER" VALIGN="MIDDLE">5년 5개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="133" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="72" ACODE="SH5_NM_T" VALIGN="MIDDLE">황용</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="72" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="72" AUNIT="SH5_BIH" AUNITVALUE="197108" VALIGN="MIDDLE">1971.08</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="72" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="72" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="72" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="72" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">경영 관리 총괄</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="72" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">서해대학교 경영학 학사 (주)네온테크 경영지원총괄('06.11~'19.06) (주)큐라클 경영관리본부 이사('19.07~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="72" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="72" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="72" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="72" ACODE="SH5_PER" VALIGN="MIDDLE">3년 6개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="72" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="156" ACODE="SH5_NM_T" VALIGN="MIDDLE">신주현</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="156" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="156" AUNIT="SH5_BIH" AUNITVALUE="197708" VALIGN="MIDDLE">1977.08</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="156" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="156" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="156" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="156" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">바이오 연구소 총괄</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="156" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">KAIST 생명과학 박사 JW 중외제약 C&C 신약연구소 선임연구원('13.10~'16.01) 레고켐바이오 항암제팀 총괄팀장('16.02~'17.11) 메디톡스 신약개발팀장('17.12~'19.01) 환인제약 외부협력연구실 부장('19.01~'19.05) 일동제약 사업개발 이사('20.11~'21.01) (주)큐라클 바이오연구본부 이사('22.02~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="156" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="156" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="156" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="156" ACODE="SH5_PER" VALIGN="MIDDLE">11개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="156" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="177" ACODE="SH5_NM_T" VALIGN="MIDDLE">김판경</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="177" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="177" AUNIT="SH5_BIH" AUNITVALUE="198003" VALIGN="MIDDLE">1980.03</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="177" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="88" HEIGHT="177" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="76" HEIGHT="177" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="177" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">임상 개발</TE>
<TE ALIGN="CENTER" WIDTH="419" HEIGHT="177" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">경북대학교, 의학 석사 녹십자연구원('05.01~'08.03) 삼양사 CRA('08.06~'10.02) LG 생명과학('10.08~'14.05) 한미약품 임상팀장('14.05~'17.04) 현대약품 임상팀장('17.04~'19.03) 유영제약 임상팀장('20.06~'22.05) (주)큐라클 임상개발본부 이사('22.05~현재)</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="177" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="177" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="177" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="177" ACODE="SH5_PER" VALIGN="MIDDLE">8개월</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="177" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나. 임원의 겸직현황</P>

<TABLE ACLASS="NORMAL" WIDTH="710" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="701"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="710" HEIGHT="30">기준일 : 2022년 12월 31일</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="712">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>성명(생년월일)</P>
</TH>

<TH WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>회사명</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>직책명</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>담당업무</P>
</TH>

<TH WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>재직기간</P>
</TH>

<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>겸직회사와청구회사의 관계</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">권영근 (64.04.05)</TD>
<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연세대학교</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">교수</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">'04~현재</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당사항없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">겸직허가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">김영명 (56.05.23)</TD>
<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">강원대학교</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">명예교수</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">'97~현재</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당사항없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">추연성 (56.03.13)</TD>
<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">(주)바이오에스파트너즈</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">대표이사</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">경영총괄</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">'19~현재</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당사항없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">최동훈 (63.06.23)</TD>
<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">신촌세브란스병원</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">교수</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">'19~현재</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당사항없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">겸직허가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">조상헌(59.12.22)</TD>
<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">서울대학교병원</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">교수</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">'92~현재</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당사항없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">서규영 (66.12.14)</TD>
<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">금융채권자조정위원회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사무국장</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">22~현재</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당사항없음</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>
</TBODY>
</TABLE>

<P></P>
<P USERMARK=" B">다. 직원 등 현황</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="791" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="424"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="433" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="793" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="646" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="287" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">연구/관리</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">16</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">16</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">1.6</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE"> 1,015 </TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE"> 64 </TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">연구/관리</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">21</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">21</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">2.3</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE"> 1,245 </TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE"> 59 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="126" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">37</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">37</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">2</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE"> 2,260 </TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE"> 62 </TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주1) 보고서 작성기준일 현재 등기임원을 제외한 수치입니다.</P>
<P USERMARK=" B">라. 미등기임원 보수 현황</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="597" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="230"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="239" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="596" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_CNT">11</TE>
<TE WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">1,032 </TE>
<TE WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">94 </TE>
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 인원수는 보고서 작성기준일 현재 재직중인 미등기임원의 수입니다.주2) 연간급여 총액은 2021년 1월 1일부터 보고서 작성기준일까지의 누계금액입니다. 주3) 1인 평균 급여액은 급여 총액을 인원수로 나누어 산출하였습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">가. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_NUM">6</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">1,000 </TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">100 </TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나. 보수지급금액</P>
<P>나-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_NUM">8</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUM"> 617 </TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_VIC"> 77 </TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 보수총액은 등기임원 전체에 대한 2022년 1월~ 12월 까지의 지급 총액이며, 1인당 평균 보수액은 보수총액을 등기임원의 수로 단순평균하여 산출하였습니다.주2) 보고서 작성기준일 현재 당사의 등기임원은 이사 6인, 감사1인입니다. 위의 인원수는 퇴임한 이사 및 감사를 포함하여 기재하였습니다. </P>
<P>나-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_NUM">4</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM"> 543 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC"> 136 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM"> 50 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC"> 25 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="AUD_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_SUM"> 24 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_VIC"> 12 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 신규 선임 및 퇴임한 임원을 포함하였습니다. </P>
<P>주2) 보수총액은 당해 사업연도 중 재임 또는 퇴임한 등기이사, 사외이사,  감사가 지급받은 소득세법상의 소득금액입니다. </P>

<P>
<SPAN>주3) 1인당 평균보수액은 보수총액을 인원수로 단순평균하여 산출하였습니다.</SPAN>
<SPAN USERMARK=" B">다. 이사ㆍ감사의 보수지급기준</SPAN>
<SPAN>당사의 이사 및 감사의 보수지급기준은 정관 제40조에 의거하여 주주총회에서 승인 받은 금액 내에서 직급과 업무를 고려하여 집행하고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 기준일 현재 "보수지급금액 5억원이상인 이사.감사 개인별 보수현황"에 해당사항 없어 기재를 생략하였습니다.</P>
<P>2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="604" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="297"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="48" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="201" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="48" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="306" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="78" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="123" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" WIDTH="306" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="123" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="123" HEIGHT="53">주식매수선택권 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="123" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="201" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="201" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 기준일 현재 "보수지급금액 5억원이상인 이사.감사 개인별 보수현황"에 해당사항 없어 기재를 생략하였습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="296"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="305" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="305" VALIGN="MIDDLE" HEIGHT="30" ACODE="CMPK_NOTPAY" ALIGN="CENTER">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 기준일 현재 "보수지급금액 5억원이상인 이사.감사 개인별 보수현황"에 해당사항 없어 기재를 생략하였습니다.</P>
<P>2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="604" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="297"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="48" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="201" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="48" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="306" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="48" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="78" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="123" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" WIDTH="306" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="123" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="123" HEIGHT="53">주식매수선택권 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="123" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="201" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="201" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="48" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="306" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 기준일 현재 "보수지급금액 5억원이상인 이사.감사 개인별 보수현황"에 해당사항 없어 기재를 생략하였습니다.</P>

<LIBRARY>
<P><주식매수선택권의 부여 및 행사현황></P>
<P><표1></P>

<TABLE-GROUP ACLASS="SUB_SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">부여받은인원수</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주식매수선택권의 공정가치 총액</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUPDATECONT="N">등기이사(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="RRT_PAY_NUM">2</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="RRT_PAY_SUMT">2,121</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사(감사위원회 위원 제외)</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_NUM">2</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUMT">202</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원 또는 감사</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">업무집행지시자 등</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="JED_PAY_NUM">-</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="JED_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">4</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUMT">2,323</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 부여된 주식매수선택권은 행사시점에 신주가 교부되는 주식매수선택권으로서 공정가치는 이항모형을 이용한 공정가치접근법을 적용하여 산정하였습니다.</P>
<P><표2></P>

<TABLE-GROUP ACLASS="SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1003" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="153" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="618" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1345" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="217"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여받은자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여방법</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초부여수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기변동수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총변동수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기말미행사수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사가격</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의무보유여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의무보유기간</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김명화</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20170331">2017.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2019.04.01~2024.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">1,410</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">상장일로부터 1.5년</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">곽현정</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20170331">2017.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2019.04.01~2024.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">1,410</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">OOO외 2인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20170331">2017.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">1,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">9,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2019.04.01~2024.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">1,410</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">박광락</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20180331">2018.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">32,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">32,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2020.04.01~2025.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">상장일로부터 3년</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">박광락</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20180331">2018.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2020.04.01~2025.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">상장일로부터 1.5년</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김명화</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20180331">2018.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">80,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">80,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2020.04.01~2025.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">상장일로부터 3년</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김명화</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20180331">2018.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2020.04.01~2025.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">상장일로부터 1.5년</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">곽현정</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20180331">2018.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2020.04.01~2025.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">표정인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20180331">2018.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2020.04.01~2025.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">OOO외 5인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20180331">2018.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">114,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">44,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">70,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2020.04.01~2025.03.31</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">이재흥</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190630">2019.06.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">50,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">50,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">강지혜</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190630">2019.06.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김명화</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190630">2019.06.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">120,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">120,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">3,384</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">상장일로부터 1.5년</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">곽현정</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190630">2019.06.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">16,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">16,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">3,384</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">안구현</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190630">2019.06.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">3,384</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">표정인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190630">2019.06.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">20,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">3,384</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김영명</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190630">2019.06.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">3,384</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">OOO외 8인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190630">2019.06.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">104,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">10,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">68,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">36,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">3,384</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김명화</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200331">2020.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">26,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">26,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2022.04.01 또는 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">6,200</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">강지혜</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200331">2020.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">14,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">14,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">14,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2022.04.01 또는 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">6,200</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">안구현</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200331">2020.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2022.04.01 또는 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">6,200</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">황용</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200331">2020.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">18,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">18,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">18,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2022.04.01 또는 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">6,200</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">OOO외 9인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200331">2020.03.31</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">69,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">32,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">12,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">36,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">21,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">12,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2022.04.01 또는 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">6,200</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">추연성</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210106">2021.01.06</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">20,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">7,750</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">최동훈</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210106">2021.01.06</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">10,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">10,720</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">OOO</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210106">2021.01.06</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">3,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">3,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2년과 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">10,720</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김명화</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210329">2021.03.29</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">100,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2023.03.30 또는 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">8,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">OOO외 3인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210329">2021.03.29</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">16,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_MCNL_CNT">12,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_CNL_CNT">12,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">4,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="53" ACODE="SH5_PER">2023.03.30 또는 상장일 중 나중에 도래하는 날부터 5년간</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_PRC">10,720</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">유재현</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20220330">2022.03.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">100,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.03.30 ~ 2029.03.29</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">21,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">조상헌</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20220330">2022.03.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.03.30 ~ 2029.03.29</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">21,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김정한</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20220330">2022.03.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">15,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.03.30 ~ 2029.03.29</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">21,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">최재진</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20220330">2022.03.30</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">15,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.03.30 ~ 2029.03.29</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">21,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">황용</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20221116">2022.11.16</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">4,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.11.16 ~ 2029.11.15</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">12,700</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">최재진</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20221116">2022.11.16</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">8,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">8,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.11.16 ~ 2029.11.15</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">12,700</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김정한</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20221116">2022.11.16</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">8,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">8,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.11.16 ~ 2029.11.15</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">12,700</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">박종현</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20221116">2022.11.16</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">30,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.11.16 ~ 2029.11.15</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">12,700</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김수정</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20221116">2022.11.16</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">15,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.11.16 ~ 2029.11.15</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">12,700</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">이원일</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20221116">2022.11.16</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">15,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.11.16 ~ 2029.11.15</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">12,700</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김판경</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20221116">2022.11.16</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">10,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="226" HEIGHT="30" ACODE="SH5_PER">2024.11.16 ~ 2029.11.15</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">12,700</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주1) 보고서 작성기준일 현재 주식의 종가
<SPAN>는 </SPAN>
<SPAN>11,350</SPAN>
<SPAN>원입니</SPAN>다. 
</P>
</LIBRARY>

<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>
<P>계열회사 현황(요약)</P>

<TABLE-GROUP ACLASS="AFF_CMP_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="262" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기업집단의 명칭</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="450" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계열회사의 수</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="BG_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="LST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="ULST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="AFF_TOT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="601" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-002|ADX-002">※상세 현황은 '상세표-2. 계열회사 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>타법인출자 현황(요약)</P>

<TABLE-GROUP ACLASS="INV_PRT_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="262" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="64"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="113" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출자목적</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="222" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출자회사수</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총 출자금액</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">비상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기초장부가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="146" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증가(감소)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기말장부가액</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취득(처분)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">평가손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" AUPDATECONT="N">경영참여</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="MP_LST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="MP_ULST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="MP_TOT_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="MP_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="MP_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="MP_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="MP_FIN_PRC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" AUPDATECONT="N">일반투자</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_LST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_ULST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_TOT_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_FIN_PRC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" AUPDATECONT="N">단순투자</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SC_LST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SC_ULST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SC_TOT_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SC_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="SC_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="SC_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="SC_FIN_PRC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_LST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_ULST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_TOT_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_FIN_PRC">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-003|ADX-003">※상세 현황은 '상세표-3. 타법인출자 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 대주주 등과의 거래내용</TITLE>
<P></P>
<P USERMARK=" B">가. 대주주등에 대한 신용공여 등</P>

<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">나. 대주주와의 자산양수도 등</SPAN>
</P>

<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">다. 대주주와의 영업거래</SPAN>
</P>

<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">라. 대주주 이외의 이해관계자와의 거래</SPAN>
</P>
<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-1-0">1. 공시내용 진행 및 변경사항</TITLE>
<P></P>
<P>당사는 보고서 작성기준일 현재 주요사항보고서 및 한국거래소 공시를 통해 공시한 사항이 공시서류제출일까지 이행이 완료되지 않았거나 주요내용이 변경된 사실이 없습니다. </P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-2-0">2. 우발부채 등에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 중요한 소송사건</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">나. 견질 또는 담보용 어음ㆍ수표 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
</P>

<P>
<SPAN USERMARK=" B">다. 채무보증 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">라. 채무인수약정 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">마. 그 밖의 우발채무 등</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
</P>
<P></P>

</SECTION-2><SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-3-0">3. 제재 등과 관련된 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 제재현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">나. 한국거래소 등으로부터 받은 제재</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">다. 단기매매차익 발생 및 반환에 관한 사항</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다. 
</P>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-4-0">4. 작성기준일 이후 발생한 주요사항 등 기타사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 작성기준일 이후 발생한 주요사항</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">나. 중소기업기준 검토표 </SPAN>
</P>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">큐라클 중소기업 등 기준검토표_fy22_1.jpg</IMG>
<IMG-CAPTION ATOC="N">큐라클 중소기업기준검토표_01</IMG-CAPTION>
</IMAGE>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">큐라클 중소기업 등 기준검토표_fy22_2.jpg</IMG>
<IMG-CAPTION ATOC="N">큐라클_중소기업기준검토표_02</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B">다. 외국지주회사의 자회사 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">라. 합병등의 사후정보</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
</P>
<P> </P>

<P></P>

<P></P>

<P></P>

<LIBRARY>
<P USERMARK=" B">마. 보호예수 현황</P>

<TABLE-GROUP ACLASS="PROT_STA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="891" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="582"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="164" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="56" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="591" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="906" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="264"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">예수주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">예수일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">반환예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보호예수기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="273" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보호예수사유</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총발행주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="30" ACODE="PROT_CNT" VALIGN="MIDDLE">2,883,067</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="30" AUNIT="PROT_DAT" AUNITVALUE="20210722" VALIGN="MIDDLE">2021.07.22</TU>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="30" AUNIT="PROT_DATE" AUNITVALUE="20240722" VALIGN="MIDDLE">2024.07.22</TU>
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="30" ACODE="PROT_PRD" VALIGN="MIDDLE">상장일로부터 3년</TE>
<TE ALIGN="CENTER" WIDTH="273" HEIGHT="30" ACODE="PROT_RSN" VALIGN="MIDDLE">한국거래소 상장규정에 따른 보호예수</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="30" ACODE="PROT_TONT" VALIGN="MIDDLE">13,845,968</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<LIBRARY>
<P USERMARK=" B">바. 특례상장기업의 재무사항 비교표 </P>

<TABLE-GROUP ACLASS="SPE_MGR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="623" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(상장일 : </TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20210722">2021년 07월 22일</TU>
<TD VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">, 인수인 : </TD>
<TE VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BASE_PRN">삼성증권</TE>
<TD VALIGN="MIDDLE" WIDTH="138" AUPDATECONT="N" HEIGHT="30">)</TD>
<TU ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" AUNIT="WON2" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="620" BORDER="1">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="86" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">추정대상</TH>
<TH WIDTH="134" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">계정과목</TH>
<TH WIDTH="134" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">예측치</TH>
<TH WIDTH="133" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">실적치</TH>
<TH WIDTH="133" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">괴리율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ACODE="MGR_YEA1" ROWSPAN="3">2021년</TE>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">매출액</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_SAL1">0</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_SAL1">6,255</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_SAL1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">영업이익</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_BSP1">-17,225</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_BSP1">-6,870</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_BSP1">60</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">당기순이익</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_GEP1">-17,079</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_GEP1">-6,678</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_GEP1">61</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ACODE="MGR_YEA2" ROWSPAN="3">2022년</TE>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">매출액</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_SAL2">16,128</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_SAL2">    3,583</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_SAL2">78</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">영업이익</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_BSP2">-3,032</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_BSP2">-11,982</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_BSP2">-295</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">당기순이익</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_GEP2">-2,784</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_GEP2">-11,406</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_GEP2">-310</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ACODE="MGR_YEA3" ROWSPAN="3">2023년</TE>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">매출액</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_SAL3">31,146</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_SAL3">-</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_SAL3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">영업이익</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_BSP3">2,837</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_BSP3">-</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_BSP3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">당기순이익</TD>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_PRD_GEP3">3,057</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_RET_GEP3">-</TE>
<TE WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="MGR_GAP_GEP3">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P>주1) 예측치는 상장시 증권신고서에 기재된 수치입니다. 주2) 2021년 10월 떼아오픈이노베이션에 기술 이전한 CU06에 대하여 계약금(upfront)을 수령하여 예측치 대비 매출액이 발생하였습니다. 주3) 인력 증가 및 연구개발비 증가의 영향으로 영업비용이 증가하였습니다.</P>

<LIBRARY>
<P USERMARK=" B">사. 특례상장기업 관리종목 지정유예 현황 </P>

<TABLE-GROUP ACLASS="SPE_MAG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="814" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="508"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="MIDDLE" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="517" HEIGHT="30" AUNIT="WONPERCENT2" AUNITVALUE="3">(단위 : 백만원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="814" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="154"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="159"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">관리종목 지정요건</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="347" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">요건별 회사 현황</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">관리종목지정요건해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="233" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">관리종목지정유예</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">항목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액/비율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종료시점</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="53" VALIGN="MIDDLE" AUPDATECONT="N">최근 사업연도말매출액 30억원 미만</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="53" VALIGN="MIDDLE" AUPDATECONT="N">최근 사업연도말 매출액(별도)</TD>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="53" ACODE="SPE_LAT_YER" VALIGN="MIDDLE">2022년</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="53" ACODE="SPE_LAT_AMO" VALIGN="MIDDLE">3,582</TE>
<TU ALIGN="CENTER" WIDTH="71" HEIGHT="53" AUNIT="SPE_LAT_ISYN" AUNITVALUE="Y" VALIGN="MIDDLE">해당</TU>
<TU ALIGN="CENTER" WIDTH="65" HEIGHT="53" AUNIT="SPE_LAT_OFF_YN" AUNITVALUE="Y" VALIGN="MIDDLE">해당</TU>
<TU ALIGN="CENTER" WIDTH="168" HEIGHT="53" AUNIT="SPE_LAT_OFF" AUNITVALUE="20251231" VALIGN="MIDDLE">2025년 12월 31일</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="120" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="4">최근 4사업연도 연속 영업손실 발생</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="120" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="4">최근 4사업연도 각 영업손익(별도)</TD>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="30" ACODE="SPE_FOR_YER1" VALIGN="MIDDLE">2022년</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SPE_FOR_AMO1" VALIGN="MIDDLE">-11,982</TE>
<TU ALIGN="CENTER" WIDTH="71" HEIGHT="120" AUNIT="SPE_FOR_ISYN" AUNITVALUE="Y" VALIGN="MIDDLE" ROWSPAN="4">해당</TU>
<TU ALIGN="CENTER" WIDTH="65" HEIGHT="120" AUNIT="SPE_FOR_OFF_YN" AUNITVALUE="Y" VALIGN="MIDDLE" ROWSPAN="4">해당</TU>
<TU ALIGN="CENTER" WIDTH="168" HEIGHT="120" AUNIT="SPE_FOR_OFF" AUNITVALUE="-" VALIGN="MIDDLE" ROWSPAN="4">-</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="30" ACODE="SPE_FOR_YER2" VALIGN="MIDDLE">2021년</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SPE_FOR_AMO2" VALIGN="MIDDLE">-6,870</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="30" ACODE="SPE_FOR_YER3" VALIGN="MIDDLE">2020년</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SPE_FOR_AMO3" VALIGN="MIDDLE">-7,853</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="30" ACODE="SPE_FOR_YER4" VALIGN="MIDDLE">2019년</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SPE_FOR_AMO4" VALIGN="MIDDLE">-5,734</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="168" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="3">자기자본 50%이상(10억원 이상에 한함)의 법인세차감전계속사업손실이 최근 3년간 2회 이상 및 최근 사업연도 법인세차감전계속사업손실 발생</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="168" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="3">최근 3사업연도각 자기자본대비 법인세차감전계속사업손익비율(연결)</TD>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="30" ACODE="SPE_LOS_YER1" VALIGN="MIDDLE">2022년</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SPE_LOS_RT1" VALIGN="MIDDLE">-11,406</TE>
<TU ALIGN="CENTER" WIDTH="71" HEIGHT="168" AUNIT="SPE_LOS_ISYN" AUNITVALUE="Y" VALIGN="MIDDLE" ROWSPAN="3">해당</TU>
<TU ALIGN="CENTER" WIDTH="65" HEIGHT="168" AUNIT="SPE_LOS_OFF_YN" AUNITVALUE="Y" VALIGN="MIDDLE" ROWSPAN="3">해당</TU>
<TU ALIGN="CENTER" WIDTH="168" HEIGHT="168" AUNIT="SPE_LOS_OFF" AUNITVALUE="20231231" VALIGN="MIDDLE" ROWSPAN="3">2023년 12월 31일</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="30" ACODE="SPE_LOS_YER2" VALIGN="MIDDLE">2021년</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SPE_LOS_RT2" VALIGN="MIDDLE">-6,678</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="108" ACODE="SPE_LOS_YER3" VALIGN="MIDDLE">2020년</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="108" ACODE="SPE_LOS_RT3" VALIGN="MIDDLE">-28,610</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P>주1) 당사는 기술성장기업으로 2021년 07월 22일 코스닥 시장에 상장하였습니다. 주2) 매출액 요건의 경우, 신규상장일이 속하는 사업연도를 포함하는 연속하는 5개 사업연도(상장일부터 상장일이 속한 사엽연도의 말일까지의 기간이 3월미만인 경우에는 그 다음 사업연도)까지 지정 유예되며, 2026년부터 대상이 됩니다. 주3) 영업손실 요건은 유예기간 없이 적용 면제됩니다. 주4) 법인세비용차감전계속사업손실 요건은 신규상장일이 속하는 사업연도를 포함한 연속하는 3개 사업연도 동안 해당 요건을 적용받지 않게 됩니다. 2024년부터 해당 요건을 적용받게 될 예정입니다.</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_APPENDIX">XII. 상세표</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 연결대상 종속회사 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="I. 회사의 개요|ADX-001|NEF-001">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="SUB_CMPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="67"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상호</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">설립일</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주소</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주요사업</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">최근사업연도말자산총액</TH>
<TH WIDTH="82" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">지배관계 근거</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주요종속회사 여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CRP_NM">-</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EST_DT">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADR">-</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="M_IND">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="KEY_IND">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="RUL_REL">-</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="M_SUB_COM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CRP_NM">-</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EST_DT">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADR">-</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="M_IND">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="KEY_IND">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="RUL_REL">-</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="M_SUB_COM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CRP_NM">-</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EST_DT">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADR">-</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="M_IND">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="KEY_IND">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="RUL_REL">-</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="M_SUB_COM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 계열회사 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="IX. 계열회사 등에 관한 사항|ADX-002|NEF-002">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="AFF_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="262" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상장여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">회사수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기업명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">법인등록번호</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="60" AUPDATECONT="N">상장</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="60" ROWSPAN="2" ACODE="LST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACODE="LST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="LST_BNUM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACODE="LST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="LST_BNUM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="60" AUPDATECONT="N">비상장</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="60" ROWSPAN="2" ACODE="ULST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACODE="ULST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="ULST_BNUM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACODE="ULST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="ULST_BNUM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">3. 타법인출자 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="610" HEIGHT="30" AUPDATECONT="N">
<A REFNO="IX. 계열회사 등에 관한 사항|ADX-003|NEF-003">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="INV_PRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="880" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="426"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="213" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="435" HEIGHT="30" AUNIT="WONSTOCKPERCENT" AUNITVALUE="1">(단위 : 원, 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="881" BORDER="1">

<COLGROUP>
<COL WIDTH="53"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="52"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="35"></COL>
<COL WIDTH="50"></COL>
<COL WIDTH="31"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="47"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" WIDTH="62" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">법인명</TH>
<TH ROWSPAN="3" WIDTH="62" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">상장여부</TH>
<TH ROWSPAN="3" WIDTH="78" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득일자</TH>
<TH ROWSPAN="3" WIDTH="47" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">출자목적</TH>
<TH ROWSPAN="3" WIDTH="47" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득금액</TH>
<TH COLSPAN="3" WIDTH="167" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기초잔액</TH>
<TH COLSPAN="3" WIDTH="157" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">증가(감소)</TH>
<TH COLSPAN="3" WIDTH="143" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기말잔액</TH>
<TH COLSPAN="2" WIDTH="118" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">최근사업연도재무현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" WIDTH="55" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="61" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="51" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부가액</TH>
<TH COLSPAN="2" WIDTH="110" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">취득(처분)</TH>
<TH ROWSPAN="2" WIDTH="47" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">평가손익</TH>
<TH ROWSPAN="2" WIDTH="44" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="59" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="40" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부가액</TH>
<TH ROWSPAN="2" WIDTH="62" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">총자산</TH>
<TH ROWSPAN="2" WIDTH="56" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">당기순손익</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="55" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">수량</TH>
<TH WIDTH="55" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="62" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">-</TE>
<TU WIDTH="62" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="-">-</TU>
<TU WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="47" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">-</TE>
<TE WIDTH="61" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="44" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">-</TE>
<TE WIDTH="59" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">-</TE>
<TE WIDTH="40" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">-</TE>
<TE WIDTH="62" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">-</TE>
<TE WIDTH="56" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="62" ALIGN="CENTER" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_PRM">-</TE>
<TU WIDTH="62" ALIGN="CENTER" HEIGHT="31" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="-">-</TU>
<TU WIDTH="78" ALIGN="CENTER" HEIGHT="31" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="47" ALIGN="CENTER" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_OBJ">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_GTM">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_BTN">-</TE>
<TE WIDTH="61" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_BPR">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_BTM">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="44" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_LTN">-</TE>
<TE WIDTH="59" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_LPR">-</TE>
<TE WIDTH="40" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_LTM">-</TE>
<TE WIDTH="62" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_NTM">-</TE>
<TE WIDTH="56" ALIGN="RIGHT" HEIGHT="31" VALIGN="MIDDLE" ACODE="INV_TPM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="5" WIDTH="296" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE">합 계</TD>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTNT">-</TE>
<TE WIDTH="61" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPRT">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTMT">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTNT">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTMT">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPMT">-</TE>
<TE WIDTH="44" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTNT">-</TE>
<TE WIDTH="59" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPRT">-</TE>
<TE WIDTH="40" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTMT">-</TE>
<TE WIDTH="62" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTMT">-</TE>
<TE WIDTH="56" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPMT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="">4. 지적재산권 보유 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="II. 사업의 내용|ADX-1|NEF-1">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1306">

<COLGROUP>
<COL WIDTH="37"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="301"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="59"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="46" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">번호</TH>
<TH WIDTH="57" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="310" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내용</TH>
<TH WIDTH="199" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">출원인</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">권리자</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">출원</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">등록</TH>
<TH WIDTH="48" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">적용</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">출원국</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD ROWSPAN="5" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">특허권</TD>
<TD ROWSPAN="5" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">신규 혈관누출 차단제</TD>
<TD ROWSPAN="5" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">연세대 산학협력단 외 1곳</TD>
<TD ROWSPAN="5" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2012.04.26</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2014.11.18</TD>
<TD ROWSPAN="38" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="1140">CU06</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
<TD ROWSPAN="5" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">특허 양수도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2010.10.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.02.27</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2010.10.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.05.04</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유럽</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2010.10.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.02.18</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2010.10.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6</TD>
<TD ROWSPAN="3" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">특허권</TD>
<TD ROWSPAN="3" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">신규 혈관누출 차단제</TD>
<TD ROWSPAN="3" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">연세대 산학협력단</TD>
<TD ROWSPAN="3" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2011.12.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2014.01.10</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="3" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">특허 양수도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2012.12.28</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.05.31</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2012.12.28</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">9</TD>
<TD ROWSPAN="6" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">특허권</TD>
<TD ROWSPAN="6" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">면역항암 보조제</TD>
<TD ROWSPAN="6" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">연세대 산학협력단, ㈜큐라클</TD>
<TD ROWSPAN="6" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">연세대 산학협력단, ㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.04.23</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.09.20</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="6" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">공동 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.04.23</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.15</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.07</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유럽</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">13</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10.28</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15</TD>
<TD ROWSPAN="2" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">특허권</TD>
<TD ROWSPAN="2" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">지방간 질환의 예방 또는 치료를 위한 약학적 조성물</TD>
<TD ROWSPAN="2" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">연세대 산학협력단, ㈜큐라클</TD>
<TD ROWSPAN="2" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.07.03</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">공동 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">16</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.06.24</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">17</TD>
<TD ROWSPAN="7" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">특허권</TD>
<TD ROWSPAN="7" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">신규 혈관누출 차단제의 고수율 제조방법</TD>
<TD ROWSPAN="7" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">㈜큐라클</TD>
<TD ROWSPAN="7" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.12.13</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.06.12</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="7" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">단독 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">18</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.07.28</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">19</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.11.24</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.09.27</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">20</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.11.25</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">인도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">21</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.12.01</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유럽</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">22</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.12.01</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.08.02</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">23</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.12.10</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.08.05</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">24</TD>
<TD ROWSPAN="15" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">특허권</TD>
<TD ROWSPAN="15" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">혈관 누출 차단제 화합물의 신규 결정형</TD>
<TD ROWSPAN="15" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">㈜큐라클</TD>
<TD ROWSPAN="15" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.05.04</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.02.26</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="15" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">단독 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">25</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.10.05</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">26</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.04.22</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">아르헨티나</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">27</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.07.07</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">28</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.07.07</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유럽</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">29</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.07.05</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">인도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">30</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.07.23</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">31</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.07.20</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">32</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10.11</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">브라질</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">33</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10.06</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">캐나다</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">34</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">러시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">35</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10.05</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">호주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">36</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.11.12</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">멕시코</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">37</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.11.15</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사우디아라비아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">38</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.04.24</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이스라엘</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">39</TD>
<TD ROWSPAN="3" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">특허권</TD>
<TD ROWSPAN="3" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">디메틸푸마레이트를 유효성분으로 포함하는 신섬유증의 예방 또는 치료용 조성물</TD>
<TD ROWSPAN="3" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">경북대 산학협력단 외 1곳</TD>
<TD ROWSPAN="3" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2013.02.13</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2014.03.24</TD>
<TD ROWSPAN="23" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="706">CU01</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="3" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">특허 양수도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">40</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2013.02.20</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">41</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2013.02.20</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017.08.08</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">42</TD>
<TD ROWSPAN="17" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="510">특허권</TD>
<TD ROWSPAN="17" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="510">디메틸푸마르산염을 함유한 장용성 정제</TD>
<TD ROWSPAN="17" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="510">㈜큐라클</TD>
<TD ROWSPAN="17" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="510">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.05.21</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.12.24</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="17" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="510">단독 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">43</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.05.21</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">44</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.20</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">45</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유럽</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">46</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.28</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">47</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">48</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.22</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">인도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">49</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10.01</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.08.09</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">캐나다</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">50</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.16</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.10.04</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">브라질</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">51</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10.11</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.10.07</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">멕시코</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">52</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.11.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사우디아라비아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">53</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.10.20</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">필리핀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">54</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.23</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">태국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">55</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.09.10</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">베트남</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">56</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.12.07</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.10.20</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">호주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">57</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.12.23</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">인도네시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">58</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.12.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">러시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">59</TD>
<TD ROWSPAN="2" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">특허권</TD>
<TD ROWSPAN="2" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">모노메틸푸마레이트를 유효성분으로 포함하는 장기 섬유증의 예방 또는 치료용 약학적 조성물</TD>
<TD ROWSPAN="2" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">㈜큐라클</TD>
<TD ROWSPAN="2" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.11.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">단독 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">60</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">2021.08.25</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">61</TD>
<TD ROWSPAN="3" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">특허권</TD>
<TD ROWSPAN="3" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">특정 약동학적 매개변수를 나타내는 디메틸푸마레이트를 유효성분으로 함유한 약학적 조성물</TD>
<TD ROWSPAN="3" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">㈜큐라클</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.03.25</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="3" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">단독 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">62</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.03.24</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">　</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">63</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.08.10</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">　</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64</TD>
<TD ROWSPAN="9" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="332">특허권</TD>
<TD ROWSPAN="7" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">천연 혼합 추출물을 유효성분으로 함유하는 당뇨합병증 및 혈관부종 예방 또는 치료용 약학적 조성물</TD>
<TD ROWSPAN="7" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">한국한의학연구원</TD>
<TD ROWSPAN="7" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">한국한의학연구원</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.05.21</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.10.27</TD>
<TD ROWSPAN="9" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="332">CU03</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="7" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">전용 실시권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">65</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.05.21</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">66</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.05.21</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">67</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.05.21</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.01.13</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유럽</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">68</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.05.21</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">69</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.05.19</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">70</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.08.26</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.03.24</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">71</TD>
<TD ROWSPAN="2" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">계지 및 목단피 혼합추출물을 유효성분으로 함유한 정제 및 이의 특정 투여 용량에 의한 치료를 위한 조성물</TD>
<TD ROWSPAN="2" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">㈜큐라클</TD>
<TD ROWSPAN="2" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">-</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.12.30</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">단독출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="92">72</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="92">2021.12.30</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="92">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="92">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">73</TD>
<TD ROWSPAN="5" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">특허권</TD>
<TD ROWSPAN="5" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">신규한 트립토판 수산화효소 저해제 및 이를 포함하는 약학 조성물</TD>
<TD ROWSPAN="5" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">광주과학기술원 산학협력단, KAIST 산학협력단, 경북대 산학협력단,㈜큐라클</TD>
<TD ROWSPAN="5" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">광주과학기술원 산학협력단, KAIST 산학협력단, 경북대 산학협력단, ㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018.08.24</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.03.05</TD>
<TD ROWSPAN="5" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">CU02</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="5" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">공동 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">74</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018.08.24</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">75</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.02.24</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.08.09</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">76</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.03.24</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.07.20</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유럽</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">77</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.04.23</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.11.29</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">78</TD>
<TD ROWSPAN="2" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">특허권</TD>
<TD ROWSPAN="2" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">AMIGO2와 3-포스포이노시티드-의존 키나아제1의 결합억제용 데코이펩타이드</TD>
<TD ROWSPAN="2" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">㈜큐라클</TD>
<TD ROWSPAN="2" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.06.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017.09.21</TD>
<TD ROWSPAN="4" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136">CU05</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">특허 양수도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">79</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.06.28</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018.11.13</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">80</TD>
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특허권</TD>
<TD ROWSPAN="2" WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">신규한 카바졸 유도체 및 이를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물</TD>
<TD ROWSPAN="2" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">㈜큐라클, 가천대 산학협력단,  연세대 산학협력단 </TD>
<TD ROWSPAN="2" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">㈜큐라클, 가천대 산학협력단,  연세대 산학협력단</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.11.29</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="2" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">공동 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">81</TD>
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">특허권</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">2021.11.10</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">PCT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">82</TD>
<TD ROWSPAN="15" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">상표 특허</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Solvadys</TD>
<TD ROWSPAN="15" WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">㈜큐라클</TD>
<TD ROWSPAN="15" WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">㈜큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.11.04</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.02.08</TD>
<TD ROWSPAN="6" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">CU06</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
<TD ROWSPAN="15" WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">단독 출원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">83</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">솔바디스</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.11.04</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.02.01</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">84</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Healvasc</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.11.04</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.02.08</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">85</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">힐바스크</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.11.04</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.02.08</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">86</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Vesaegis</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.11.04</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.02.01</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">87</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">베세지스</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.11.04</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.02.08</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">88</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Dybnee</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD ROWSPAN="6" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">CU01</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">89</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">디브니</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">90</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Dnitier</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">91</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">디니티어</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">92</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Qunef</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">93</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">큐네프</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.01.27</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">94</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CURACLE</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.09.11</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.10.21</TD>
<TD ROWSPAN="3" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">기타</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">95</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">THE CURACLE</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.09.11</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.10.21</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">96</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">큐라클</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.09.11</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.10.21</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">자료: ㈜큐라클</P>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P>보고서 작성기준일 현재 해당사항이 없습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P></P>
<P>보고서 작성기준일 현재 해당사항이 없습니다.</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>